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Summary 
 
Genome stability is of upmost importance to life. DNA polymerases are essential for the 
duplication and maintenance of the genome but they cannot themselves begin synthesis 
of a DNA chain, and require the activity of specialised RNA polymerases called primases. 
In eukaryotic cells distinct enzymes catalyse these two essential processes. This thesis 
contains the characterisation of coiled-coil domain containing protein (CCDC)111, a 
previously uncharacterised protein conserved in a broad range of unicellular and 
multicellular eukaryotes including humans. CCDC111 is a member of the archaeao-
eukaroytic primase (AEP) superfamily and uniquely for a eukaryotic enzyme possesses 
both primase and polymerase activities, and was thus renamed PrimPol. The work in this 
thesis implicates PrimPol in the process of DNA damage tolerance, a universal 
mechanism by which cells complete genome duplication in spite of potentially lethal DNA 
damage. The first results chapters detail the essential role of a PrimPol homologue 
(TbPrimPol2) in the important protozoan pathogen Trypanosoma brucei. A combination 
of molecular, cell biology, and biochemical analyses indicate a role for TbPrimPol2 in the 
post-replication tolerance of endogenously occurring DNA damage using its trans-lesion 
DNA synthesis activity. The remaining results chapters characterise PrimPol in human 
cultured cells, and demonstrate that this enzyme is present in both the nucleus and 
mitochondria. In the nucleus PrimPol functions in the cellular tolerance of ultraviolet (UV)-
induced DNA damage, and is required to protect xeroderma pigmentosum variant (XP-V) 
cells, deficient in the UV lesion bypass polymerase Pol !, from the cytotoxic affects of 
UV radiation. Together, this thesis establishes the involvement of PrimPol in DNA 
damage tolerance from one of the earliest diverging eukaryotic organisms to man. 
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1. Introduction 
Genome stability is of upmost importance to life. DNA polymerases are essential for the 
duplication and maintenance of the genome but they cannot themselves begin synthesis 
of a DNA chain, and require the activity of specialised RNA polymerases called DNA 
primases. In eukaryotic cells distinct enzymes catalyse these two essential processes. 
This thesis contains the characterisation of a novel enzyme present in eukaryotic cells 
that is capable of both polymerase and primase activities, and aims to determine the role 
of this novel enzyme in human cells but also in an important protozoan pathogen. The 
introduction of this thesis will review our current understanding of DNA polymerases and 
DNA primases, the cellular processes of genome duplication and DNA damage tolerance 
of which DNA polymerases are central, and also introduce the African trypanosome and 
the novel primase-polymerase CCDC111.  
 
1.1. DNA Polymerases 
In 1956 an enzyme was discovered in Escherichia coli that could catalyse the accurate 
replication of deoxyribonucleic acid (DNA), and the name “DNA Polymerase” was coined 
(Kornberg et al., 1956; Lehman et al., 1958). Shortly after, an enzyme with identical 
activity was partially isolated from mammalian tissues (Bollum and Potter, 1958). Over 50 
years later, a plethora of DNA polymerases have been identified in all branches of life. 
These proteins are essential for genome duplication and are critical in protecting cells 
against the affects of DNA damage.  
 
1.1.1. Overview of eukaryotic DNA polymerases 
DNA polymerases are enzymes that synthesise DNA, and are required for all DNA 
synthetic processes that occur within a cell. The human genome encodes at least 15 
distinct DNA-dependant DNA polymerases (Figure 1.1). They can be broadly classified 
into four families based on their phylogenetic relationships with other DNA polymerases, 
the A-, B-, X-, and Y-families (Ito and Braithwaite, 1991 and 1993; Ohmori et al., 2001). 
The faithful duplication of the nuclear genome in eukaryotes is largely carried out by Pol 
alpha (α), delta (δ) and epsilon (ε), all B-family polymerases (reviewed in Garg and 
Burgers, 2005a), due of their phylogenetic relationship with Pol II from E. coli. The 
replication of the mitochondrial genome is carried out by Pol gamma (γ) (reviewed in 
Kaguni, 2004), an A-family polymerase, owing to its phylogenetic relationship to Pol I 
from E. coli. As the sole mitochondrial DNA polymerase, Pol γ is also required for DNA 
repair processes that occur within this essential organelle. The repair of the nuclear 
genome is largely performed by the X-family polymerases (reviewed in Uchiyama et al., 
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2009), Pol beta (β), lambda (λ), and mu (μ), classified due to their homology with human 
Pol β. These enzymes are dedicated to repairing single-base lesions and double-strand 
breaks in DNA. An X-family member exempt from the polymerase nomenclature is 
Terminal Transferase (TdT) that plays a role in immunoglobulin diversity. Despite the 
numerous DNA repair mechanisms present within a cell, some DNA damage will 
inevitably escape repair and be encountered by the DNA replication machinery, resulting 
in DNA replication stalling. One solution is provided in the form of the Y-family 
polymerases, eta (η), iota (ι), kappa (κ), and REV1 (reviewed in Sale et al., 2012), 
classified due to their homology with E. coli DinB. These specialised polymerases are 
capable of synthesising DNA opposite DNA lesions that would otherwise stall a 
replicative DNA polymerase, thus allowing completion of replication in the presence of 
DNA damage. The B-family polymerase Pol ζ is also required for this process (reviewed 
in Gan et al., 2008). In the nucleus there are also two A-family polymerases, theta (θ) and 
nu (ν), whose cellular roles remain unclear. 
 
1.1.2. Mechanism and structure of a DNA polymerase 
Our understanding of the chemistry of DNA synthesis originates from Arthur Kornberg’s 
and colleagues discovery of the first DNA polymerase in E. coli (now known as Pol I) 
(Kornberg et al., 1956; Lehman et al., 1958). The mechanism outlined in these seminal 
studies, detailed in Figure 1.2, has proven true for all DNA and RNA polymerases 
identified to date (Rothwell and Waksman, 2005). A DNA polymerase uses single-
stranded DNA as a template to assemble an exact complementary replica by successive 
polymerisation of four complementary deoxynucleotides. However, a universal feature of 
DNA polymerases is their inability to initiate DNA synthesis de novo, i.e. starting with the 
polymerisation of two deoxynucleotides. Rather, a DNA polymerase extends from the 3’ 
end of an already existing DNA or RNA chain (called a primer), synthesising DNA in a 5’ 
to 3’ direction. The mechanism of DNA synthesis is a repetitive cycle; first, the incoming 
deoxynucleotide 5’ triphosphate (dNTP) substrate is paired by hydrogen bonding to the 
complementary templated base. The polymerase then catalyses the nucleophillic attack 
of the 3’ hydroxyl group of the primer terminus on the α-phosphate group of the dNTP to 
be added. A phosphoryl transfer reaction occurs producing a phosphdiester bond that is 
the backbone of the DNA molecule. As with all enzymes that use dNTPs as substrates, 
metal ions are essential for catalysis, with magnesium ions (Mg2+) presumably used in 
vivo. Two of the 3 phosphates present on the dNTP are subsequently released as 
pyrophosphate (PPi), and the catalytic cycle begins again at the next templated base if 
necessary. 
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Understanding of the molecular basis of DNA synthesis began with the first DNA 
polymerase structure to be solved crystallographically. This was of the so-called Klenow 
fragment of E. coli DNA Polymerase I, which encompasses the polymerase and 
exonuclease domain (Klenow and Overgaard!Hansen, 1970). The structure of the DNA 
polymerase domain was likened to a human right hand, composed of a “palm”, “fingers”, 
and “thumb” sub-domains that together form a “U” shaped cleft  (Figure 1.3) (Ollis et al., 
1985). Despite the amino acid sequence diversity among DNA polymerases throughout all 
branches of life, the overall architecture of the active site proved to be similar for all DNA 
polymerase structures solved to date (Joyce and Steitz, 1994; Rothwell and Waksman, 
2005). The DNA molecule resides in the palm of the polymerase and is grasped by the 
fingers and thumb sub-domains (Figure 1.3c). The fingers sub-domain makes important 
interaction with the incoming dNTP substrate and the paired template base, and 
undergoes a conformational change at each nucleotide addition step. The palm sub-
domain contains the catalytic carboxylates required for phosphoryl transfer to create the 
phosphodieser bond to link the deoxynucleotides. Lastly, the thumb sub-domain 
interacts with and thereby positions the double-stranded DNA. Structural studies of DNA 
polymerases also delineated the importance of metal ions in catalysis. Phosphorly 
transfer is catalysed by a two-metal ion mechanism, first proposed by analogy to the 3’-
5’ exonuclease reaction (Beese and Steitz, 1991; Steitz 1993). Both metal ions are 
present in the active site; one interacts with the three phosphates of the incoming dNTP 
(metal ion B) whilst the second interacts with the hydroxyl group and the α-phosphate of 
the dNTP (metal ion A) (Figure 1.4). Both metal ions A and B stabilise the transition state 
of the enzyme. Metal ion A activates the hydroxyl group and facilitates the nucleophilic 
attack required for phosphoryl transfer, whilst metal ion B facilitates the leaving of PPi. 
 
1.1.3. Processivity and fidelity – important features of a DNA polymerase 
Processivity is an important attribute of a DNA polymerase, defined as the number of 
deoxynucleotides incorporated by the DNA polymerase into a DNA chain in a single 
binding event to the DNA template (Von Hippel et al., 1994; Bambara et al., 1995). This 
can vary substantially depending on the function of the DNA polymerase. For instance, 
the B-family polymerase Pol δ from Saccharomyces cerevisiae is able to polymerise over 
7000 deoxynucleotides in a single binding event to a DNA template in vitro (Burgers, 
1991). This high processivity is ideal for the timely duplication of the nuclear genome in 
eukaryotic cells. In contrast, the Y-family polymerase Pol η from S. cerevisiae, 
incorporates only 6 or 7 deoxynucleotides into a DNA chain in a single binding event in 
vitro (Washington et al., 1999). This low processivity, also referred to as distributive DNA 
synthesis, is ideal as this polymerase is required to synthesise DNA opposite DNA 
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lesions that only span a few deoxynucleotides of a DNA chain. Processivity of a DNA 
polymerase is largely determined by interactions between the thumb sub-domain of the 
polymerase and the primer-template DNA, illustrated by B-family polymerases having 
large thumb sub-domains whilst Y-family polymerases have stubby thumb sub-domains 
(Rothwell and Waksman, 2005; Sale et al, 2012). Additional proteins that interact with the 
DNA polymerase can also greatly influence the processivity of DNA synthesis through 
two different mechanisms (reviewed in Kelman et al., 1998). The first mechanism is 
exemplified by so-called sliding clamps, such as the eukaryotic Proliferating Cell Nuclear 
Antigen (PCNA), which encircles the DNA molecule and physically clamps the DNA 
polymerase to the template thereby preventing dissociation of the polymerase (Krishna 
et al., 1994). The second mechanism is through interaction of the DNA polymerase with a 
specific accessory subunit that results in increased fidelity, exemplified by the accessory 
subunit of the mitochondrial replicase Pol γ (Lim et al., 1999). 
 
Fidelity of DNA synthesis is also an important attribute of a DNA polymerase, and 
again, varies depending on the function of the polymerase. High fidelity DNA synthesis is 
extremely important as accurate duplication of DNA is essential for life, whilst low fidelity 
DNA synthesis is important for generating genetic diversity in the development of the 
immune system (reviewed in Weill and Reynaud, 2008). Polymerase fidelity is defined as 
the ratio of incorporation of the correct over incorrect nucleotide, which is determined 
largely by the efficiency of the polymerase to insert the correct nucleotide (Beard et al., 
2002). The fidelity of DNA replication in human cells is astonishingly high with a single 
error occurring for every 109-1010 bases replicated (Loeb, 1991), but this is only partly 
attributed to the accuracy of DNA polymerases, as post-replication mismatch repair 
improves the fidelity of DNA replication by several orders of magnitude (reviewed in 
Jiricny, 2006). High fidelity of DNA synthesis by a DNA polymerase is achieved by a 
number of mechanisms (reviewed in Kool, 2002). Watson-Crick hydrogen bonding only 
contributes in part to a DNA polymerases ability to select the correct over incorrect dNTP 
(Loeb et al., 1974), and it is in fact the active site geometry of the polymerase that is 
proposed to play large part in maintaining fidelity (Goodman, 1997). The active site of a 
DNA polymerase fits snugly around bases in a Watson-Crick pair, whilst mismatched 
bases result in steric clashes (Johnson and Beese, 2004). These clashes are predicted to 
reduce the binding affinity of the dNTP, affect the conformational change required to set 
up the active site geometry for catalysis, and reduce the rate of phosphodiester bond 
formation, thus making the selection of the correct dNTP much more favourable 
(McCulloch and Kunkel, 2008). To further increase the fidelity of DNA synthesis, some 
family-B DNA polymerases also contain a 3’-5’ exonuclease domain allowing 
! 6!
proofreading of newly synthesised DNA. In the event of polymerising a mismatched 
base, the subsequent extension is of lower efficiency and so is delayed, allowing the 
primer terminus to enter the exonuclease active site where the mismatched base is 
excised allowing the correct nucleotide to be incorporated (reviewed in Steitz, 1999). 
 
1.2. Genome Duplication 
The quintessential role of DNA polymerases is genome duplication. Complete and 
accurate DNA replication prior to cell division is essential for maintaining genome 
stability in all organisms. This process occurs during a defined period in the cell cycle, 
termed the DNA synthesis (S)-phase, and is highly regulated to ensure coordination with 
the cell cycle processes of mitosis and cytokinesis, in addition to coupling with DNA 
repair, chromatin re-assembly and retention of epigenetic markers, and transcription. It is 
the family-B polymerases α, δ, and ε that are central to DNA replication.  
 
1.2.1. Replication origins – where to build a replication fork 
A pioneering study by Huberman and Riggs in the 1960’s noted that the total 
chromosomal DNA in a mammalian cell was of a tremendous length, and in order to be 
replicated completely during a single S-phase, DNA replication must initiate from 
multiple sites throughout the genome (Figure 1.5) (Huberman and Riggs, 1966). They 
later referred to these sites as “origins” and found that they were between 15 and 300 
kilo bases apart (Huberman and Riggs, 1968). We now understand that the human 
genome contains an excess of origins (10,000 and 100,000), which have no sequence 
consensus, and only a subset are fired once per cell cycle, during S-phase, to allow 
complete genome duplication (reviewed in Me !chali, 2010). It is at origins that replication 
forks assemble, the structures by which cellular DNA is replicated, first visualised in E. 
coli (Cairns, 1963), and shortly after by Huberman and Riggs, with the latter initiating bi-
directional DNA synthesis (Huberman and Riggs, 1968). In order to assemble replication 
forks at an origin it must first be licensed (Figure 1.6), a process that occurs during late 
mitosis and G1 phase in which a pre-replication complex (pre-RC) assembles that can 
recruit the necessary components for the initiation of DNA replication. The first 
component of the pre-RC is the origin recognition complex (ORC) (Bell and Stillman, 
1992), which together with two other proteins (CDC6 and CDT1) loads the 
heterohexameric mini-chromosome maintenance (MCM) 2-7 complex, the core of the 
putative replicative DNA helicase. However the MCM helicase is loaded in its inactive 
form, and at the G1-S transition the activities of two cell cycle kinases facilitate the 
loading of replication proteins onto the pre-RC. These activate the MCM helicase and 
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thus allow unwinding of the duplex DNA at the origin and assembly of the replication fork 
(reviewed in Bell and Dutta, 2002). 
 
1.2.2. Initiation – biogenesis of a replication fork 
The general mechanism of chromosomal DNA replication in eukaryotes was first 
characterised by biochemical studies using the Simian Virus 40 (SV40) replication system 
with cell extracts and purified mammalian proteins (reviewed in Waga and Stillman, 
1998). Indeed, essential DNA replication components were originally identified in these 
studies, such as the heterotrimeric single-stranded DNA binding protein Replication 
Protein A (RPA) (Wobbe et al., 1987; Fairman and Stillman 1988; Wold and Kelly 1988) 
and the DNA polymerase clamp loading complex Replication Factor C (RFC) (Tsurimoto 
and Stillman, 1989). Similarly these studies uncovered the essential role of the DNA 
polymerase sliding clamp PCNA in replication (Prelich et al., 1987) and led to the original 
purification of human Pol δ (Melendey and Stillman, 1991).  
 
The first DNA polymerase activity required at the unwound origin is that of Pol α. 
In all eukaryotic organisms characterised to date, Pol α is a heterodimeric enzyme 
composed of a catalytic and accessory (B) subunit that exists associated to the 
heterodimeric DNA Primase, itself composed of a small catalytic (Prim1) and large 
accessory (Prim2) subunit (reviewed in Kaguni and Lehman, 1988). This complex, called 
Pol α-Prim, possesses the unique ability in eukaryotic cells of being able to initiate DNA 
synthesis de novo, due to the DNA-dependant RNA polymerase activity of DNA Primase 
(reviewed in Muzi-Falconi et al., 2003; Frick and Richardson, 2001; see section 1.6). 
Upon local unwinding of the duplex DNA at the origin, RPA first binds to and stabilises 
the single-stranded DNA (Figure 1.7). Pol α-Prim is then recruited to the single-stranded 
DNA and the primase component synthesises a short ~10 ribo-oligonucleotide molecule 
that provides the 3’ hydroxyl group required to start DNA synthesis by Pol α, which 
subsequently extends the RNA primer with a DNA chain of ~20 nucleotides (Matsumoto 
et al., 1990; Murakami et al., 1992). Owing to the anti-parallel nature of duplex DNA and 
that DNA polymerases synthesise DNA in a 5’ to 3’ direction, the two strands of DNA are 
synthesised in a different manner during chromosomal DNA replication, which was first 
proposed by Okazaki and colleagues (Sakabe and Okazaki, 1966; Okazaki et al., 1967). 
The leading strand is synthesised continuously (or at least largely), whilst the lagging 
strand is synthesised in a discontinuous manner via ~200 nucleotide so-called Okazaki 
fragments. On the leading strand, Pol α-Prim is required to initiate DNA synthesis at 
replication origins, whilst on the lagging strand, it is required to initiate synthesis of each 
Okazaki fragment. Following synthesis of the RNA-DNA primer a DNA polymerase switch 
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occurs, displacing Pol α-Prim and loading the replicative DNA polymerases required for 
bulk DNA synthesis (Figure 1.7). This switch is mediated by RFC-dependant loading of 
the homotrimeric polymerase clamp PCNA  (Tsurimoto and Stillman, 1991a and b), and 
marks the beginning of the elongation phase of DNA replication.  
 
1.2.3. Elongation – progression of the replication fork  
Using the cell-free SV40 replication system and purified mammalian proteins both 
leading and lagging strand synthesis were reconstituted in vitro (Tsurimoto et al., 1990; 
Waga and Stillman, 1994). However one caveat to this system was its requirement for 
only two DNA polymerases, Pol α and δ, whilst genetic studies in yeast demonstrated 
that a third B-family DNA polymerase, Pol ε, was also required for chromosomal DNA 
replication (Morrison et al., 1990). Studies from the Kunkel laboratory have largely solved 
this discrepancy using active site mutants of Pol δ and ε with normal rates of DNA 
synthesis but high error frequencies. They demonstrated in S. cerevisiae that Pol ε 
participates in leading strand synthesis (Pursell et al., 2007) and that Pol δ is responsible 
for the majority of lagging strand synthesis (Nick McElhinny et al, 2008). This division of 
labour at the replication fork, depicted in Figure 1.7b, was shown to be evolutionarily 
conserved in S. pombe also (Miyabe et al., 2011), and given the conservation of 
replication fork components from yeast to man (Errico and Costanzo, 2010), a similar 
division of labour would be expected at the human replication fork, although this is yet to 
be tested. One apparent area of controversy remaining is the extent of Pol ε-dependant 
DNA synthesis on the leading strand, with an alternate model existing in which Pol ε is 
required for only initial DNA synthesis on the leading strand, with Pol δ then taking over 
(reviewed in Pavlov and Shcherbakova, 2009). Pol δ and ε are both mulit-subunit 
enzymes of high processivity and with a 3’-5’ exonuclease proofreading activity ensuring 
high fidelity (reviewed in Kunkel and Burgers, 2008). On the lagging strand Pol δ 
synthesises each Okazaki fragment up until the RNA-DNA primer of the next Okazaki 
fragment, then the process of Okazaki fragment maturation occurs with the combined 
activities of the flap endonuclease FEN1 and DNA Ligase I (reviewed in Waga and 
Stillman, 1998; Burgers, 2009). On the leading strand, DNA synthesis is largely thought 
to be continuous in the absence of DNA damage, and so the leading strand polymerase 
will synthesise DNA until the replication fork converges with an adjacent replicon. The 
termination of DNA replication is less well understood than initiation and elongation. 
Evidence from SV40 and yeast studies indicate that sister chromatids become catanated 
at replication termination sites and require DNA topoisomerase II for resolution (DiNardo 
et al., 1984; Fields-Berry and DePamphilis et al., 1989; Sundin and Varshavsky, 1980; 
Cuvier et al., 2008). It has been suggested that, in contrast to DNA replication initiation, 
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DNA replication termination occurs randomly (Santamaria et al., 2000). However, a 
recent study in S. cerevisiae has shown that eukaryotic chromosomes do contain DNA 
replication termination regions, like in bacteria, and these regions contain replication fork 
pausing elements and mediate replication fork fusion (Fachinetti et al., 2010). 
 
1.3. Overview of DNA damage and repair 
DNA is subject to continuous damage within a cell, which if not repaired can have 
catastrophic consequences, particularly if encountered by the replication fork. Lesions 
within DNA arise from three main sources (Figure 1.8). Firstly, the DNA molecule has a 
limited chemical stability and as a result some of the chemical bonds within DNA have a 
tendency to spontaneously decay (reviewed in Lindahl, 1993). The spontaneous 
hydrolysis of the base-sugar bond in DNA results in the removal of the base residue 
whilst leaving the phosphodiester backbone intact, creating an abasic site, which can 
impede DNA replication. Additionally, hydrolytic deamination of the bases themselves 
can, for example, change a cytosine to a uracil, which will be misread by the replicative 
DNA polymerase creating a mutation. Secondly, (by)-products of normal cellular 
metabolism are an abundant source of DNA damage. Reactive oxygen species (ROS) 
such as superoxide anions, hydrogen peroxide, and hydroxyl radicals, created from 
oxidative phosphorylation in mitochondria, readily attack the DNA molecule (reviewed in 
Cadet et al., 2003). Perhaps the most abundant DNA lesion in the cell results from the 
oxidation of guanine to produce the miscoding 8-oxo-2’-deoxyguanosine (8-oxo-G) 
lesion. Thirdly, environmental agents pose a significant threat to the genome, such as the 
ultraviolet (UV) component of sunlight, ionising radiation (IR), and genotoxic agents. Of 
particular interest to this thesis are the DNA lesions resulting from exposure of cells to 
UV radiation, detailed in Figure 1.9. UV irradiation of DNA results in the formation of 
covalent adducts between adjacent pyrimidines on the same DNA strand, predominantly 
cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) pyrimidone photoproducts 
(reviewed in Rastogi et al., 2010). It is UV-C radiation (< 280 nm) that is predominantly 
used in the laboratory and causes these lesions, however UV-B radiation (280-315 nm), 
which terrestrial organisms are exposed to, can also induce formation of these 
photoproducts. These lesions are bulky and distort the DNA double helix (Figure 1.9b) 
and therefore significantly block DNA transactions, such as replication and transcription, 
and therefore can prove lethal (reviewed in Batista et al., 2009). 
 
 Given the importance of maintaining genome stability it is not surprising that a 
plethora of distinct DNA repair pathways exist within cells, shown in Figure 1.8. The first 
observation of a DNA repair mechanism was over 60 years ago when two independent 
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researchers serendipitously observed the biological effects of UV radiation could be 
reversed by illumination with visible light (Kelner, 1949; Dulbecco, 1949). This 
phenomenon is now known as photoreactivation, an example of direct DNA repair, in 
which a light-dependant enzyme (photolyase) performs a series of photochemical 
reactions to reverse the dimerisation of adjacent pyrimidines caused by UV irradiation. 
Over a decade later thymine dimers were identified as stable, naturally occurring DNA 
lesions in cells exposed to UV light (Setlow et al., 1963), and the monitoring of these 
lesions within cells and their subsequent removal led to the discovery of excision repair 
in bacteria (Setlow and Carrier, 1964; Boyce and Howard-Flanders, 1964) and 
mammalian cells (Rasmussen and Painter, 1964). Over half a century later we can now 
broadly divide DNA repair into 6 distinct pathways: direct repair, mismatch repair (MMR), 
base excision repair (BER), nucleotide excision repair (NER), nonhomologous end-joining 
(NHEJ), and homologous recombination (HR) (Figure 1.8). All of these pathways, with the 
exception of direct repair, require a DNA synthetic step, highlighting the crucial role of 
DNA polymerases in protecting cells against the effects of DNA damage. 
 
NER, BER, and MMR, all have a common general mechanism: first the damaged 
DNA is excised, a DNA polymerase then synthesises a replacement using the 
undamaged strand as a template, and finally the pieces are ligated together restoring the 
DNA double helix. NER is concerned with bulky, helix-distorting, DNA lesions that 
generally disrupt DNA transcription and replication, such as the UV-induced pyrimidine 
dimers (Figure 1.9). In humans NER requires at least 30 different proteins that are needed 
to make excisions either side of the damaged DNA, typically excising 30 nucleotides. 
The replicative polymerases δ and ε, along with the Y-family Pol κ, are then required for 
the DNA synthesis step (reviewed in Lehmann, 2011). Damaged bases that are not 
recognised by NER will be typically repaired by BER, which is concerned with small, 
single-base lesions, which do not distort the DNA helix but frequently miscode. The X-
family Pol β is a central player in BER. MMR is concerned with correcting the replication 
errors caused during DNA replication and it is the replicative polymerases that are 
involved. NHEJ and HR are both concerned with repairing DNA breaks that occur in both 
strands of the DNA molecule. NHEJ is predominantly used during G1 phase due to the 
lack of a sister chromatid, and is inherently an error-prone process, whilst HR is used 
when a sister chromatid is present following genome duplication and is inherently error-
free. The X-family polymerases are required for NHEJ, whilst the both B-family and Y-
family polymerases have been implicated in HR (Lange et al., 2011). 
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1.4. DNA damage tolerance 
Replication of the 6 billion nucleotides that constitute the human genome is a herculean 
task that is further complicated by the presence of DNA damage. DNA can become 
distorted and its bases modified by various environmental insults and endogenous 
processes, and if not corrected prior to replication, can result in the physical blockage of 
the replicative DNA polymerases. This is because the high fidelity of the replicative 
polymerases is not compatible with replicating damaged DNA. If not resolved, stalled 
replication forks pose a severe threat to genomic stability. The DNA lesion can no longer 
be repaired by BER or NER as the lesion is in single-stranded DNA. Reversal of the 
replication fork, thus placing the lesion in double-stranded DNA, has been shown in 
bacteria (Courcelle et al., 2003), but little evidence of this process exists in eukaryotes 
(Lopes et al., 2006). One solution that is present in all branches of life is DNA damage 
tolerance in which DNA replication proceeds in spite of the damaged DNA. DNA damage 
tolerance can be broadly divided into two pathways: error-free template switching and 
“error-prone” trans-lesion synthesis (TLS), which are both depicted in Figure 1.10.   
 
1.4.2. Discovery of DNA damage tolerance 
The study of DNA damage tolerance began with the seminal work of Rupp and Howard-
Flanders in 1968. They observed that in UV irradiated E. coli, which were deficient in the 
UV photoproduct repair pathway NER, DNA was synthesised with only a minimal delay, 
however the daughter strands were synthesised discontinuously. These discontinuities or 
gaps were of a size similar to the spacing of pyrimidine dimers within the template 
strand, suggesting they were present opposite the lesions, and these gaps were 
subsequently sealed (Rupp and Howard-Flanders, 1968; reviewed in Bridges, 2005). This 
phenomenon was termed “post-replication repair”, in reference to the repair of the post-
replication gaps rather than the repair of the UV photoproducts, and was later 
demonstrated in mammalian cells (Lehmann, 1972). Shortly after, post-replication repair 
became clinically relevant with the discovery of a defect in this process in a group of 
patients with xeroderma pigmentosum (XP) (Lehmann et al., 1975), an inherited disorder 
characterised by hypersensitivity of the skin to sunlight. Meanwhile genetic studies in 
budding yeast had identified numerous genes involved in the cellular response to UV 
radiation: the RAD genes (Cox and Parry, 1968) of which mutants were sensitive to UV 
and/or IR, and the REV genes (Lemontt, 1971) of which mutants had reduced UV-
induced mutagenesis; and it was these genes that were required for post-replication 
repair (DNA damage tolerance) in budding yeast (Di Caprio and Cox, 1981; Prakash, 
1981). These genes were subsequently classified as the RAD6 epitasis group, with both 
Rad6 and Rad18 being essential for damage tolerance, and could be divided into two 
!"#$%"
&'()*+,-'."
!"#$%$&'()*+,$)(
/0"
1" -.,//*0(1&)2(
3*4+)$5*0(1&)2(
12
/3"
6,789.*)(%.),'0(8,+(
:;-(
:*5+/,.*(%<$.#9(
:;-(
:*5+/,.*(%<$.#9(
=>+,%%(,.(.9*(1&)2(
?&%.4)*+/$#,@&'(A>+,%%(
B$87)*(CDCED(FG*)G$*<(&1(6HI(0,5,8*(.&/*),'#*(5*#9,'$%5%($'(*72,)>&@#(#*//%D(
#$%"4,56"765)'.5",86"869,)86("4:"6;+)5)'."869,)8"&6+<,.)5&5"=<,=">56"=<6">.(,&,?6("5=8,.("
,5","=6&97,=6"='"865='86"?6.6-+").=6?8)=:@"A=")5").6B)=,476"=<,="5'&6"#$%"765)'.5"C(69)+=6("'."
=<6" 76,().?" 5=8,.(" ,4'B6D"E)77" 65+,96" 869,)8" ,.(" 6.+'>.=68" =<6"#$%" 8697)+,-'." F'8G@" AF" =<)5"
765)'."9'565","47'+G"='"=<6"8697)+,-B6"#$%"9'7:&68,56")="E)77"5=,77"=<6"8697)+,-'."F'8GH",.(",5"
=<6"#$%"765)'.")5".'E"98656.=")."5).?76I5=8,.(6("#$%H")="+,.".'"7'.?68"46"86&'B6("4:"6;+)5)'."
869,)8@" #,&,?6" ='768,.+6" &6+<,.)5&5" C(69)+=6(" ,5" ," ?866." 7).6D" 6;)5=" ='" 'B68+'&6" =<)5"
98'476&H" 6)=<68" 4:" >5).?" J6;)476"#$%" 9'7:&68,565" +,9,476" 'F" >5).?" =<6" (,&,?6(" =6&97,=6"
C=8,.5I765)'."5:.=<65)5H"KL1D"'8">5).?"=<6"7,??).?I5=8,.(",5","#$%"=6&97,=6"C=6&97,=6"5E)=+<D"='"
'B68+'&6" =<6"47'+G6("98)&68" =68&).>5@"K<656"&6+<,.)5&5"+,."'++>8"()86+=7:",=" =<6" F'8G"'8"
9'5=I8697)+,-B67:@" A."=<6"+,56"'F"=<6" 7,M68H"47'+G,?6"'F"=<6" 76,().?"5=8,.("9'7:&68,56"+,>565"
>.+'>97).?" 'F" 76,().?" ,.(" 7,??).?" 5=8,.(" 5:.=<65)5" 98'(>+).?" 7'.?" =8,+=5" 'F" 5).?76I5=8,.(6("
#$%@"#$%"5:.=<65)5"+,."86I).)-,=6"('E.5=86,&"'F"=<6" 765)'."'."=<)5"5).?76I5=8,.(6("#$%"4:"
86I98)&).?H" 76,B).?" ," 5).?76I5=8,.(6(" ?,9" 6.+'&9,55).?" =<6" 765)'." )." =<6" (,>?<=68" 5=8,.(@"
N)=<68"KL1"'8"=6&97,=6"5E)=+<).?"+,."=<6."46">56("='"*77"=<)5"(,>?<=68"5=8,.("?,9",.("865='86"
=<6" 765)'." E)=<)." (>976;" #$%H" E<686" )=" +,." 46" 5,F67:" 869,)86(@" $'=6" =<,=" ," 765)'." '." =<6"
7,??).?I5=8,.("E'>7(" 865>7=" ).","(,>?<=68"5=8,.("?,9"(>6" ='"()5+'.-.>'>5"OG,P,G)" F8,?&6.="
5:.=<65)5@"
! 12!
sub-pathways: an error-free pathway including Rad5 and an ‘error-prone’ pathway with 
Rad30 and REV3. A number of the genes of the RAD6 epitasis group were found to be 
involved in protein ubiquitylation, such as Rad6, Rad18, and Rad5 (Jentsch et al., 1987; 
Bailly et al., 1997; Ulrich and Jentsch, 2000), and components of the replication 
machinery had been implicated in this pathway also, such as PCNA (Torres-Ramos et al., 
1996). These studies were unified with the key finding that the target of the ubiquitylation 
proteins was PCNA (Hoege et al., 2002). It also became apparent that the error-free 
pathway of the RAD6 epistasis group was template switching, whilst the ‘error-prone’ 
pathway was TLS. Rev3 and Rev7 were found to be the B-family Pol ζ (Nelson et al., 
1996a), and Rev1 was discovered to be a deoxycytidine monophosphate (dCMP) 
transferase (Nelson et al., 1996b). Rad30 was also a DNA polymerase, Pol η, and could 
accurately and efficiently bypass CPDs (Johnson et al., 1999a), and was found to be the 
gene mutated in XP-variant (XP-V) patients (Masutani et al., 1999b; Johnson et al., 
1999b). Further novel DNA polymerases were discovered in all branches of life and 
together these were classified as the Y-family polymerases (Ohmori et al., 2001). 
 
1.4.3. Y-family DNA polymerases and Pol ζ 
TLS is a universal mechanism by which cells tolerate DNA damage. It involves the direct 
replication of damaged DNA by specialised DNA polymerases thus allowing the 
completion of genome duplication despite the lack of a pristine DNA template. This can 
occur by the action of a single TLS polymerase, or the combined action of two, with one 
polymerase inserting opposite the lesion and second extending from the (mis)paired 
terminus, before the replicative polymerases resume (Figure 1.11). The most abundant 
group of TLS polymerases belong to the Y-family, which in higher eukaryotes consists of 
Pol η, ι, κ, and REV1. The B-family Pol ζ is also an important player in TLS. Additionally, 
various other specialised polymerases from the X-family and a number of novel A-family 
polymerases have been implicated in this process, but it is the Y-family polymerases that 
are uniquely adapted for TLS. 
 
1.4.3.1. Features of Y-family DNA polymerases 
The key feature of the Y-family DNA polymerases is their ability to replicate past 
damaged bases, and this is accompanied with low-processivity DNA synthesis and a 
reduced fidelity on undamaged DNA. Additionally, each Y-family polymerase, particularly 
those in eukaryotes, appears to be specialised to bypass particular DNA lesions. The first 
crystallographic structures solved of Y-family polymerases highlighted the features that 
enable these enzymes to catalyse TLS; they were of Pol η from S. cerevisiae (Trincao et 
al., 2001) shortly followed by the archaeal DinB homologue Dpo4, the latter in a ternary 
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complex with DNA and an incoming dNTP (Ling et al., 2001). Since then, all the Y-family 
polymerases in human cells have been co-crystallised with DNA: Pol ι (Nair et al., 2004), 
REV1 (Nair et al., 2005), Pol kappa (Lone et al., 2007), and Pol η during bypass of a CPD 
(Biertümpfel et al., 2010). As well as these structures documenting the unifying features 
of the Y-family polymerases, they also display the distinct (and sometimes unusual) ways 
in which each enzyme is adapted for TLS.  
 
There are several unifying features of the Y-family DNA polymerases. Despite 
possessing little sequence homology to other DNA polymerases, the catalytic domain of 
a Y-family polymerase still adopts the right hand topology. The fingers and thumb sub-
domains, although of different secondary structure, have the same location in the tertiary 
structure and their roles in interacting with the incoming dNTP and DNA are conserved, 
and the palm sub-domain still contains the catalytic carboxylate residues. However, 
unlike the replicative polymerases of the B- and A-families, the active site cleft of the Y-
family polymerases is much more spacious, thus allowing accommodation of bulky 
adducts on the templating base. Also in contrast to the replicative polymerases are the 
shorter and stubbier fingers and thumb sub-domains, making fewer contacts with the 
DNA and incoming nucleotide, which facilitates TLS but contributes to low fidelity and 
decreased processivity. In addition the Y-family polymerases lack a 3’-5’ exonuclease 
proofreading domain, which will further contribute to decreased fidelity. The Y-family 
polymerases also posses an additional sub-domain, referred to as a polymerase-
associated domain (PAD) (Trincao et al., 2001) or “little finger” (Ling et al., 2001), the 
latter in keeping with the human right hand nomenclature. Whilst in the replicative 
polymerases it is the finger sub-domain that is most mobile (closing with each nucleotide 
addition) in the Y-family polymerases it is the little finger sub-domain, which together 
with the thumb sub-domain grasps the DNA. The little finger sub-domain is the least 
conserved part among the Y-family polymerases catalytic domain, and has been 
implicated in the lesion specifity of each polymerase. This was demonstrated by 
swapping the little finger domains of two archeal DinB homologues (Dpo4 and Dbh) and 
observing that the enzymatic properties of the resulting chimeras were also swapped 
(Boudsocq et al., 2004).  
 
1.4.3.2. DNA polymerase η 
Pol η (also called Rad30A, XP-V) is perhaps the best-characterised polymerase of the Y-
family and has served as a model for the other members of this family. This is largely due 
to the clinical relevance of understanding Pol η, as mutations in the gene encoding this 
polymerase result in the disorder XP-V (Masutani et al., 1999b; Johnson et al., 1999b). 
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XP-V is an autosomal recessive disorder characterised by hypersensitivity of the skin to 
sunlight along with an increased risk of skin cancers (reviewed in Lehmann et al., 2011). 
Whilst the majority of XP disorders result from mutations in any of the seven key NER 
genes (XP-A to –G), required to repair UV light induced DNA lesions, XP-V results from 
an inability to efficiently replicate UV damaged DNA (Lehmann et al., 1975). This is 
consistent with the ability of Pol η to accurately bypass cis-syn cyclobutane thymine 
dimers (Johnson et al., 1999; Masutani et al., 1999a), the most common lesion generated 
by UV in DNA, which it does with a similar efficiency to replicating undamaged DNA 
(McCulloch et al., 2004). This suggests Pol η is largely responsible for the bypass of 
these lesions in vivo. The greater frequency of UV induced mutations and altered UV 
mutations spectrum of XP-V patients will result from other, less accurate, DNA 
polymerases performing TLS of CPDs. This has been suggested to be Pol ι (Dumstorf et 
al., 2006) along with Pol κ and ζ (Ziv et al., 2009) (Figure 1.11). The extent of Pol η’s 
specialisation to replicate past CPDs was recently demonstrated in a set of crystal 
structures (Silverstein et al., 2010; Biertümpfel et al., 2010). The active site of Pol η is 
large, capable of accommodating both thymines of the CPD, and the linked thymines are 
stabilised to allow correct pairing with adenine. As the CPD remains in duplex DNA, 
problems can arise following TLS of the dimer, as the CPD distorts the DNA making it 
possible for slippage of the polymerase to occur producing frameshift mutations. 
However, the little finger domain of Pol η acts as a molecular splint to stabilise the CPD 
containing DNA into normal B-form conformation. Additionally, to prevent the low-fidelity 
of Pol η (Matsuda et al., 2000) introducing mutations beyond the lesion, following 
replication of three bases, steric clashes occur with the DNA ensuring the dissociation of 
Pol η (Biertümpfel et al., 2010). 
 
Although Pol η is unable to bypass the other major UV DNA lesion, the 6-4 
photoproduct, stalling following incorporation of a single base opposite the 3’ T 
(Masutani et al., 2000; Johnson et al., 2001), Pol η can catalyse TLS of a number of other 
lesion in vitro (reviewed in Lehmann et al., 2002), although less efficiently than a CPD. For 
example Pol η can efficiently bypass an 8-oxo-G in vitro (Haracska et al., 2000; Zhang et 
al., 2000c), although this does not appear to be an in vivo function of this enzyme (Avkin 
and Levneh, 2002). Pol η can also catalyse TLS across a cisplatin adduct (Masutani et 
al., 2000) and XP-V cells are sensitive to cisplatin suggesting this could be an additional 
role of Pol η (Albertella et al., 2005). In addition to TLS of DNA lesions, Pol η has also 
been implicated in homologous recombination (McIlwraith et al., 2005), DNA replication 
during an unperturbed S-phase, possibly in the replication of chromosomal fragile sites 
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(Rey et al., 2009), gene hypermutation during development of the immune system (Zeng 
et al., 2001), and the repair of clustered oxidative damage (Zlatanou et al., 2012).  
 
1.4.3.3. DNA polymerase ι 
Pol ι (also called Rad30B) was identified as a paralogue of Pol η (McDonald et al., 1999), 
and is a highly distributive and low-fidelity polymerase (Tissier et al., 2000a). The extent 
of Pol ι’s participation in TLS of UV photoproducts is a debated topic (reviewed in Vidal 
and Woodgate, 2009); with regards to the CPD lesion some studies have reported that 
Pol ι is completely blocked (Johnson et al., 2000b; Zhang et al., 2000a), whilst other 
studies have reported incorporation opposite the 3’ T followed by limited complete 
bypass (Tissier et al., 2000b). With regards to the 6-4 photoproduct, Pol ι has been 
suggested to be involved in a two-step mechanism, by which it incorporates opposite 
the lesion and a second TLS polymerase, namely Pol ζ, extends from the mismatched 
terminus (Tissier et al., 2000b; Johnson et al., 2000b). Various studies have 
demonstrated that Pol ι is required for the bypass of a subset of UV-induced DNA 
lesions in vivo (Ohkumo et al., 2006; Dumstorf et al., 2006; Gueranger et al., 2008) with 
its role becoming more apparent with the lack of Pol η in XP-V cells (Ziv et al., 2009). 
 
Pol ι has a particularly intriguing feature in that it exhibits over a thousand-fold 
difference in fidelity depending on the templating base, with a modest fidelity opposite a 
templated adenine but a high error rate opposite a templated thymine (Zhang et al., 
2000a). The reason for this is due to residues in the finger domain of Pol ι that restricts 
the position of the templating base preventing a Watson-Crick pairing, instead promoting 
Hoogsteen base pairing, which uses alternative hydrogen bond donors/acceptors on the 
purine rings altering the geometry of the double helix (Nair et al., 2004). This feature 
enables Pol ι to correctly incorporate opposite the important oxidative lesion 8-oxo-G, 
as it restricts the geometry of the 8-oxo-G promoting the formation of the most stable 
and correct pair with dC (Kirouac et al., 2011). Pol ι has also been implicated in repair of 
oxidative lesions through the BER pathway. It was discovered that Pol ι has 5’-
deoxyribose phosphate (dRP)-lyase activity, which coupled with its polymerase activity 
and the addition of purified BER components, could successfully reconstitute in vitro 
BER of uracil containing DNA (Bebenek et al., 2001). Similarly, the activity of Pol ι has 
been shown to complement BER-deficient cell extracts lacking Pol β (Prasad et al., 
2003). A more recent study has further demonstrated Pol ι’s role in protecting cells 
against the effects of oxidative damage; showing that Pol ι knockdown cells are 
hypersensitive to oxidative damage coupled with a reduced BER activity, and that Pol ι 
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is recruited to sites of oxidative damage and interacts with X-ray repair cross-
complementing protein (XRCC)1, a scaffold for BER components. (Petta et al., 2008).  
 
1.4.3.4. DNA polymerase κ 
Pol κ (also called DinB) was identified by homology searching for eukaryotic homologues 
of the E. coli DinB gene (Ogi et al., 1999; Gerlach et al., 1999; Johnson et al., 2000a), 
which encodes the E. coli TLS polymerase Pol IV, and is the only Y-family polymerase 
conserved throughout all domains of life (Ohmuri et al., 2001). Like all Y-family 
polymerases it is a low-fidelity DNA polymerase, however it is the most accurate of its 
family (Johnson et al., 2000a). This is thought to be due to an additional feature of the Pol 
κ catalytic domain, an amino-terminal clasp (called N-clasp), which makes additional 
interactions with DNA allowing Pol κ to encircle the DNA molecule (Lone et al., 2007). In 
addition to the relatively restricted active site of Pol κ (in comparison to other Y-family 
members) this partly explains the differing TLS capabilities of this Y-family polymerase 
(Lone et al., 2007). Pol κ is unable to incorporate opposite UV photoproducts and 
incorporates with a low efficiency opposite a number of other lesions in vitro (Zhang et 
al., 2000b; Ohashi et al., 2000). However, it has been shown to be an efficient extender 
of mispaired termini (Washington et al., 2002; Haracska et al., 2002b), and this extender 
function of Pol κ is particularly apparent in XP-V cells (Ziv et al., 2009). A group of DNA 
lesions that Pol κ can efficiently bypass are those caused by polycyclic aromatic 
hydrocarbons, which are ubiquitous environmental carcinogens and are present in 
tobacco smoke (Phillips, 1983). One such example is benzo[a]pyrene-guanine, with 
bypass being demonstrated in vitro (Zhang et al., 2000b) and in vivo, confirming this is a 
cellular role of Pol κ (Ogi et al, 2002; Avkin et al., 2004). Pol κ has also been implicated in 
replicating structured DNA in vivo, which can also impede DNA replication (Bétous et al., 
2009) 
 
Despite Pol κ only having a possible minor role in the bypass of UV 
photoproducts in vivo, cells deficient in Pol κ are sensitive to UV light, and it was found 
that these cells actually had a deficiency in NER (Ogi and Lehmann, 2006). It was later 
demonstrated that Pol κ is required for the DNA synthetic step during NER, functioning in 
the same pathway as Pol δ and together accounting for half of NER activity (with the 
other half being Pol ε) (Ogi et al., 2010). It has been speculated that Pol κ is required for 
NER during times of low dNTP concentrations or when the DNA template contains 
difficult to replicate structures (Ogi et al., 2010; Lehmann, 2011). 
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1.4.3.5. REV1 
REV1 is the only member of the Y-family to escape the Greek letter nomenclature. This is 
because REV1 is not a DNA polymerase but a dCMP transferase, capable of 
incorporating dCMP opposite templated guanines (Nelson et al., 1996). REV1’s TLS 
capabilities are limited, being able to efficiently incorporate opposite bulky adducted 
guanines (Zhang et al., 2002) and abasic sites (Nelson et al., 1996). Bypass of abasic 
sites has been shown to be an in vivo function of REV1, as without the catalytic activity 
of REV1 the mutation spectrum is altered in vertebrate cells immunoglobulin gene 
hypermutation (Masuda et al., 2009; Ross and Sale, 2006; Jansen et al., 2006) and 
during bypass of endogenous abasic sites in yeast (Mudrak and Jinks-Robertson, 2011). 
The crystal structure of REV1 revealed how this enzyme is adapted for its cellular role. 
Rather than using Watson-Crick bonding to detect the correct pairing of the incoming 
dCMP and the templated dG, residues in the little finger of REV1 temporarily coordinate 
the templated dG and actually flip this base out, whilst the incoming dCMP hydrogen 
bonds with an arginine residue. The base flipping creates space to accommodate bulky 
guanine adducts and the hydrogen bonding to the incoming dCMP remove the need for 
a guanine base for correct incorporation (Nair et al., 2007). 
 
REV1, like the other REV genes, is required for UV-induced mutagenesis in yeast 
(Lemontt, 1971) and also humans (Gibbs et al., 2000). Although curiously, the catalytic 
activity of REV1 is not required for mutagenesis, as without catalytic activity the 
mutagenesis still occurs but the mutation spectrum is altered (Otsuka et al., 2005). This 
potential non-catalytic role of REV1 was first noted by Nelson and colleagues in yeast, as 
REV1 was essential for in vivo bypass of a 6-4 photoproduct yet could not insert a single 
nucleotide opposite the lesion in vitro (Nelson et al., 1996; Nelson et al., 2000). The 
carboxyl-terminus of REV1 interacts with all other Y-family polymerases and Pol ζ 
(Murakumo et al., 2001; Guo et al., 2003; Ohashi et al., 2004; Tissier et al., 2004) and the 
amino-terminus contains a BRCT (BRCA1 carboxyl-terminus) domain that is important 
for PCNA interaction and survival following exposure to UV light (Guo et al., 2006a). 
These studies of REV1 show the alternate role is mediated by protein-protein interaction 
and that REV1 acts as a binding platform for other TLS polymerases, playing an 
important regulatory role in TLS (discussed further below). Other reported roles for REV1 
include immunoglobulin gene somatic hypermutation as mentioned previously, the 
replication of G-quadruplex DNA (Sarkies et al., 2010), and HR (Sharma et al., 2012) 
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1.4.3.6. DNA polymerase ζ 
Pol ζ is a member of the B-family polymerases and was originally characterised as a 
heterodimer composed of a catalytic (Rev3 in yeast, Rev3L in higher eukaryotes) and 
accessory (Rev7) subunit (Nelson et al., 1996b). However recent studies in yeast have 
shown that Pol ζ consists of four subunits, sharing accessory subunits Pol31 and Pol32 
(p50 and p66 in humans) from the replicative Pol δ. These were demonstrated as 
essential subunits in yeast Pol ζ (Johnson et al., 2012) and another study suggests this 
also may be the case in human cells (Baranovskly et al., 2012). Our understanding of the 
in vitro TLS capabilities of Pol ζ come from experiments with the yeast enzyme, as an 
active form of mammalian Pol ζ (with REV3L being over 3000 amino acids) remains to be 
purified. Compared to the Y-family polymerases, the fidelity of DNA synthesis by Pol ζ is 
relatively high (Zhong et al., 2006), and more akin to that of Pol α (Thomas et al., 1991). 
Also like Pol α, Pol ζ does not contain a 3’-5’ exonuclease proofreading activity. Pol ζ 
can bypass a number of DNA lesions completely, such as a CPD (Nelson et al., 1996b) 
and thymine glycol (Johnson et al., 2003), but with a low efficiency. Rather, it is the 
extension of mispaired termini that Pol ζ appears to be specialised for. Pol ζ can extend 
from bases paired opposite a DNA lesion often with the same efficiency as if the base 
was paired with undamaged DNA, exemplified by extension from a CPD, 6-4 
photoproduct (Johnson et al., 2000a) and thymidine glycol (Johnson et al., 2003). This 
extension from lesions reflects an in vivo role of Pol ζ in mammalian cells, demonstrated 
for 6-4 photoproducts (Yoon et al., 2010a) and thymidine glycol (Yoon et al., 2010b). 
 
 One striking difference between Pol ζ and the Y-family polymerases is that 
disruption of the Pol ζ (REV3L) gene is embryonic lethal in mice, demonstrating an 
essential role in mammalian embryonic development (Wittschieben et al., 2000; Esposito 
et al., 2000; Bemark et al., 2000). Pol ζ is essential for normal cell proliferation in 
mammalian cells, with the bypass of endogenous oxidative damage being partly 
responsible (Lange et al., 2012). In yeast, Pol ζ has been demonstrated to be required for 
the post-replication damage tolerance of genomic rNTPs (Lazzaro et al., 2012) that are 
frequently misincorporated by the replicative DNA polymerases (Nick McElhinny et al., 
2010). This is known to be a plentiful source of endogenous DNA damage in mammalian 
cells (Reijns et al., 2012) and may also contribute to the essential function of Pol ζ. In 
addition to its roles in TLS, Pol ζ has been shown to participate in the repair of double-
strand breaks, along with REV1, via HR (Sharma et al., 2012). 
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1.4.4. The PCNA switchboard and the regulation of TLS 
The Y-family polymerases η, ι, κ, and REV1, are all nuclear proteins and localise to sites 
of active DNA replication during S-phase, called replication factories (Kannouche et al., 
2001, 2003; Tissier et al., 2004; Ogi et al., 2005). Although they are in close proximity to 
the replication fork their access to the primer terminus must be tightly regulated to 
ensure these low-fidelity polymerases are only used when required; and the post-
translational modification of the sliding clamp PCNA is central to this regulation (Figure 
1.12). Upon encountering a bulky DNA adduct (on the leading strand for example) the 
replicative DNA polymerase will stall due to an inability to catalyse DNA synthesis and 
the MCM helicase will continue to unwind duplex DNA. This functional uncoupling of the 
replicative helicase and polymerase produces long stretches of unwound primed single-
stranded DNA that will become coated with RPA (Byun et al, 2005). RPA-coated primed 
single-stranded DNA is the trigger for ubiquitination of PCNA (Change et al., 2006). RPA 
recruits and interacts with the ubiquitin-ligase (E3) Rad18, which together with its 
cognate ubiquitin-conjugator (E2) Rad6, mono-ubiquitinate PCNA on the conserved 
lysine-164 residue (Davies et al., 2008). It is this mono-ubiquitination that activates the 
so-called ‘error-prone’ TLS pathway (Stelter and Ulrich, 2003). Additionally, a second E2-
E3 pair, the E2 Ubc12-Mms2 and the E3 Rad5 (in yeast), use the mono-ubiquitination as 
a substrate for poly-ubiquitination via the lysine-63 linkage of ubiquitin (Davies et al., 
2008). In S. cerevisiae this activates the error-free template switching pathway (Stelter 
and Ulrich, 2003), however in mammalian cells it is more complex and so less well 
understood. Although evidence of non-TLS damage tolerance, mediated by poly-
ubiquitinated PCNA (suggestive of template switching), does exist in mammalian cells 
(Chui et al., 2006), following treatment of cells with replication fork blocking agents it is 
mono-ubiquitantion of PCNA that is predominant (Kannouche et al., 2004; Chui et al., 
2006). Further, mammalian homologues of Rad5, SHPRH and HLTF, are both involved in 
the TLS pathway (Lin et al., 2011). Together these reports suggest it is TLS that is the 
dominant mechanism of DNA damage tolerance in human cells. 
 
A number of interactions between the Y-family DNA polymerases and PCNA 
mediate the switch from replicative to TLS polymerase. Pol η, ι, and κ, contain PCNA-
interacting protein (PIP) motifs at their extreme carboxyl-terminus that allow interaction 
with PCNA (Haracska et al., 2001a, 2001b, 2002a), and these have been shown to be 
partly responsible for the localisation of these polymerases at replication forks stalled at 
DNA lesions (Kannouche et al., 2001, 2003; Tissier et al., 2004; Vidal et al., 2004; Ogi et 
al., 2005). Additionally, the mono-ubiquitination of PCNA upon replication fork stalling 
increases affinity of the sliding clamp for the Y-family polymerases, which was 
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demonstrated initially for Pol η (Kannouche et al., 2004; Watanabe et al., 2004). All Y-
family polymerases contain ubiquitin-binding motifs (UBM), which in the case of Pol η 
and κ are zinc-fingers and so are called ubiquitin-binding zinc-fingers (UBZs). These 
promote the interaction of the Y-family polymerases with mono-ubiquitinated PCNA and 
are therefore critical to their role in DNA damage tolerance (Bienko et al., 2005; Plosky et 
al., 2006; Guo et al., 2006b, 2008). In addition to facilitating access of the TLS 
polymerase to the primer terminus, mono-ubiquitinated PCNA can also specifically 
increase the efficiency of these polymerases on damaged DNA. In vitro experiments have 
demonstrated that whilst mono-ubiquitination of PCNA does not change its properties as 
a processivity factor for Pol δ, ε, and even Pol η on undamaged DNA, the TLS efficiency 
of Pol η and REV1 were substantially increased on an abasic site containing template 
(Garg and Burgers, 2005b). Selection of the required TLS polymerase at the primer 
terminus remains an important question. However given the different bypass capabilities 
of the TLS polymerases it may be simply down to enzyme kinetics, i.e. whether or not the 
polymerase can catalyse DNA synthesis and then dissociate from the template. 
Responsible for removing ubiquitin from PCNA is the de-ubiquitination enzyme (DUB) 
ubiquitin specific protease 1 (USP1) (Huang et al., 2006). DUBs are cysteine proteases 
that specifically cleave ubiquitin conjugates (Amerik and Hochstrasser, 2004). USP1 
keeps the levels of ubiquitinated PCNA low in undamaged cells and undergoes an auto-
cleavage reaction following treatment of cells with UV radiation (Huang et al., 2006).  
 
This simple and elegant model of TLS regulation in eukaryotes, summarised in 
Figure 1.12, is not the complete picture however, as further investigations have revealed 
complexities. For instance many different proteins affect the ubiquitination of PCNA, 
such as the checkpoint kinase Chk1 (Yang et al., 2008), p21 and p53 (Avkin et al., 2006; 
Soria et al., 2006), and chromatin remodelers such as BAF180 (Niimi et al., 2012). Also, a 
recent study has shown that a subset of TLS in mammalian cells occurs independently of 
PCNA ubiquitination, and is instead partly mediated by protein-protein interactions with 
the Y-family polymerase REV1 (Hendel et al., 2011). Additionally, there are conflicting 
reports on the necessity of the ubiquitin-binding motifs of TLS polymerases. Reports 
have shown that the UBZ of Pol η is required for correct localisation following UV 
irradiation, complementation of the XP-V phenotype, and in vitro bypass of a CPD using 
cell extracts (Bienko et al., 2005; Plosky et al., 2006; Sabbioneda et al., 2009; Schmutz et 
al., 2010). However a number of studies from the Prakash laboratory suggest the UBZ of 
Pol η is dispensable for this enzymes function in both yeast and human cells. A recent 
study has attempted to clarify these discrepancies and concluded that both the PIP box 
and UBZ motif co-operate to retain Pol η at stalled replication forks, and whilst individual 
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mutation of each domain results in slight phenotypes, mutation of both renders cells with 
XP-V characteristics (Despras et al., 2012). In addition to the post-translational 
modifcation of PCNA playing an important regulatory role in TLS, the Y-family 
polymerases themselves are also targets for modification. Pol η is mono-ubiquitinated 
and this is suggested to promote intermolecular interactions with its UBZ (Bienko et al., 
2010) and also the UBM of Pol ι (McIntyre et al., 2012), thereby preventing unwanted 
interaction with PCNA. Pol η is also phosphorylated by the intra-S checkpoint kinase 
ATR, which has been demonstrated to be important for its crucial role in the bypass of 
UV photoproducts (Göhler et al., 2011). 
 
1.4.5. Fork-associated or post-replicative DNA damage tolerance? 
The timing of lesion bypass has been a long-standing question in the TLS field. More 
precisely, whether TLS is associated with chromosomal DNA replication or is separate, 
occurring after the replication fork has progressed (Figure 1.10) (reviewed in Lehmann 
and Fuchs, 2006). Early experiments suggested bypass occurred post-replicatively 
(Rupp and Howard-Flanders, 1968; Lehmann 1972) whilst since then models have 
focussed on bypass in situ at blocked forks. These models largely arose due to the semi-
discontinuous nature of DNA synthesis. A lesion on the lagging strand would be 
predicted not to block progression of the replication fork due to the discontinuous 
synthesis of this strand, as the re-initiation of a downstream Okazaki fragment would 
allow progression and a gap would be left behind. A lesion on the leading strand 
however, would be predicted to inhibit DNA synthesis to a greater extent owing to the 
continuous synthesis of this strand. This differing leading and lagging strand synthesis of 
damaged DNA has been observed in vitro (Svoboda and Vos, 1995). However, the initial 
report of DNA damage tolerance in E. coli by Rupp and Howard-Flanders clearly 
demonstrated that a DNA lesion does not block bulk DNA synthesis (Rupp and Howard-
Flanders, 1968). This would be consistent with discontinuous synthesis on the leading 
strand also. Upon the replication fork encountering a leading strand lesion and following 
uncoupling of the replicative helicase and polymerase, DNA synthesis would be re-
initiated downstream of the lesion leaving a single-stranded gap in the daughter strand. 
The mechanism of replication restart by re-priming has been elegantly demonstrated in 
bacteria in vitro (Heller and Marians, 2006; Yeeles and Marians, 2012), however this has 
not been clearly demonstrated in eukaryotes. A number of studies imply this process 
occurs (Lehmann, 1972; Jansen et al., 2009b; Elvers et al., 2011), and perhaps most 
convincingly, the single-stranded gaps produced by re-priming of damaged DNA have 
been visualised in vivo by electron microscopy in yeast (Lopez et al., 2006). Further 
studies in yeast have shown that DNA damage tolerance can occur separately from 
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chromosomal replication with no adverse effects (Daigaku et al., 2010; Karras et al., 
2010), whilst TLS in mammalian cells has been shown to occur in G2 phase as well as 
during S-phase, interestingly with a different mutational spectrum (Diamant et al., 2012).  
 
Fork-associated bypass and post-replicative bypass were first genetically 
distinguished in chicken cells. Mono-ubiquitination of PCNA was required for post-
replicative bypass and bypass at the fork required the Y-family polymerase REV1, 
specifically the carboxyl-terminus of REV1 that is known to interact with other Y-family 
polymerases (Edmunds et al., 2008). This genetic distinction, however, has not held true 
for mammalian cells. Although mono-ubiquitinated PCNA is involved in post-replicative 
bypass (Niimi et al., 2008), and evidence of an ‘early’ (fork-associated) and ‘late’ (post-
replicatve) TLS pathway has been shown in mammalian cells, REV1 and ubiquitination of 
PCNA were involved in both pathways (Jansen et al., 2006; Temviriyanukul et al., 2012). 
This shows that there are clearly differences in the regulation of TLS between 
eukaryotes. It is likely that the timing of damage bypass is dependant on a number of 
variables, including the location of the lesion (leading versus lagging) and the nature of 
the lesion (reviewed in Sale, 2012; Daigaku, 2012). It can be envisaged that if the DNA 
lesion on the leading strand is efficiently bypassed by TLS then perhaps it is bypassed 
quickly and directly at the fork, allowing continued progression of this fork. However if 
the lesion is bypassed inefficiently and therefore takes longer, the uncoupled helicase 
will progress further producing more single-stranded DNA on which re-priming could 
occur. This will produce a gap encompassing the lesion on the daughter strand that will 
be susbsequently filled by damage tolerance mechanisms behind the fork (Figure 1.10). 
 
1.5. The African Trypanosome - Trypanosoma brucei 
Trypanosoma brucei, the African trypanosome, along with the closely related 
Trypanosoma cruzi and the Leishmania’s, are protozoan parasites of significant medical 
importance. T. brucei is the causative agent of human African trypanosomasis, also 
called African sleeping-sickness, a typically fatal condition endemic in sub-Saharan 
Africa, whilst T. cruzi and the Leishmania’s and responsible for Chagas disease 
(American trypanosomasis) and Leshmania respectively. Together these pathogens 
affect more than 20 million people worldwide and cause approximately 110,000 deaths 
annually (World Health Organisation, 2008). These three unicellular microbes are 
members of the family Trypanosomatidae of the order Kinetoplastida, and are 
characterised by a single flagellum and a mitochondrion whose genome is arranged in a 
unique and complex catanated network termed a kinetoplast. In addition to their medical 
importance, trypanosomatids offer a unique evolutionary perspective as they are 
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amongst the earliest diverging organisms from the eukaryotic tree (Simpson et al., 2006). 
As a result, these morphologically rather simple organisms possess a number of features 
considered peculiar among eukaryotes, including polycistronic transcription of most their 
genome and trans-splicing of all mRNA transcripts (Martínez-Calvillo et al., 2010), the 
previously mentioned unique mitochondrial DNA architecture along with a complex 
method of mitochondrial RNA editing (Liu et al., 2005; Luke" et al., 2005), and the various 
mechanisms used by these parasites to escape their host’s immune system (Machado et 
al., 2006; Horn and McCulloch, 2010). 
 
1.5.1. African sleeping sickness 
T. brucei is an extracellular parasite and is spread among its mammalian hosts by the 
blood-feeding tsetse flies of the genus Glossina. The tsetse fly is restricted to the African 
continent from south of the Sahara to north of the Kalahari Desert, and thus confines the 
transmission of T. brucei and the distribution of the disease. Three morphologically 
identical sub-species of T. brucei exist; two infect humans, T. brucei gambiense and 
rhodesiense, and a third, T. brucei brucei, infects cattle causing Nagana (animal 
trypanosomaisis). T. brucei gambiense is largely in central and west Africa and results in 
a slow and chronic disease, whilst T. brucei rhodesiense is largely in east and southern 
Africa and results in a more acute disease. If untreated, human African trypanosomaisis 
in invariably fatal. The disease progresses in two distinct stages; first is the 
haemolymphatic phase in which the parasites invade the bloodstream and lymphatic 
system which results in fever, headaches, and swelling of the lymph nodes. Second is 
the neurological phase in which the parasites cross the blood-brain barrier and invade 
the central nervous system. This disrupts circadian rhythms leading to altered sleep 
patterns (giving rise to the name sleeping sickness) and eventually leads to coma and 
death (reviewed in Barrett et al., 2003; Brun et al., 2010). 
 
 To facilitate the cyclical transmission between its mammalian hosts and fly 
vector, T. brucei employs a complex life cycle with a number of distinct phases involving 
morphological, surface coat, and biochemical changes (reviewed in Matthews et al., 
2004). When in the tsetse salivary gland the trypanosomes are in their infectious non-
dividing metacyclic form, and when the infected tsetse fly bites, the trypanosomes are 
inoculated into the mammalian host. These trypanosomes then re-enter the cell cycle 
and become the morphologically long-slender form and begin to express the 
bloodstream-stage specific antigens, called variant surface glycoproteins (VSGs), which 
allow these parasites to evade the host’s immune system. When the parasite density 
becomes high the trypanosomes stop dividing and become the morphologically stumpy 
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form, which is pre-adapted for the tsetse fly environment but has a limited life span in the 
host’s bloodstream. This is thought to prevent the trypanosome infection killing the host 
and therefore increasing the probability of transmission. When a tsetse fly bites the 
infected host, the stumpy-form trypanosomes are ingested in the bloodmeal into the gut 
and again re-enter the cell-cycle and differentiate into the procyclic form, shedding their 
VSG coat for a procyclic surface antigen coat. The parasites then migrate to the salivary 
gland of the tsetse fly and eventually mature to the non-dividing metacyclic form. In the 
laboratory the non-human infective T. brucei brucei is commonly used in either its 
procyclic form or the pathogenic long-slender bloodstream-form, with the latter being 
exclusively used in this thesis. 
 
1.5.2. Organisation and replication of the nuclear genome 
In contrast to higher eukaryotes, our understanding of nuclear DNA metabolism in 
trypanosomes pales in comparison to its mitochondrial counterpart, particularly with 
respect to DNA replication. In a similar vain to the mitochondrial genome, the nuclear 
genome of trypanosomatids has a novel organisation. This was first observed using 
pulse-field gel electrophoresis (Van der Ploeg et al., 1984a and 1984b), as unlike other 
eukaryotes, the nuclear DNA of trypanosomatids does not condense during mitosis and 
thus prevents determination of the chromosomal karyotype by cytological methods. The 
nuclear chromosomes of T. brucei can be divided into three different classes based on 
their migration during pulse-field gel electrophoresis: the megabase chromosomes (1-6 
Mb), the intermediate chromosomes (200-900 kb), and the minichromosomes (30-150 
kb). The megabase chromosomes are diploid, with 11 pairs, and contain the majority of 
the protein-coding genes, whilst there are approximately 5 intermediate chromosomes 
and 100 minichromosomes, which are probably anueploid (El-Sayed et al., 2000; Daniels 
et al., 2010).  
 
The replication fork machinery responsible for duplicating the nuclear genome is 
largely thought to resemble the higher eukaryotic machinery, given that much of the 
components are conserved in trypanosomatid genomes (El-Sayed et al., 2005). However, 
there are a number of differences, particularly in the initiation of DNA replication. Analysis 
of the whole genome sequences of T. brucei (Berriman et al., 2005), T. cruzi (El-Sayed et 
al., 2005), and L. major (Ivens et al., 2005), collectively called the TriTryp’s, identified only 
a single ORC subunit rather than the six present in higher eukaryotic genomes, and 
additionally the ORC subunit had homology to CDC6, which is higher eukaryotes is a 
distinct protein. This led to the suggestion that initiation of DNA replication in 
trypanosomes could resemble the archaeal mechanism (El-Sayed et al., 2005), as 
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archaeal genomes encode a single ORC1-CDC6 protein (Kelman and Kelman, 2003). 
This was further suggested following initial characterisation of the T. brucei and T. cruzi 
ORC1-CDC6 protein (Godoy et al., 2009). However, subsequent studies have identified 
additional putative divergent ORC homologues, some of which are so divergent they 
could represent trypanosomatid innovations. It remains to be established whether the 
five potential ORC homologues form a complex as in higher eukaryotes but they do 
interact with each other, and knockdown of these proteins results in similar phenotypes 
that could be consistent with a role in DNA replication (Dang and Li, 2009; Tiengwe et al., 
2012a). Despite the divergence of the ORC proteins, the TriTryp genomes encode the six 
subunits of the MCM2-7 helicase complex (El-Sayed et al., 2005), which was 
demonstrated to form a heterohexamer as in higher eukaryotes (Tiengwe et al., 2012a). 
Similarly the MCM helicase complex interacts with some of the ORC homologues (Dang 
and Li, 2009; Tiengwe et al., 2012a) and forms an active DNA helicase when complexed 
with the trypanosome CDC45 and GINS complex (Dang and Li, 2009), as in higher 
eukaryotes. This suggests the divergence of trypanosomatid replication machinery may 
be restricted to the early steps of DNA replication initiation. It is notable that although the 
three replicative B-family DNA polymerases, α, δ, and ε, are present in the TriTryp 
genomes, homologues of the some of the accessory subunits for each of these 
polymerases were not identified (El-Sayed et al., 2005), suggesting these proteins have 
diverged significantly or perhaps the replicative polymerases in trypanosomatids exist as 
different complexes. The catalytic subunits of each these polymerases were identified as 
essential genes in a recent genome-wide RNAi screen (Alsford et al., 2010), which would 
be consistent with a role in DNA replication.  
 
 A recent study significantly advanced our current understanding of DNA 
replication in T. brucei, by mapping the replication origins in the 11 diploid megabase 
chromosomes through determining ORC1-CDC6 binding sites (Tiengwe et al. 2012b). 
This study revealed a striking co-ordination of DNA replication and transcription that is 
unprecedented in eukaryotes. The origins of replication were located to the boundaries 
of the transcribed domains, and further, ORC1-CDC6 binding to these locations helped 
define these transcription boundaries. The investigators speculated that this may be due 
to the novel arrangement of the protein-coding genes in T brucei, which are arranged in 
clusters that on average contain 50 or more genes that are constitutively transcribed in a 
polycistronic fashion, and subsequently regulated on a post-transcriptional level 
(reviewed in Daniels et al., 2010). Another striking observation from this study was the 
scarcity of replication origins required to completely replicate the 11 megabase 
chromosome pairs, being predicted as fewer than 100. It was also noted that, unlike 
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bacteria and other eukaryotes, there was several instances were DNA replcation and 
transcription were opposed, which is known to be a cause of genetic instability (reviewed 
in Bermejo et al., 2010). It is clear from these and other studies that although our 
understanding of DNA replication is advancing in these important human pathogens, 
there is much further work to be done. 
 
1.5.3. DNA repair and damage tolerance  
DNA repair is of particular relevance to trypanosomatids, given the hostile environment 
of their mammalian hosts in which these parasites proliferate. Additionally, both T. brucei 
and T. cruzi have co-opted DNA repair mechanisms, HR and MMR respectively, to 
create genetic diversity that is used to escape from their host’s immune system. The 
TriTryp genomes encode many key DNA repair proteins suggesting these parasites are 
capable of catalysing most repair mechanisms (El-Sayed et al., 2005), however there are 
differences. The trypanosomatid genomes encode enzymes capable of directly repairing 
oxidative and alkylation DNA damage, with the recent preliminary characterisation of a T. 
brucei AlkB homologue being reported, which showed this enzyme was capable of 
repairing alkylation damage as would be expected (Simmons et al., 2012). Components 
of the BER pathway are encoded in trypanosomatid genomes, however homologues of 
XRCC1 and DNA ligase III have not yet been identified, suggesting short-patch BER may 
not occur or is significantly diverged from higher eukaryotes. Interestingly, T. brucei 
contain two distinct Pol β enzymes that are both active polymerases and dRP-lyases, 
and strikingly localise to the mitochondrion (Saxowsky et al., 2003). These two enzymes 
have been further characterised in T. cruzi and are suggested to have complementary 
roles in BER of kinetoplast (k)DNA (Lopes et al., 2008; Schamber-Reis et al., 2012). This 
example of otherwise nuclear eukaryotic proteins that are mitochondrial in 
trypanosomatids is frequently observed, and underlines the importance of maintaining 
kDNA in these protists. It is possible that Pol β may also be nuclear, as the L. infantum 
enzyme is nuclear (Taladriz et al., 2001) and shares a high degree of similarity with both 
the T. brucei and T. cruzi enzymes. It is notable that Pol β was the only X-family 
polymerase identified in the trypanosomatid genomes (El-Sayed et al., 2005). The 
majority of NER components are present in trypanosomatid genomes, however the 
mechanism of repair may differ slightly due to the duplication of some genes and the 
lack of others, exemplified by XP-A, of which no homologue was identified (El-Sayed et 
al., 2005). Also, given the previously mentioned absence of XRCC1 and DNA ligase III 
homologues, the ligation step during NER may have diverged significantly. It has been 
suggested that given the constitutive polycictronic transcription of protein-coding genes 
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in trypanosomes, that transcription-coupled NER may have an important role (Passos-
Silva et al., 2010), although this is yet to be tested. 
 
The MMR pathway is of particular relevance to T. cruzi, as it is thought to be an 
important source of antigenic diversity found within T. cruzi populations (reviewed in 
Machado et al., 2006). In T. brucei characterisation of MMR components thus far is 
consistent with this repair process operating (Bell et al., 2004). However, unlike T. cruzi it 
does not contribute to antigenic diversity, but does appear to have a regulatory role in 
HR, as following disruption of MMR components an increase in HR was observed, and 
this was regardless of whether DNA molecules were perfectly matched or contained 
mismatches (Bell and McCulloch, 2003). Double-strand break repair operates in T. 
brucei, however NHEJ appears to be absent. The trypanosomatid genomes lack key 
components such as DNA Ligase IV, XRCC4, and the majority of X-family polymerases 
(El-Sayed et al., 2005). Although Ku is present, DNA end-joining is not dependent upon 
this protein and is instead mediated by micro-homology (Burton et al., 2007). Glover et 
al., (2008) demonstrated that HR and micro-homology mediated end-joining repair the 
majority of chromosomal breaks in T. brucei, and observed no evidence for the presence 
of NHEJ. Ku has been implicated in telomere maintenance in T. brucei (Conway et al., 
2002a). HR is particularly well characterised in T. brucei as these important pathogens 
use this DNA repair pathway in antigenic variation to escape their host’s immune system. 
When in the mammalian host, the VSG protein coat of the trypanosome shields surface 
antigens from the host immune response. VSGs are expressed from a single allele, and 
HR is used to relocate VSG genes from sub-telomeric repositories to the promoter 
containing expression sites. By switching the VSG expressed the trypanosome can 
successfully escape the host’s immune response (reviewed in Horn and McCulloch, 
2010). A key eukaryotic HR component studied in T. brucei is the Rad51 recombinase; 
inactivation of this enzyme in cells impairs both HR and VSG switching (McCulloch and 
Barry, 1999). Additionally, a Rad51-independent HR pathway exists that is capable of 
recombining DNA with very short lengths of sequence homology, and this pathway also 
contributes to antigenic variation (McCulloch and Barry, 1999; Conway et al., 2002b). A 
key regulator of Rad51 is BRCA2 (breast cancer type 2 susceptibility protein); in T. brucei 
BRCA2 has undergone an expansion of BRC repeats, which are the motifs that facilitate 
interaction with Rad51, and these have been shown to be important for efficiency of HR 
and Rad51 localisation (Hartley and McCulloch, 2008). A recent report has suggested a 
dual role for BRCA2, in which this protein is required to maintain the VSG reporitories at 
sub-telomeric regions, and facilitate the re-localisation of Rad51 following DNA damage 
(Trenaman et al., 2012).  
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DNA damage tolerance remains largely uncharacterised in trypanosomatids. 
Central players in the regulation of TLS are present in trypanosomatid genomes, such as 
Rad6 and PCNA, in addition to a number of TLS polymerases. Genes encoding REV1, 
REV3 and 7 (Pol ζ), Pol η, and Pol κ are present, however, the Pol η paralogue Pol ι was 
not identified (El-Sayed et al., 2005). Stikingly, the T. brucei genome actually encodes 10 
Pol κ’s (El-Sayed et al., 2005). Only Pol η and κ have been initially characterised in T. 
cruzi (De Moura et al., 2009; Rajão et al., 2009). Pol η was a nuclear enzyme and 
although its ability to bypass UV photoproducts may be conserved, the authors suggest 
that in T. cruzi this enzyme is important for the cellular response to oxidative damage (De 
Moura et al., 2009). Similar conclusions were made for Pol κ also, however the Pol κ 
characterised (there are two in T. cruzi) was a mitochondrial enzyme (Rajão et al., 2009) 
and subsequent unpublished data from these authors suggest that the other Pol κ is 
nuclear (Passos-Silvia et al., 2010). Given the scarcity of active replication origins in 
these parasites (Tiengwe et al., 2012b), they may be more reliant on DNA repair and 
particularly damage tolerance mechanisms than other eukaryotes, and further 
characterisation of components of these pathways will no doubt prove insightful. 
 
1.6. DNA Primases 
A universal feature of DNA polymerases is their inability to initiate DNA synthesis de 
novo. Early studies by Arthur Kornberg and colleagues made observations to this effect, 
noting that although they had seen DNA polymerases extend already existing DNA 
chains, they had no evidence of these enzymes beginning the synthesis of a new DNA 
chain (Goulian and Kornberg, 1967; Goulian et al., 1968). They later implicated RNA 
polymerases in the initiation of DNA replication (Brutlag et al., 1971), which would 
synthesise short RNA chains to prime DNA synthesis (Wickner et al., 1972). In support of 
this, short RNA chains were found linked to nascent DNA in E. coli (Sugino et al., 1972). 
Subsequent work has showed that cellular DNA replication is absolutely dependant upon 
specialised DNA-dependant RNA polymerases that are distinct from classical RNA 
polymerases, and these enzymes were named primases (Scherzinger et al., 1977; Rowen 
and Kornberg, 1978). 
 
1.6.1. Archaeal-eukaryotic primase (AEP) superfamily 
DNA primases can be broadly divided into two superfamilies, those of the prokaryotic 
DnaG-like superfamily and those of the archaeo-eukaryotic primase (AEP)-like 
superfamily. Although functionally related, these two families have no evolutionary 
relationship (Avarind et al., 1998; Iyer et al., 2005) and are structurally distinct (Keck et 
al., 2000; Augustin et al., 2001). DnaG-like primases are required for the initiation of DNA 
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replication in bacteria and their phages and are functional as monomers, although often 
associating with the replicative DNA helicases. Whilst AEP-like primases are essential for 
the initiation of DNA replication in eukaryotes and archaea, and are usually heterodimeric 
enzymes composed of a small catalytic subunit and a large accessory subunit. In 
eukaryotes the heterodimeric primase exists in a complex with Pol α (Figure 1.13a) 
(reviewed in Frick and Richardson, 2001). Members of the AEP superfamily share 
homology with the small catalytic subunit (Prim1) of the eukaryotic heterodimeric 
primase, and robust sequence alignment methods have expanded this family to include 
homologous primases in viruses and bacteria (Aravind and Koonin, 2001; Weller and 
Doherty, 2001; Iyer et al., 2005).  
 
1.6.2. Mechanism and structure of a DNA primase 
The mechanism(s) of DNA primases remain poorly understood compared to other 
polymerases. This is largely due to the lack of high resolution stuctures, particularly in a 
ternary or quaternary complex with DNA and/or NTPs. The best-studied primases are 
those of the prokaryotic DnaG-like superfamily, with structures existing of these enzymes 
bound to single-stranded DNA (Corn et al., 2006) and NTPs (Rymer et al., 2012), in 
addition to apo structures (Keck et al., 2000; Kato et al., 2003). However, as initially 
suggested based on sequence analysis (Leipe et al., 1999), the topoisomerase/primase 
(TOPRIM) catalytic fold of DnaG-like primases is structurally distinct from that used by 
AEPs, and this was evident with the solving of the first structure of an AEP (Augustin et 
al., 1999; reviewed in Keck and Berger, 2000) (Figure 1.13b), therefore the mechanism of 
catalysis may differ between these two superfamilies.  
 
Currently three structures exist of replicative AEPs: the initial apo (Augustin et al., 
1999), bound to uridine 5’-triphosphate (UTP) (Ito et al., 2003), and as a heterodimeric 
complex (Lao-Sireix et al., 2005). However these are all archaeal enzymes, with no high 
resolution structure of a eukaryotic primase being solved to date. What is evident from 
these structures is that AEPs have a unique structure, and this common AEP catalytic 
fold has been observed in structures of divergent AEP homologues also (Lipps et al., 
2004; Pitcher et al., 2007a). An extensive in silico analysis of the AEP superfamily by Iyer 
et al., (2005) has defined this shared catalytic core as consisting of two modules. The 
first is an amino-terminal (αβ)2 unit that has no equivalent structure in the PDB database, 
and the second is a carboxyl-teriminal unit that, like the A- B- and Y-family DNA 
polymerases, is a highly derived RNA recognition motif (RRM). Three sequence motifs 
are highy conserved among the AEP catalytic fold: motif I is hhhDhD (where ‘h’ is a 
hydrophobic residue), motif II is sxH (where ‘s’ is a small residue), and motif III is h- 
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(where ‘-‘ is an acidic residue). Various structural and site-directed mutagenesis studies 
of AEPs have shown that these three motifs are essential for catalysis, with residues in 
motif I and III being required for binding of a divalent metal ion and motif II required for 
nucleotide binding (Copeland and Tan, 1995; Augustin et al., 2001; Ito et al., 2003; Lao-
Sirieix and Bell, 2004). These catalytic motifs reside between the two modules of the AEP 
catalytic fold. Despite being a unique structure, the catalytic sites of AEPs and some 
DNA polymerases, namely the X-family Pol β, are super-imposable (Augustin et al., 
2000), which is consistent with the homology between AEPs and X-family polymerases 
first discovered by Kirk and Kuchta (1999). This architectural similarity, in addition to the 
requirement for divalent metal ions for catalysis, suggests that AEPs use the two-metal 
ion dependant mechanism for elongation, like DNA polymerases (Figure 1.4) (Steitz et al., 
1994). This is supported by a recent structure of a divergent bacterial AEP, the NHEJ 
polymerase PolDom, in which this AEP was crystallised bound to a DNA end, UTP, and 
two divalent metal ions, notably without a primer strand provding the 3’ hydroxyl group. 
The binding of both metal ions rendered the catalytic centre of this enzyme ready for 
phosphoryl transfer (Brissett et al., 2011). Interestingly, a two-metal ion dependant 
mechanism of catalysis has also been suggested for the structurally distinct bacterial 
DnaG primase (Rymer et al., 2012). However, for a complete understanding of AEPs, in 
particular eukaryotic AEPs and the mechanism of initiation, further high resolution 
structures are required.  
 
 There is a minimum of five discrete steps proposed for oligoribonucleotide 
synthesis by a DNA primase (reviewed in Frick and Richardson, 2001; Arezi and Kuchta, 
2000). First, the primase binds to a single-stranded DNA template, then, as primer 
synthesis does not occur randomly, the enzyme slides along the DNA until the initiation 
site is located. The eukaryotic primases require a minimal initiation sequence compared 
to their archaeal and bacterial counterparts, requiring a templated pyrimidine to code the 
5’ terminal nucleotide of the primer (Davey et al., 1990; Grosse and Krauss, 1985; Tseng 
and Ahlem, 1984). Once at the initiation sequence the primase sequentially binds two 
NTPs, with one proposed to bind the so-called initiation site and a second bind the 
active site (Frick et al., 1999). The initiation site binds the second NTP providing the 3’ 
hydroxyl to attack the α-phosphate of the first NTP that binds to the active site. Thus the 
first NTP bound becomes the second NTP of the primer (Sheaff and Kuchta, 1993). With 
a quaternary structure formed of enzyme-DNA-NTP-NTP, the primase catalyses 
dinucleotide formation. This occurs in the unorthodox direction of 3’-5’, and results in the 
release of an inorganic pyrophosphate (Sheaff and Kuchta, 1993). The primer is then 
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extended at the 3’ end with NTPs until hand-off to a DNA polymerase (e.g. Pol α), which 
utilises the 3’ hydroxyl group and subsequently extends with dNTPs. 
 
1.6.3. Eukaryotic AEPs – priming DNA replication 
The eukaryotic replicative DNA primase (Prim1) is conserved from the earliest diverging 
eukaryotes to man, and in all organisms examined thus far, has existed as a four-subunit 
complex with Pol α, and every subunit of this complex is essential for cell viability 
(Lucchini et al., 1987; Foiani et al., 1989; Sugino, 1995; Muzi-Falconi et al., 2003). This 
underlines the critical role of the Pol α-Prim complex in DNA replication, for the initiation 
of replication at origins and each Okazaki fragment (see section 1.2.2). Of the four-
subunit complex, the catalytic DNA primase Prim1 subunit is the smallest (50 kDa in 
humans), and is capable of primer synthesis on its own but is very unstable, requiring its 
accessory Prim2 subunit (p58) (Schneider et al., 1998). In addition to being required for 
efficient primer synthesis, the Prim2 subunit is also required for functional interaction 
with the catalytic Pol α subunit (Longhese et al., 1993). A recent study demonstrated an 
important role for Prim2 in loading the Pol α-Prim complex on RPA-coated single 
stranded DNA, through specific interactions between a highly conserved carboxyl-
terminal domain of Prim2 with RPA (Vaithiyalingam et al., 2010). The Prim2 subunit also 
contains a nuclear localisation signal that is required for the correct localisation of the 
catalytic subunit, through a so-called “piggy-back” mechanism (Mizuno et al., 1996). As 
would be expected for an essential enzyme, Pol α-Prim is under strict regulation 
(reviewed in Muzi-Falconi et al., 2003). The mammalian enzyme is phosphorylated in a 
cell cycle dependant manner (Nasheuer et al., 1991), and this has been shown to effect 
catalytic activity, with maximum activity observed when the B-subunit of Pol α is 
phosphorylated but the catalytic Pol α subunit is not (Schub et al., 2001).  
 
In addition to its central role in DNA replication, Pol α-Prim is also inherently 
important for the cellular response to DNA damage, as continued primer synthesis at 
stalled replication forks is critical for activation of the intra-S-checkpoint (Micheal et al., 
2000; MacDougall et al., 2007; Van et al., 2010). In addition it has been shown to be both 
necessary and sufficient for ubiquitinated-PCNA mediated DNA damage tolerance 
(Chang et al., 2006; reviewed in Chang and Kimprich 2009). Work in yeast using primase 
mutants suggested that Prim1 was involved in coupling DNA replication to the DNA 
damage response, through a pathway dependant upon the ATM and Chk2 kinases 
(Marini et al., 1997). The authors speculated that regulation of Pol α-Prim is required to 
prevent re-priming after replication-fork blocking lesions, thus slowing replication and 
providing time for repair (reviewed in Foiani et al., 1997). The chromatin remodeler 
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BAF180 was recently implicating in facilitating this re-priming in yeast and mammalian 
cells (Niimi et al., 2012). Despite numerous studies regarding re-priming in eukaryotic 
cells (discussed previously in section 1.4.5), no mechanistic demonstration has been 
reported to date. However, a mechanism for re-priming has been delineated using 
bacterial proteins. Heller and Marians (2006) demonstrated that when the 3’ hydroxyl 
group of the nascent leading strand is unavailable, a single replicative helicase (DnaB) 
complex is sufficient to co-ordinate DnaG-dependant priming downstream on both the 
leading and lagging strand. Subsequent work has shown this discontinous leading 
strand synthesis occurs on a plasmid containing a leading strand CPD in vitro, and that 
this process was not dependant upon a replication restart machinery but the DnaG 
primase, demonstrating it is an inherent feature of the bacterial replisome (Yeeles and 
Marians, 2011). 
 
In addition to the essential replicative DNA primase of the Pol α-Prim complex, 
two recent studies have identified novel AEPs present in trypanosomatid genomes, with 
the T. brucei homologues of these AEPs being initially characterised (Hines and Ray, 
2010 and 2011). These two enzymes were confusingly named Pri1 and Pri2 and both 
localised to the mitochondrion, and so will be referred in this thesis kinetoplast (k)Pri1 
and kPri2. Both were demonstrated to be active DNA primases in vitro, capable of de 
novo DNA-dependant RNA synthesis to produce RNA primers that could be 
subsequently extended by a DNA polymerase. kPri1 and kPri2 were both reported to be 
essential for cell growth, suggestive of a role in kDNA replication. The mitochondrial 
genome of T. brucei consists of a few thousand so-called minicircles (~1 kb) and a few 
dozen maxicircles (~23 kb), catenated into a chainmail like structure that in vivo forms a 
kDNA disk (reviewed in Liu et al., 2005). kPri1 was suggested to be primarily responsible 
for initiating DNA synthesis of the maxicircles, whilst kPri2 was suggested to be 
responsible for intiating minicircle DNA replication (Hines and Ray, 2010 and 2012).  
 
1.6.4. Archaeal AEPs – versatile primase-polymerases? 
The archaeal AEPs consisting of a small catalytic (PriS) and a large accessory (PriL) 
subunit, provide the only high resolution structures of replicative AEPs as discussed 
previously, and possess some novel activities (Figure 1.14). Initial studies of the 
replicative AEP from a Pyrococcus species demonstrated this enzyme was capable of 
initiating DNA synthesis with dNTPs and synthesising fragments up to 6 kilo bases in 
length, although it was incapable of generating RNA primers (Bocquier et al., 2001). 
However, a subsequent study showed that when this enzyme functioned as a 
heterodimer rather than a monomer, the length of DNA chains synthesised were greatly 
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reduced, and the enzyme was able to generate RNA primers (Liu et al., 2001). No such 
versatility of the eukaryotic primase has been reported to date. This activity was not 
restricted to the Pyrococcus enzyme as a Sulfolobus enzyme was also demonstrated to 
initiate DNA synthesis with both NTPs and dNTPs, and synthesise chains of up to 1 and 
7 kb respectively (Lao-Sirieix and Bell, 2004), suggesting this may be a conserved 
feature of archaeal AEPs. A question remains as to whether there is an in vivo function to 
initiating strand synthesis with dNTPs, and current data suggests against it: archaeal 
Okazaki fragments are known to contain a 5’ RNA chain (Matsunaga et al., 2003; Beattie 
and Bell, 2012) and the archeal enzymes have a much greater affinity for NTPs (Lao-
Sirieix and Bell, 2004). Another striking activity of these enzymes is there ability to 
catalyse terminal transferase (Lao-Sirieix and Bell, 2004; De Falco et al., 2004), providing 
yet another link between the family-X polymerases and AEPs. Additionally, a recent 
study suggested through in vitro experiments that the archaeal AEP can bridge non-
complementary DNA ends and facilitate repair of double-strand breaks (Hu et al., 2011), 
however no in vivo work has verified this model. 
 
 A novel AEP-like enzyme has been characterised in another Sulfolobus species 
encoded on the pRN1 plasmid. This is a multidomain protein with ATPase, primase, and 
polymerase activities (Lipps et al., 2003). The AEP-like domain of this enzyme, referred to 
as pRN1-PrimPol, is another example of the versatility of an AEP. Although only 
accepting dNTPs for elongation, this enzyme could initate DNA synthesis using a single 
NTP and extend with dNTPs, and further extend the subsequent RNA-DNA primer over 
several kilo bases (Beck and Lipps, 2007). The crystal structure of this enzyme confirmed 
its polymerase domain was a member of the AEP superfamily, and it shared significant 
structural similarity to other archaeal AEPs (Lipps et al., 2004) 
 
1.6.5. Bacterial AEPs – NHEJ polymerases 
One of the first hints of an alternate function for an AEP was the identification of AEP 
homologues in bacteria, as bacteria already contain a dedicated DnaG replicative 
primase. Notably, the AEP homologues were often part of a multidomain protein called 
Ligase D (LigD), consisting of putative DNA ligase and nuclease domains, encoded by a 
gene that was co-operonic with homologues of the eukaryotic Ku DNA repair protein 
(Koonin et al., 2000; Aravind and Koonin, 2001; Doherty et al., 2001; Weller and Doherty, 
2001). Ku is an essential component of the NHEJ double-strand break repair pathway in 
eukaryotes, required for recognition and synapsis of broken DNA ends and initiating the 
recruitment of repair enzymes (reviewed Brissett and Doherty, 2009). Given that co-
operonic genes in bacteria can often function in a common pathway (Dandekar et al., 
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1998), this inferred the existence of NHEJ in prokaryotes (Koonin et al., 2000; Aravind 
and Koonin, 2001; Doherty et al., 2001; Weller and Doherty, 2001). Shortly after, a 
physical and functional interaction between Ku and LigD in the repair of double-strand 
breaks was demonstrated (Weller et al., 2002), and further, it was demonstrated that just 
these two proteins comprise a minimal two-component NHEJ repair machine in bacteria 
(Della et al., 2004). This is largely due to the versatility of LigD, which provides the entire 
DNA end processing activities (polymerase, nuclease, and ligase) required to repair a 
break (Della et al., 2004). The AEP polymerase domain (PolDom) of LigD was 
demonstrated to be a particularly versatile polymerase, with this single domain being 
capable of catalysing a variety of nucleotidyl transferase activites (Figure 1.14). PolDom 
could perform template-dependant DNA/RNA polymerase and gap-filling activity, 
template-dependant RNA-priming activity, and template-independent terminal 
transferase activity on both single-stranded and blunt ended double-stranded DNA (Della 
et al., 2004; Pitcher et al., 2005, 2007a). Additionally, PolDom could perform error-free 
gap-filling opposite 8-oxo-G containing templates (Pitcher et al., 2007a). PolDom was 
also particularly specialised at recognising DNA breaks, with a major determinant being 
the 5’ phosphate moiety (Pitcher et al., 2007a), and has even been shown to mediate 
DNA end-synapsis using microhomology (Brissett et al., 2007). In summary, PolDom 
possesses all the DNA/RNA synthetic processes that could be required at a DNA break, 
which in eukaroytes is divided between three family-X DNA polymerases. A notable 
feature of PolDom was its marked preference of incorporating NTPs instead of dNTPs, 
which in vivo is suspected to be required when cellular pools of dNTPs are low, as in the 
case of stationary phase bacteria (Della et al., 2004; Pitcher et al., 2007a). Additionally, 
the bacterial LigD is co-opted by mycobacteriphage encoded Ku to facilitate the 
circularisation of their genome (Pitcher et al., 2006). Various structures exist of PolDom 
(Zhu et al., 2006; Pitcher et al., 2007a) confirming it is an AEP polymerase and is 
therefore the only AEP with a proven cellular role outside of DNA replication. 
 
1.7. PrimPol, a novel eukaryotic primase-polymerase 
The Doherty laboratory has a long-standing interest in AEP-like enzymes, demonstrated 
by the extensive characterisation of the bacterial NHEJ primase-polymerase PolDom, as 
detailed in the previous section (reviewed in Pitcher et al., 2007b; Brissett and Doherty, 
2009). The identification of a variety of novel AEPs in bacteria prompted the question of 
whether additional uncharacterised AEPs existed in eukaryotes. Iterative searching of the 
available eukaryotic genomes for genes with sequence homology to AEPs identified the 
human gene CCDC111 (alternate name FLJ33167), which is located on chromosome 4 
(4q35.1) and encodes coiled-coil domain containing protein (CCDC)111. This gene was 
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also identified by Iyer and colleagues to be a member of the AEP superfamily based on 
in silico analysis (referring to the protein an EukPrim2 for eukaryotic primase 2), 
specifically a member of the nucleo-cytoplasmic large DNA virus (NCLDV)-herpesvirus 
primase clade (Iyer et al., 2005), but to date has remained uncharacterised. Preliminary 
characterisation of CCDC111 in the Doherty lab and collaborators Luis Blanco’s 
(CBMSO, Madrid) demonstrated that the recombinant human protein was a versatile 
nucleotidyl transferase in vitro, capable of template-dependant primase and polymerase 
activities with both NTPs and dNTPs, resembling the catalytic activities of the versatile 
bacterial and archaeal AEP enzymes. Thus, in keeping with primase nomeculature, 
CCDC111 was renamed PrimPol (primase-polymerase) to reflect its intrinsic enzymatic 
activities. 
 
 As reported by Iyer and colleagues (2005), iterative BLAST searching with human 
PrimPol and putative homologues indicates PrimPol is present in a broad range of 
unicellular and multicellular eukaryotes including animals, plants, and protists, but is not 
present in prokaryotic and archaeal genomes. PrimPol is not conserved throughout all 
eukaryotes however, notably absent from Drosophila, Caenorhabditis elegans and all but 
one fungus, the parasitic Batrachochytrium dendrobatidis. Iyer and colleagues suggest 
that the unusual distribution of PrimPol homologues suggests that the gene for this 
protein was acquired early in eukaryotic evolution and then lost independently on 
multiple occasions in fungi and animals (Iyer et al., 2005). Alignment of putative PrimPol 
homologues reveals several conserved regions, principally divided into two domains; the 
first is a catalytic AEP domain towards the amino-terminus thus identifying PrimPol as a 
member of the AEP superfamily (Figure 1.15 and 1.16). The PrimPol AEP domain 
contains the three catalytic motifs conserved in all AEP-like enzymes (Figure 1.15) (see 
section 1.6.2) (Iyer et al., 2005). Motif I in PrimPol homologues has the consensus 
LYFDLE with invariant DxE residues, which is unusual among members of the AEP 
superfamily as motif I usually contains invariant DxD with the exception of the pRN1-
PrimPol (Lipps et al., 2003). Motif II in PrimPol homologues is an invariant SxH, and motif 
III is an invariant xD. Based on previous studies of AEPs (Copeland and Tan, 1995; 
Augustin et al., 2001; Ito et al., 2003; Lao-Sirieix and Bell, 2004) residues in motif I and III 
would be predicted to be required for binding of a divalent metal ions and motif II 
required for nucleotide binding. The second conserved region among PrimPol 
homologues is a carboxyl-terminal invariant CHC2 motif with homology to the human 
herpesvirus (HHV) UL52 primase (Figures 1.15 and 1.16), and is predicted to be a highly 
derived zinc-finger/ribbon (Iyer et al., 2005). Zinc binding domains are a common feature 
among primases and often play a number of critical roles in primer synthesis (reviewed in 
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Kutcha and Stengel, 2010). The zinc finger of the HHV UL52 primase has been 
implicated in DNA binding, primase activity, and for correct functioning of the 
heterotrimeric HHV helicase-primase complex (Biswas and Weller, 1999; Chen et al., 
2001). 
 
 The overall aim of this thesis was to determine the cellular role of PrimPol. Two 
approaches were used, the first was to characterise a PrimPol homologue in a relatively 
‘simple’ eukaryotic model organism using both cellular and biochemical methods 
(Chapters 3 and 4). The second approach was to characterise PrimPol in cultured human 
cells, to first determine its localisation within the cell (Chapter 5) and then build on this 
information, and other research from the Doherty laboratory, to uncover the specific 
function(s) of this novel polymerase in human cells (Chapter 6). Attempts were also made 
to identify interacting partners of human PrimPol, with the aim of shedding light on the 
cellular pathways it may operate in (Chapter 7). 
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Chapter 2 
 
Materials and Methods 
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All chemicals were purchased from Sigma Aldrich or Fisher Scientific unless stated. 
 
2.1. Preparation of plasmid DNA 
2.1.1. Preparation of competent E. coli DH5α 
The E. coli strain DH5α was used to prepare DNA plasmids. Three millilitres lysogeny 
broth (also called Luria-Bertani, LB) medium (1 % (w/v) tryptone, 0.5 % (w/v) yeast 
extract, 1 % (w/v) NaCl, pH 7) was inoculated with a single colony of DH5α and 
incubated overnight with shaking at 37 oC. The saturated culture was then diluted in 250 
ml super optimal broth (SOB) medium (2 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 10 
mM NaCl, 2.5 mM KCl, 10 mM MgSO4, 10 mM MgCl2) and incubated at 18 oC in a 
baffled flask with shaking until the optical density measured at 600 nm (OD600) was ~0.4. 
Following 10 minutes cooling on ice, cells were collected by centrifugation (4000 rpm, 10 
minutes, 4 oC), resuspended in 80 ml ice-cold transformation buffer (100 mM PIPES pH 
6.7, 15 mM CaCl2, 250 mM KCl, 55 mM MnCl2) and incubated on ice for a further 10 
minutes. Cells were again collected by centrifugation and gently resuspended in 20 ml 
ice-cold transformation buffer. Dimethyl sulfoxide (DMSO) was added to a final 
concentration of 7 % and following 10 minutes on ice, cells were divided into 50 – 200 μl 
aliquots and frozen in liquid nitrogen to be stored at -80 oC. 
 
2.1.2. Transformation of competent DH5α 
To 50 μl chemically competent DH5α (section 2.1.1), which had been thawed on ice, 
typically 1 μl plasmid DNA from a MiniPrep (~100 ng) (section 2.1.3) or 3-5 μl ligation 
reaction (section 2.1.4) was added. The cell and DNA mix was incubated on ice for 10 
minutes and then heat shocked at 42 oC for 1 minute before being incubated on ice for a 
further 15 minutes. To the mixture, 1 ml LB medium was added before incubation at 37 
oC with shaking for ~40 minutes. One hundred microliters was plated on LB agar plates 
(LB medium solidified with 1.5 % (w/v) agar) containing the appropriate antibiotics and 
incubated overnight at 37 oC to allow colonies to grow. Ampicillin was used at 100 μg/ml 
and kanamycin at 30 μg/ml final concentrations. 
 
2.1.3. Plasmid DNA amplification and purification 
Plasmid DNA was transformed into DH5α (section 2.1.2) and a single colony selected to 
inoculate 3 ml of LB medium containing the appropriate antibiotic (100 μg/ml ampicillin 
or 30 μg/ml kanamycin). Following overnight incubation at 37 oC with shaking, the DNA 
was prepared using the QIAprep Spin MiniPrep Kit (Qiagen) according to the 
manufacturer’s instructions and stored at -20 oC. Plasmid DNA was typically eluted in 50 
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μl providing a final concentration of 100 ng/μl. If a larger quantity of DNA was required, 
the 3 ml starter culture was incubated for ~8 hours before using 0.5-1 ml to inoculate 50-
100 ml LB medium with the appropriate antibiotic. Following an overnight incubation at 
37 oC with shaking, the DNA was prepared using the QIAfilter Plasmid Midi Kit (Qiagen) 
according to the manufacturer’s instructions. Plasmid DNA was typically eluted in 50 μl 
providing a final concentration of ~2-3 μg/μl. The yield was determined using a 
NanoDrop spectrophotometer (Thermo Scientific) and the DNA stored at -20oC. 
 
2.1.4. Agarose gel electrophoresis of DNA 
DNA was typically resolved on a 1 % (w/v) agarose TAE (0.4 M Tris-Acetate pH 8, 1 mM 
EDTA) gel containing ~0.3 μg/ml ethidium bromide and electrophoresed at 100 V for ~20 
minutes. Samples were loaded in DNA loading buffer (2.5 % (w/v) Ficoll 400, 11 mM 
EDTA, 3.3 mM Tris pH 8, 0.017 % (w/v) SDS, 0.015% (w/v) bromophenol blue), which 
was supplied in a 6x stock (New England Biolabs), and resolved alongside a 1 kb DNA 
ladder (New England Biolabs). DNA was visualised using a UV illuminator (Syngene 
InGenius Gel Documentation System) and images analysed using GeneSnap (Syngene).  
 
2.2. Molecular cloning 
2.2.1. Polymerase chain reaction 
Primers for the polymerase chain reaction (PCR) were designed typically to have a Tm of 
~55-65 oC, with the Tm difference being limited to 2-3 oC between primers, using the 
modified Breslauer's method (Breslauer et al, 1986) with the Finnzymes Tm calculator 
(Thermo Scientific). The PCR was performed using Phusion high-fidelity DNA polymerase 
(Thermo Scientific) according to the manufacturer’s instructions. Reactions of 50 μl were 
assembled in 0.2 ml tubes containing typically ~10 ng template plasmid or ~200 ng 
genomic DNA, 0.5 μM forward and reverse primers, and 1 U Phusion. In a Techne 
TC3000G thermo-cycler the reaction was initially denatured for 3 minutes at 98 oC before 
25 cycles of 98 oC for 15 seconds, annealing temperature for 15 seconds, and elongation 
at 72 oC, and a final elongation of 72 oC for 2 minutes. The annealing temperature was 
typically 3 oC above the Tm’s of the primers, and the elongation time was calculated 
according to the desired amplicon’s size, with the polymerase’s synthesis rate of 1 kb 
every 15-30 seconds. Optimisation of the PCR reaction often entailed trying a range of 
annealing temperatures and/or inclusion of DMSO or extra MgCl2 into the reaction. To 
determine whether the PCR was successful, 5 μl of the product was resolved by agarose 
gel electrophoresis (section 2.1.4). The remaining PCR product was purified using the 
QIAquick PCR purification kit (Qiagen) according to the manufacturer’s protocol. 
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2.2.2. Mutagenesis and inverse deletion PCR 
Primers were designed for site-directed mutagenesis using either the QuickChange 
protocol (from Stratagene), which uses a completely complementary primer pair 
containing the mutation, or a modified version of the QuickChange protocol from Zheng 
et al. (2004), in which partially overlapping primers are used. The latter protocol 
minimises primer dimerisation to ensure primer-template annealing is more favourable 
than primer-primer annealing during the PCR. Phusion high fidelity DNA polymerase 
(Thermo Scientific) was used for the reactions, with the contents of the reaction and the 
program being the same as previously described (section 2.2.2), except the final 
elongation at 72 oC was 10 minutes. Optimisation involved titration of template (0.1-100 
ng) and primers (0.2-2 μM) as well as inclusion of DMSO and MgCl2. If the primer Tm’s 
were above 72 oC then a two-step PCR was performed, in which the annealing step was 
omitted. As a control, a mutagenesis PCR reaction was setup omitting Phusion DNA 
polymerase. The successful PCR product (ideally visible when resolved by agarose gel 
electrophoresis), along with the ‘no phusion’ control, were subjected to the QIAquick 
PCR purification kit (Qiagen) and digested with an excess of 10-20 U DpnI (New England 
Biolabs) in a 30 μl reaction for ~3 hours at 37 oC. One microliter of the reaction products 
were transformed into DH5α and around a third of the transformation plated and 
incubated overnight at 37 oC. Colonies were screened by digest (section 2.2.3) if a 
restriction site was also inserted, or otherwise checked by sequencing (section 2.2.5). 
 
Inverse PCR requires a primer pair in a “back-to-back” orientation, being the 
opposite of a usual PCR. By having a phosphate present on the 5’ end of these primers, 
allowing ligation of these ends, this strategy can be used to remove sequences from a 
construct by having the primers flanking the area to be deleted (Ochman et al., 1988; 
Hemsley et al., 1999). Following the PCR reaction, the product was treated with DpnI and 
then an overnight ligation was set up at 12 oC using 100 ng PCR product and 1 μl (400 
U) T4 DNA Ligase (with a no DNA ligase control). The products were transformed into 
DH5α (section 2.1.2) and the subsequent colonies screened by restriction digest (2.2.3).  
 
2.2.3. Restriction digest 
When using restriction endonucleases in generating a construct, typically 20 μl of 
MiniPrep plasmid DNA (~2 μg) or 20 μl of purified PCR product were digested in a 40 μl 
reaction with an excess of ~20 U of the appropriate restriction enzyme(s) and reaction 
buffer (New England Biolabs). Following incubation at 37 oC for between 1 and 16 hours 
the digested plasmid or PCR product were purified using either the QIAquick PCR 
purification kit or first resolved by agarose gel electrophoresis (section 2.1.4) and purified 
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from an excised gel slice using the Geneclean II kit (Qbiogene Inc.), both according to 
manufacturer’s instructions. 
 
Restriction digestion was also used to screen clones when generating a 
construct. The sequence of the theoretical construct was analysed using the NEBcutter 
web tool (Vincze et al, 2003) and restriction enzyme(s) chosen to identify the correctly 
made construct. Digests were performed typically with 3 μl of miniprep plasmid DNA in a 
final volume of 10 μl with ~10 U restriction endonuclease. Half of the reaction was 
resolved by agarose gel electrophoresis (section 2.1.4) and compared to the digested 
parental plasmid DNA and the theoretical digest from NEBcutter, to determine if the 
clone was correct. 
 
2.2.4. Ligation 
T4 DNA Ligase (New England Biolabs) was used to ligate restriction digested plasmid 
DNA and PCR products when generating a construct. The concentration of the digested 
DNA was determined using a NanoDrop spectrophotometer (Thermo Scientific) and the 
ligation reaction was set up with an insert (I) to vector (V) ratio of 6:1 using the equation 
I(ng) = 6x [I(bp) /V(bp)] x V(ng). Two hundred units (0.5 μl) of T4 DNA Ligase was used, in a final 
volume of 20 μl with diluted T4 DNA Ligase buffer (New England Biolabs). The ligation 
was incubated at room temperature for 1 hour before 3-5 μl was transformed into DH5α 
(section 2.1.2), the remainder of the ligation was incubated at 12-16 oC overnight and 
transformed if required, otherwise stored at -20 oC. 
 
2.2.5. Sequencing 
Sequencing of plasmid DNA or PCR products was performed by GATC biotech using 
universal primers or gene specific primers (Tables 2.4, 2.6, 2.9, 2.11). The sequencing 
chromatogram was read using Chromas (Technelysium Pty. Ltd.) or 4Peaks (Mekentosj). 
 
2.3. Protein electrophoresis and Western blot analysis 
2.3.1. Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
Protein samples to be resolved by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) were prepared in Laemmli sample buffer (Laemmli, 1970) 
(final concentrations: 2 % (w/v) SDS, 10 % (v/v) beta-mercaptoethanol, 20 % (v/v) 
glycerol, 0.002 % (w/v) bromophenol blue, 0.125 M Tris pH 6.8). The XCell SureLock 
Mini-Cell Electrophoresis System (Invitrogen) was used for SDS-PAGE. Tris-glycine gels 
were prepared in either 1 or 1.5 mm Novex Gel Cassettes (Invitrogen) as described by 
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Sambrook and Russell (2001); a resolving gel consisted of 8-12 % 
acrylamide/bisacylamide 30 % (37.5:1) mix (National Diagnostics), 375 mM Tris pH 8.8, 
0.1 % (w/v) SDS, 0.1 % (w/v) ammonium persulphate (APS), 0.04 % (v/v) TEMED. 
Isopropanol and water were placed on top of the resolving mix when setting, and then 
removed and washed with water before addition of the stacking gel mix (5 % acylamide 
mix, 125 mM Tris pH 6.7, 0.1 % (w/v) SDS, 0.1 % (w/v) APS, 0.1 % (v/v) TEMED) and 
comb. Wells were washed with water and SDS running buffer (25 mM Tris, 250 mM 
glycine, 0.01 % (w/v) SDS) and samples loaded along with a molecular weight marker, 
Precision Plus (BioRad) or Precision Plus Dual Colour (BioRad) for Coomassie staining or 
Western blot analysis respectively. Electrophoresis was then performed at 150 V in SDS 
Running Buffer until the dye was running off the bottom of the gel. 
 
2.3.2. Coomassie blue staining 
Gels were stained with Coomassie blue solution (50 % (v/v) methanol, 10 % (v/v) acetic 
acid, 0.5 % (w/v) Coomassie blue) for ~10 minutes with rocking. Coomassie blue solution 
was removed and the gel washed briefly with water before addition of destaining solution 
(10 -20 % methanol, 10 % acetic acid). Gels were destained for 3-16 hours until 
sufficient decoloration, before removing the solution and replacing it  with water. For 
detection of nanogram levels of protein the Colloidal Blue Staining Kit (Invitrogen) was 
used according to the manufacturer’s instructions. Gels were dried using the GelAir 
Drying System (Biorad) following the manufacturer’s instructions. 
 
2.3.3. Western blot analysis 
All primary and secondary antibodies used in Western blot analysis are detailed in Tables 
2.1 and 2.2 respectively. Samples to be analysed by Western blot were first resolved by 
SDS-PAGE (section 2.3.2). The electrophoresed gel was washed with water and 
equilibrated in Transfer buffer (20 mM Tris, 50 mM glycine, 10 % (v/v) methanol) before 
transferring to polyvinyladine fluoride (PVDF) membrane (Millipore) previously activated 
with methanol. Transfer was performed using the XCell II Blot Module (Invitrogen) 
according to the manufacturer’s instructions. Proteins were transferred in transfer buffer 
at 25 V for 60-90 minutes, or 10 V for 10 hours. The membrane was then blocked with 
Tris buffered saline (TBS: 280 mM NaCl, 20 mM Tris) containing 0.05 % (v/v) Tween 20 
and 5 % (w/v) non-fat dried milk (Marvel) for at least 1 hour on a room temperature 
rocker. The primary antibody was then diluted in fresh blocking buffer and added to the 
membrane, typically 3 ml in a 50 ml Falcon tube containing the membrane, and 
incubated at 4 oC overnight on a roller. The membrane was then washed 3 times in TBS 
supplemented with 0.05 % (w/v) Tween 20 whilst the primary antibody and milk mix 
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could be stored at -20 oC for further use. Following washes, the secondary antibody 
which is conjugated to horse radish peroxidase (HRP) was added in blocking buffer and 
incubated on a room temperature rocker for ~1 hour. The membrane was then washed a 
further 3 times before chemiluminescent detection with Amersham ECL Western Blotting 
Detection Reagent (GE Healthcare) was performed according to the manufacturer’s 
instructions. Light emission was captured with autoradiography film (GE Healthcare) 
using a Xograph compact 4 automatic X-Ray film processor. 
 
2.3.4. Far-Western blot analysis of slot-blotted recombinant proteins 
This method was used to test for protein-protein interactions in vitro. A recombinant 
protein was first slot-blotted using a slot blot manifold (GE Healthcare) onto a methanol-
activated PVDF membrane according to the manufacturer’s instructions. Typically, 
increasing concentrations of recombinant protein (between 250 ng and 2 μg) were 
blotted onto the membrane. For far-Western analysis the membrane was first blocked as 
described previously for Western blot analysis (section 2.3.3), and then incubated with 
blocking buffer containing 0.1 μg/ml (typically 10 ml was used) of the candidate 
interacting recombinant protein. The membrane was then washed, probed with primary 
and secondary antibodies, and subjected to chemiluminescent detection as described 
previously (section 2.3.3). The primary antibody used would be specific for the candidate 
interacting recombinant protein, and chemiluminescence detected if interaction between 
the two proteins occurred. 
 
2.4. T. brucei methods 
All plasmid constructs and the primers used to generate stable T. brucei strains are 
detailed in Tables 2.3 and 2.4 respectively. 
 
2.4.1. Strains and maintenance 
Bloodstream-form T. brucei, Lister 427, MiTat 1.2, clone 221a, and the transgenic 
derivative 2T1-strain (Alsford and Horn, 2008) were maintained in Hirumi's modified 
Iscove's (HMI)-11 medium (Hirumi and Hirumi, 1994), which is the same as HMI-9 but 
lacks Serum plus. Cells were typically maintained in 36 ml medium in a 25 cm2 flask. 
Cells were split every day to a cell density of 1 x 105 cells/ml (counting on a 
haemocytometer) in fresh pre-warmed HMI-11 medium and incubated at 37 oC with 5 % 
CO2. For storage, 0.9 ml of culture (~1 x 106 cells/ml) was added to 100 μl of 100 % 
glycerol (giving 10 % final) in a cryotube, cooled to -80oC, and then placed in liquid 
nitrogen. 
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2.4.2. Stable transformation 
Stable transformation of T. brucei was performed as described by Alsford and Horn 
(2008). The constructs to be transfected were prepared by MidiPrep (Qiagen) (section 
2.1.3), linearised by restriction endonuclease digest (section 2.2.3), and then subjected to 
phenol-chloroform extraction. Approximately 2.5 x 107 cells were collected by 
centrifugation (1000 g, 10 minutes) and resuspended in ~25 ml cytomix (120 mM KCl, 
0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4 pH 7.6, 25 mM HEPES pH 7.6, 2 mM EGTA pH 
7.6, 5 mM MgCl2, 0.5 % glucose, 100 μg/ml BSA, 1 mM hypoxanthine) (adapted from 
van der Hoff et al, 1992). Cells were then centrifugated again and resuspended to ~6 x 
107 cells/ml in cytomix. Transfections were performed in duplicate, 0.4 ml of cell 
suspension was added to ~3 μg DNA which was mixed and electroporated (1.4 kV, 25 
μF; Gene Pulser II, BioRad) before addition of 36 ml HMI-11 medium. After 6 hours, 
selection antibiotics were added and cells divided into 12/24 well plates and clones 
allowed to grow over ~5 days. Antibiotic concentrations were as follows: blasticidine 10 
μg/ml, hygromycin 2.5 μg/ml, phleomycin 2 μg/ml, puromycin 2 μg/ml. Tetracycline was 
used for induction of dsRNA or recombinant protein expression at a concentration of 1 
μg/ml. 
 
2.4.3. Preparation of genomic DNA 
Genomic DNA was prepared from T. brucei using the DNeasy Blood and Tissue Kit 
(Qiagen). Cells from 10 ml of a mid-log phase culture (~1 x 106 cells/ml) were collected 
by centrifugation (1000g, 10 minutes) and washed in PBS before extraction of genomic 
DNA following the manufacturer’s protocol. 
 
2.4.4. Preparation of cell lysates 
Cells from 10 ml of a mid-log phase culture (~1 x 106 cells/ml) were collected by 
centrifugation (1000 g, 10 minutes), washed in PBS, and resuspended to a final 
concentration of 1 x 107 cells per 100 μl of Laemmli sample buffer. Lysates were 
incubated at 95 oC for 5 minutes and 10 μl resolved by SDS-PAGE (section 2.3.1), the 
remaining sample was stored at -20 oC. 
 
2.4.5. Immunofluorescence microscopy 
Cells from 1 ml of mid-log phase culture (~1 x 106 cells/ml) were collected by 
centrifugation (6000 g, 1 minute), washed in 1 ml PBS, and then resuspended gently in 
the remaining 50 μl PBS. To this, 50 μl of 4 % (v/v) formaldehyde in PBS was added to 
fix the cells in a final concentration of 2 % (v/v) formaldehyde, and was then stored at 4 
! 45!
oC for 1 hour to 7 days. The cells were washed twice with 1 ml ice cold PBS, once with 1 
% BSA in PBS, and finally resuspended in the remaining ~30 μl 1 % BSA. Around 5 μl 
was transferred to a well of a 12-well slide (MP Biomedicals) and allowed to dry 
overnight.  
 
Primary and secondary antibodies used in immunofluorescence analysis are 
detailed in Tables 2.1 and 2.2 respectively. For immunofluorescent staining the slides 
were first washed in PBS for 5 minutes in Coplin jars. Cells were permeabilised with 0.5 
% Triton X-100 in PBS for 15 minutes then washed with PBS. Excess PBS was removed 
from the slide and to the wells 50 % (v/v) foetal bovine serum (FBS) in PBS was added 
for at least 15 minutes to block non-specific binding of antibodies. The FBS was 
removed and the primary antibody diluted in 3 % (v/v) FBS in PBS was added and left for 
at least 45 minutes. Following 2 washes with PBS in the Coplin jar, excess PBS was 
removed and secondary antibody diluted in 3 % (v/v) FBS in PBS was added to the wells 
of the slide and incubated in the dark for 45 minutes, before washing as previous. The 
cells were counterstained with DAPI (final concentration 0.1 μg/ml) in Vectashield (Vector 
Laboratories Inc.) and a cover slip placed over the wells and sealed with nail varnish. 
Images were captured using a Nikon Eclipse E600 epifluorescence microscope (Nikon) in 
conjunction with a Coolsnap FX (Photometrics) charge-coupled device (CCD) camera 
and processed in Metamorph 5.0 (Photometrics). 
 
2.4.6. TUNEL staining 
Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) was performed 
to detect DNA strand breaks in T. brucei, using the Fluorescein In Situ Cell Death 
Detection Kit (Roche). Cells were fixed and mounted on microscope slides as described 
for immunofluorescence microscopy (section 2.4.5), and the TUNEL staining was 
performed according to the manufacturer’s instructions. Images were captured as 
described previously (section 2.4.5). 
 
2.4.7. Flow cytometry 
Cells from 1 ml of mid-log phase culture (~1 x 106 cells/ml) were collected by 
centrifugation (6000 g, 1 minute), washed in cold PBS, and resuspended in the remaining 
300 μl PBS. To this, 700 μl ice cold 100 % methanol was added (therefore fixing in 70 % 
methanol) and mixed by gently inversion before storing overnight at 4 oC. Fixed cells 
were collected by centrifugation (200 g, 10 minutes, 4 oC), washed in PBS, and 
resuspended in 1 ml PBS before transfer to a FACS tube (BD Biosciences) and addition 
of 10 μg/ml RNase A and 10 μg/ml propidium iodide (PI). The tube was shaken gently to 
! 46!
mix and incubated in the dark for 45 minutes at 37 oC. A FACScalibur (BD Biosciences) 
was used to analyse samples with CellQuest software and detector FL2-A with an Amp 
gain value of 1.75. Data analysis was carried out using FlowJo (Treestar). 
 
2.5. Preparation of recombinant proteins in E. coli 
Plasmid constructs used and generated in this thesis for the production of recombinant 
proteins in E. coli, and the primers used to make these constructs, are detailed in 
chapters 2.5 and 2.6 respectively 
 
2.5.1. Preparation of chemically competent B834s 
The E. coli strain B834 (DE3) pLysS (B834s) (Novagen) was used to over-express 
recombinant proteins used in this thesis. The TSS method (Chung et al, 1989) was used 
to produce competent cells, which requires no heat shock during transformation, an 
advantage given that cells containing pLysS are more susceptible to lysis. A fresh 
overnight culture of B834s was diluted 1:100 into LB medium and incubated at 37 oC 
with shaking until OD600 of 0.3-0.4. An equal volume of 2x transformation and storage 
solution (2x TSS; LB medium with 20 % PEG 3350, 10 % DMSO, 100 mM MgSO4, pH 
6.5) was added, mixed gently, and the mixture aliquoted and snap frozen before storage 
at -80oC. 
 
2.5.2. Transformation of competent B843s 
A 50 μl aliquot of competent B834s was thawed on ice and 1 μl of MiniPrep plasmid 
DNA (section 2.1.3) of the appropriate expression construct was added. Following a 15 
minutes incubation on ice, 1 ml LB medium was added and the cell DNA mixture 
incubated at 37 oC with shaking for at least 40 minutes. The cells were collected by 
centrifugation, resuspended in ~100 μl LB medium, and plated on LB agar plates 
containing 30 μg/ml chloramphenicol (for pLysS of B834s) and the antibiotic resistance 
of the expression construct. Colonies were allowed to grow overnight at 37 oC. Plates 
containing transformants were stored at 4 oC or for long term storage glycerol stocks 
were made. Briefly, 750 μl overnight culture was added to 250 μl sterile 60% % glycerol 
in a cyrotube and stored at -80 oC.  
 
2.5.3. Recombinant protein expression trials 
B834s transformed with the appropriate expression construct (section 2.5.2), either from 
a fresh single colony or a glycerol stock, was used to inoculate 50 ml of LB medium 
containing 30 μg/ml chloramphenicol and the antibiotic resistance present on the 
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expression construct. Following an overnight incubation at 37 oC with shaking, the 
culture was diluted 1:100 into fresh LB medium (~250 ml) containing the relevant 
antibiotics and grown at 37 oC until an OD600 of 0.6. The culture was then cooled on ice, 
a pre-induction sample taken (~1ml of cells spun down), and then divided between 
multiple flasks depending on induction conditions to be tested. Typically short inductions 
at 30 and 37 oC were tried, longer inductions were performed at 25 oC, and overnight 
inductions at 18 oC. If desired, at different time-points (every hour), the OD600 was 
measured, 1 ml of cells spun down and lysed in Laemmli sample buffer for whole cell 
extract, and a further 10 ml culture centrifugated for fractionation into soluble and 
insoluble samples (section 2.5.4). Expression was first tested on whole cell lysate, 
loading an equivalent to 0.15 OD600 equalling ~40 μg, and if expression visible, the 
proportion of soluble protein could be determined by processing the 10 ml pellet. 
Samples were analysed by SDS-PAGE and Coomassie staining, as well as detection of 
the epitope tag by Western blot (section 2.3). 
 
2.5.4. Protein expression and preparation of E. coli lysate  
For purification of recombinant proteins, first an overnight culture of B834s transformed 
with the appropriate expression construct was diluted 1:100 into fresh LB medium, 
typically 3 L divided into six 0.5 L cultures, containing the relevant antibiotics. The 
cultures were grown at 37 oC until the OD600 was 0.6-0.8 (~3-4 hours), then cooled 
rapidly on ice for 10 minutes before addition of Isopropyl !-D-1-thiogalactopyranoside 
(IPTG) and returned to the incubator for the desired amount of time. Cells were collected 
by centrifugation (5000 rpm, 10 minutes, 4 oC) and lysed into a small volume of buffer A 
(according to the chromatography column to be used) (10 ml per litre of culture) and 
stored at -80 oC. 
 
The cell lysate was thawed on ice and further diluted with buffer A, up to 30 ml 
per litre of culture grown, then placed on a stirrer on ice for ~30 minutes with the addition 
of 0.1 mg/ml lysozyme. The lysate was then sonicated (Vibra-Cell Sonicator) on ice, 4 
rounds of 20 second pulses at 30 % amplitude, resting for at least 1 minute in between 
pulses, before being cleared by centrifugation (18 000 rpm, 1 hour, 4 oC; Sorvall RC26 
Plus, SS-34 rotor). The soluble fraction was then passed through a 0.45 μm filter 
(Millipore) and kept on ice for subsequent chromatography analyses. 
 
2.5.5. Immobilised metal affinity chromatography 
Immobilised metal affinity chromatography (IMAC) was used to purify proteins fused to a 
histidine tag. Chromatographic columns were run using the ÄKTAprime system (GE 
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Healthcare), and all buffers and cell lysate were kept on ice. A column charged with 5 ml 
of nickel-nitrilotriacetic acid (Ni2+-NTA) agarose resin (Qiagen) was equilibrated in IMAC 
buffer A (10 % (v/v) glycerol, 0.5 M NaCl, 50 mM Tris pH 7.5, 5 mM β-mercaptoethanol, 
30 mM imidazole, 17 μg/ml PMSF, 34 μg/ml benzamidine) and then the soluble E. coli 
lysate was loaded onto the column at a flow rate of 2-3 ml/min. The column was washed 
extensively at 5 ml/min with IMAC buffer A until all the unbound proteins were removed, 
which was determined by the absorbance at 280 nm (A280) returning to background 
levels. The column was then washed with 10 % IMAC buffer B (same as buffer A except 
addition of 300 mM imidazole) and then bound proteins eluted at 2-3 ml/min with 100 % 
IMAC buffer B (300 mM imidazole). Samples were analysed by SDS-PAGE with 
Coomassie staining and anti-His Western blot analysis (section 2.3). 
 
2.5.6. Heparin affinity chromatography 
Heparin agarose is commonly used to purify DNA binding proteins as it is a phosphate 
mimetic. If the IMAC elution was to be further purified by heparin chromatography the 
elution was first diluted at least 10-fold to reduce the salt concentration, as this would 
prevent binding. The elution was diluted in heparin buffer A (10 % (v/v) glycerol, 50 mM 
Tris pH 7.5, 2 mM DTT) and loaded onto a 5 ml Hi-Trap Heparin sepharose column (GE 
Healthcare) which was pre-equilibrated in buffer A. Following an extensive wash with 
buffer A, and 10 % buffer B (same as A except 1 M NaCl), step elution was performed.  
 
2.5.7. Storage of recombinant proteins 
Purified recombinant protein was concentrated using a Vivaspin sample concentrator 
(GE Healthcare) with the appropriate molecular weight filter and the concentration 
measured at A280 using a Nanodrop spectrophotometer (Thermo Scientific). Once the 
desired concentration reached, the purified proteins were aliquoted in small volumes (for 
single use) and snap frozen in liquid nitrogen, then stored at -80 oC.  
 
2.6. Primer extension assay 
The primer extension assay and associated protocols were modified from Jozwiakowski 
and Connolly, 2011. 
 
2.6.1. Primer-template substrates 
The DNA oligomers used to prepare the synthetic primer-template substrates were 
designed by Stanislaw Jozwiakowski (Sussex, UK) and were HPLC grade manufactured 
by ATDbio. The DNA oligomer containing the thymine-thymine pyrimidine (6-4) 
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pyrimidone photoproduct was a gift from Alan Lehmann (Sussex, UK), and the 3-deaza-
3-methyl-2’-deoxyadenosine (3dMeA) containing oligomer was a gift from Roger 
Woodgate (NIH, Maryland, USA) (Plosky et al, 2008). All primers contain a 5’ 
hexachlorofluorescein label and the sequences of all the oligonucleotides used in the 
primer extension assays in this thesis are detailed in Table 2.7. 
 
2.6.2. Annealing of primer-template substrates 
To anneal primer-template substrates the labelled DNA primer and the DNA template 
were mixed in an equimolar ratio in annealing buffer (50 mM Tris pH 8, 50 mM NaCl, 1 
mM EDTA) and incubated at 95 oC for 3 minutes before allowing to cool down to room 
temperature for a further 30 minutes. Annealed substrates (200 nM) were stored at -20 
oC.  
 
2.6.3. Primer extension assay 
Reactions were assembled at room temperature; to 1x reaction buffer (NEBuffer 1, New 
England Biolabs; 10 mM Bis-Tris-Propane pH 7, 10 mM MgCl2, 1 mM DTT) 20 nM 
primer-template substrate was added with 200 μM dNTP(s) (Roche) and lastly 100 - 125 
nM polymerase. Volume for a single reaction was 20 μl, which was scaled up if multiple 
time-points were performed. Reactions were incubated at 37 oC for the desired time (10-
30 minutes) and then quenched with an equal volume of 2x stop buffer (95 % formamide, 
40 mM EDTA, 200 nM competitor oligonucleotide, with bromophenol blue and xylene 
cyanol), either by adding directly to the tube or, if multiple time-points were being 
performed, 20 μl removed and added to a clean tube containing 20 μl 2x stop buffer. 
The competitor oligonucleotide in the stop buffer is complementary to the template 
strand in the assay, and this prevents re-annealing of the labelled reaction products with 
the template strand, which would interfere with gel electrophoresis analysis. Quenched 
reactions were then heated to 95 oC for 3 minutes and allowed to cool down before half 
of the reaction was resolved by DNA-PAGE, and the remainder stored at -20 oC.  
 
2.6.4. DNA-polyacrylamide gel electrophoresis  
The products of primer extension reactions were resolved by denaturing urea-PAGE. 
Gels consisted of 15 % polyacrylamide bis-acrylamide (19:1) solution (National 
Diagnostics), 7 M urea, TBE (89 mM Tris, 2 mM EDTA, 0.89 M Boric Acid, pH 8.3), 0.1 % 
APS, 0.03 % TEMED. Gels were cast between 16.5 x 28 cm glass plates with 0.75 mm 
spacers and a 20-well comb, and resolved on a Dual Vertical Slab Gel Kit (CBS 
Scientific). Gels were pre-run at a constant wattage of 15 watts for 30 minutes in TBE, 
before loading the samples and electrophoresis for 3-4 hours at 15-17 watts. To detect 
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the hexachlorofluorescein label of the reaction products, the gel was scanned (Cy3, 532 
nm) using a FLA-1500 scanner (FUJI). 
 
2.7. Human cell culture 
The cell media, supplements, and antibiotics, were purchased from Gibco Invitrogen. 
Cell culture flasks, plates, dishes, and cryotubes were purchased from Nunc. Plasmid 
constructs used and generated in this thesis in cultured human cells, and the primers 
used to make these constructs, are detailed in Tables 2.8 and 2.9 respectively.  
 
2.7.1. Cell lines 
Osteosarcoma U2OS and 143B cells, human embryonic kidney (HEK)-293 cells, and 
retinal pigment epithelium (RPE) cells were cultured in Dulbecco’s modified Eagle 
Medium (DMEM) supplemented with 10 % (v/v) foetal calf serum (FCS), 100 U/ml 
penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine. Flp-In T-REx-293 cells, 
engineered for inducible expression of for epitope tagged PrimPol, were cultured in the 
same media containing 15 μg/ml Blasticidine and 100 μg/ml Hygromycin, whilst the 
parental cells were cultured in 100 μg/ml Zeocin and 15μg/ml Blasticidine. SV40 
transformed normal (MRC5V1) and XP-V (XP30RO(sv), (gift from Alan Lehmann, Sussex, 
UK; Cleaver et al, 1999) fibroblasts were cultured in Minimum Essential Media (MEM) 
supplemented with 15 % FCS and penicillin, streptomycin, and L-glutamine as above. In 
this thesis these cells are referred to as MRC5 and XP30RO. All cells were grown in a 37 
oC incubator with a humidified atmosphere containing 5 % CO2. 
 
2.7.2. Cell maintenance 
Cells were maintained in a 75 cm2 cell culture flask with 10 ml medium and split every 3-
5 days. At each passage, medium was first removed and the cells washed with 
phosphate buffered saline (PBS, 137 mM NaCl, 0.3 mM KCl, 10 mM Na2HPO4, 1.7 mM 
KH2PO4) before incubation with trypsin (250 mg/ml in PBS) for ~5 minutes at 37 oC. Pre-
warmed medium was then added and cells detached by gentle agitation or pipetting, 
and recovered by centrifugation and the cell pellet resuspended in fresh medium. An 
appropriate amount of the cell suspension was transferred to a clean flask and diluted 
into fresh medium before being returned to the incubator, typically cells were split 1:8 or 
1:10. HEK-293 and the Flp-In T-REx-293 cells did not require trypsinisation, and were 
resuspended in PBS instead. 
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2.7.3. Cell storage 
To generate cell stocks, cells were collected as described above and the cell pellet 
resuspended in pre-warmed fresh medium containing 10 % (v/v) DMSO. Usually, a 
confluent 75 cm2 flask was divided into four 1 ml aliquots in cryotubes, which were 
frozen slowly in a cryobomb placed at -80 oC before being transferred to liquid nitrogen 
for long term storage. To restart a cell culture, a frozen aliquot of cells was quickly 
thawed at 37 oC and added dropwise to 10 ml of pre-warmed fresh medium. To remove 
the DMSO, the cell suspension was centrifugated and the pellet resuspended in fresh 
medium, before transferring to a clean 75 cm2 flask. 
 
2.8. Cultured human cell methods 
2.8.1. Preparation of cell lysates 
To prepare whole cell extracts, cells were either collected first by centrifugation and then 
washed with PBS before addition of lysis buffer, or scraped directly into lysis buffer if 
only a small number of cells were present. Typically, a cell pellet was resuspended in 
NETN buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris pH 7.5, 0.5 % NP-40, with Roche 
protease inhibitor) and incubated on ice for 30 minutes – 1 hour with occasional 
vortexing, before sonication in a chilled ultrasonic bath and centrifugation (13 000 rpm, 
10 minutes, 4 oC) to remove cell debris. Usually, 50 μl was used for a confluent 3.5 cm 
dish and 200 μl for a 10 cm dish. To determine the protein concentration the Lowry 
method (Lowry et al, 1951) with the DC Protein Assay (BioRad) was used, typically using 
5 μl of the lysate and using BSA to generate a standard curve. Usually a 40 μg sample 
was prepared in Laemmli sample buffer, final volume ~20 μl, and boiled for 5 minutes.  
 
2.8.2. Stable transformation on Flp-In T-REx-293 cells 
To generate stable inducible cell lines the Flp-In T-REx system from Invitrogen was used. 
Parental Flp-In T-REx-293 cells (HEK-293 derivative) and the pcDNA5/FRT/TO and 
pOG44 vectors were gifts from Ian Holt (MRC, Cambridge). Twenty-four hours prior to 
transfection cells were counted using a haemocytometer and seeded in a 6-well plate: 2 
x 105 cells/well giving ~70 % confluency the following day. Co-transfection of 
pcDNA5/FRT/TO (containing cDNA of interest) and pOG44 in a 1:9 ratio was done with 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. A control 
mock transfection with water rather than DNA was performed alongside. Forty-eight 
hours after transfection cells were transferred to 10 cm dishes and the following day 
antibiotic selection applied (15 μg/ml Blasticidine, 100 μg/ml Hygromycin). Selective 
medium was replaced every 3-4 days until large colonies had formed and all cells were 
! 52!
dead in the mock transfection (~2 weeks). Dishes were then trypsinised and stocks of 
the cell lines made. To assess whether the stable transfection was successful cells were 
seeded in a 6-well plate with media supplemented with 10 ng/ml doxycycline, and 24 
hours later, cells were harvested and analysed by Western blot. 
 
2.8.3. RNA interference 
Small interfering (si)RNA duplexes targeting PrimPol mRNA were designed by Julie 
Bianchi (GDSC, Brighton) and manufactured by Invitrogen as Stealth RNAi siRNA. The 
sequence of the siRNA duplex was 5’-GAGGAAACCGUUGUCCUCAGUGUAU-3’, 5’-
AUACACUGAGGACAACGGUUUCCUC-3’. Cells were transfected using Lipofectamine 
RNAiMAX (Invitrogen); 1 μl RNAiMAX was added to a well of a 24-well plate containing 
100 μl OPTI-MEM medium (Invitrogen) with 10 nM siRNA duplex (final concentration), to 
this a 400 μl suspension of 2 x 104 cells was added and returned to the incubator 
(reverse transfection protocol, see manufacturer’s guide). Twenty-four hours later a 
transfection mix composed of 100 μl OPTI-MEM, 1 μl RNAiMAX, and 10 nM siRNA (final) 
was added to the well before returning to the incubator (forward transfection protocol, 
see manufacturer’s guide). Usually, a well became confluent 48 hours after seeding and 
initial transfection, and required passaging into an appropriate size dish; experiments 
were usually performed the following day (72 hours from the starting point). The number 
of wells seeded was scaled up as required. In some instances only a single round of 
transfection was performed either when seeding or on the following day, as described 
above. In this case, 4 x 104 cells were seeded and further experiments were performed 
48 hours later. Mock transfections that contained water instead of siRNA were performed 
alongside as a control. 
 
2.8.4. DNA damaging agents and drug treatments 
UV-C irradiation at 254 nm was performed with a germicidal lamp at a fluence rate of 0.5 
J/m2/sec. Cells plated in dishes were aspirated of their medium, washed with PBS, and 
with no liquid present in the dish and lid removed, exposed to the desired dose of UV-C 
radiation. Pre-warmed media was then added to the cells before returning to the 
incubator for the appropriate recovery time. Exposure of cells to ionising radiation was 
performed with 250 kV X-rays at 12 mA with a dose rate of 0.5 Gy/min. Cells plated in 
dishes were irradiated in their medium with the lid removed. Hydroxyurea (HU) was made 
fresh prior to use and added to cell medium to a final concentration of 10 mM for 6 
hours. Aphidicolin was prepared in DMSO and added to cell medium to a final 
concentration of 2 μg/ml for 16 hours, and when releasing from block, at least 2 PBS 
washes were performed before adding pre-warmed fresh medium. Doxycycline, to 
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induced expression of recombinant PrimPol in Flp-In T-REx-293 cells, was added to a 
final concentration of 10 ng/ml for 16-24 hours. 
 
2.8.5. UV-C clonogenic survival assay 
MRC5 and XP-V fibroblasts were treated with 2 rounds of PrimPol or mock RNAi as 
detailed previously (section 2.8.3). Six wells of a 24-well plate for each condition (i.e. 
mock RNAi MRC5, PrimPol RNAi MRC5, etc) were enough to set up the survival and 
check PrimPol knockdown by Western blot. Forty-eight hours after seeding and initial 
transfection, cells were trypsinised and counted using haemocytometer and plated on 10 
cm dishes. For MRC5: 200, 400, 1000, and 2000, cells were plated; and XP-V: 400, 800, 
2000, and 4000, cells plated, all in triplicate, for mock irradiation, 2 J/m2, 4 J/m2, and 6 
J/m2 irradiation respectively. Less than 24 hours after plating, cells were exposed to the 
desired dose of UV-C irradiation and returned to the incubator until large colonies had 
grown, typically ~10 days. Cells were then washed with PBS, fixed with 100 % ethanol, 
and washed with distillated water before staining with methylene blue for 10 minutes. 
Cells were then washed again with water to remove the excess staining, and left to dry 
before counting using a cell counter and calculating the average percentage survival for 
each UV-C dose. 
 
2.8.6 Immunofluorescence microscopy 
Primary and secondary antibodies used in this thesis for immunofluorescence analysis 
are detailed in Tables 2.1 and 2.2 respectively. Cells were grown on glass cover slips, 
which for Flp-In T-REx-293 cells were poly-L-lysine coated (Invitrogen), in typically 3.5 
cm dishes with 2-3 cover slips per dish. Cell medium was removed and cells washed in 
PBS before fixing in 3 % (v/v) paraformadlehyde (in PBS) for 15 minutes. Following 
fixation, dishes of fixed cells were often stored at 4 oC in PBS until immnofluorescent 
staining. Cells were permeabilised with 0.2 % (v/v) Triton X-100 (in PBS) for 10 minutes, 
then washed with PBS before blocking with 3 % BSA (in PBS) for at least 30 minutes. 
Primary antibodies were diluted in blocking buffer and added dropwise to the surface of 
the cover slips, and incubated for at least 1 hour at room temperature. Cells were then 
washed with PBS before incubation with the secondary antibody also diluted in blocking 
buffer, for at least 30 minutes in the dark. Following further washes with PBS, the excess 
PBS was removed from the cover slip before mounting onto a glass slide with Prolong 
Gold anti-fade (Invitrogen), which contains 4',6-diamidino-2-phenylindole (DAPI). Nail 
varnish was then used to coat the edge of the cover slips to create a seal and the slides 
were stored at 4 oC until analysis. If slides were to be scored, they were analysed on an 
E400 (Nikon) microscope with a 100x oil immersion objective. For image acquisition, 
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slides were analysed with a DeltaVison Core (Applied Precision) microscope on either 
60x or 100x objective. Images were taken, deconvolved, and processed using 
softWoRk® (Applied Precision) and transferred to OMERO (Allan et al, 2012) for storage 
and further processing. 
 
To immunofluorescently detect chromatin bound proteins, cells were pre-
extracted before fixation with a rapid wash with 0.5 % Triton X-100 in PBS. To visualise 
mitochondria, cell medium was supplemented with 250 nM MitoTracker Deep Red 
(Invitrogen) and cells returned to the incubator for 30 minutes before fixation. To detect 
S-phase cells the Click-iT EdU Alexa Fluor 488 Imaging Kit (Invitrogen) was used 
according to the manufacturer’s instructions. Cell medium was supplemented with 10 
μM EdU (final concentration) 20 minutes before fixing.  
 
2.8.7. Flow cytometry 
To analyse the DNA content of human cultured cells by flow cytometry, cells were first 
seeded in a 6-well plate so that they are ~80 % confluent when harvested. Cells were 
trypsinised and collected by centrifugation, washed with PBS, then resuspended in a 
small volume of PBS and fixed with ice cold 70% (v/v) ethanol added dropwise with 
gentle agitation, before storage overnight at -20 oC. Cells were then washed twice with 
PBS to remove the ethanol and resuspended in a PBS containing 5 μg/ml propidium 
iodide, 250 μg/ml RNase and transferred to FACS tubes (BD Biosciences) to be kept 
overnight in the fridge until analysis. The DNA content of the cells was analysed using a 
FACSCanto flow cytometer (BD Biosciences) and the DNA content versus cell count was 
plotted using FACSDiva software (BD Biosciences) 
 
2.8.8. Sub-cellular fractionation 
2.8.8.1. Mitochondrial isolation 
Mitochondria were isolated from human cells using the Mitochondrial Isolation kit for 
cultured cells (Thermo Scientific) according to the manufacturer’s instructions. The 
resulting mitochondrial pellet was lysed in RIPA buffer (20 mM Tris pH 8.0, 150 mM 
NaCl, 1% NP40, 0.5 mM EDTA, 10% glycerol, 0.1% SDS, 1% Na-deoxycholate), and 
protein concentration was determined as previously described (section 2.8.1). Equivalent 
concentrations of cytoplasmic fraction and mitochondrial lysate were prepared and 
analysed by Western blot (section 2.3.3).  
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2.8.8.2. Protease protection assay 
For the protease protection assay, mitochondria were first isolated from cells as 
previously described (section 2.8.8.1), and the resulting mitochondrial pellet 
resuspended in 100 μl PBS and divided into 4 eppendorf tubes. An equal volume of 
protease protection assay buffer (0.6 M mannitol, 10 mM Tris pH 7.4) was added to each 
tube, and supplemented with either 0.5 % (v/v) Triton X-100, or 0.5 mg/ml Proteinase K 
(New England Biolabs), or a combination of the two, or neither. After a 30 minute 
incubation on ice, 10 mM PMSF (final concentration) was added followed immediately by 
Laemmli sample buffer before boiling the samples. The contents of each tube was then 
analysed by Western blot (section 2.3.3) with an anti-PolG2 antibody (gift from Ian Holt, 
MRC, Cambridge) used as a control for a mitochondrial protein. 
 
2.8.8.3. Soluble and insoluble (chromatin) fractionation and DNase treatment 
The fractionation protocol was modified from Kannouche et al, 2004. Fractionation of 
Flp-In T-REx-293 cells over-expressing PrimPol required a single confluent 10 cm dish 
per condition; in order to detect chromatin bound PrimPol, whilst detecting endogenous 
PrimPol in MRC5 fibroblasts required three 10 cm dishes per condition. Cells were 
harvested by scraping into 1-2 ml PBS and a quarter of this suspension transferred to an 
eppendorf tube and pelleted by centrifugation (3000 rpm, 5 minutes, 4 oC) for the whole 
cell extract. The cell pellet was resuspended in 50 μl NETN buffer (150 mM NaCl, 5 mM 
EDTA, 50 mM Tris pH 7.5, 0.5 % NP-40, with Roche protease and phosphatase inhibitor 
cocktails), incubated on ice before sonication in a chilled ultrasonic bath. The remaining 
three quarters of the cell suspension was pelleted by centrifugation and resuspended in 
150 μl cytoskeletal (CSK) buffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM 
PIPES pH 6.8, 1 mM EGTA, 0.2 % (v/v) Triton X-100, with Roche protease and 
phosphatase inhibitor cocktails), and incubated on ice for 5 minutes before centrifugation 
at 13 000 rpm for 10 minutes at 4 oC. The supernatant, being the soluble fraction, was 
transferred to a clean eppendorf tube. The insoluble pellet was washed twice with PBS 
before being resuspended in 150 μl Laemmli sample buffer and boiled for 10 minutes. 
The protein concentration of the whole cell extract was determined (section 2.8.1) and 
equivalent amounts of the soluble and insoluble fractions were analysed by Western blot 
(section 2.3.3). Detection of Histone H1 was used as a control for the fractionation.  
 
For DNase treatment of the Triton X-100 insoluble fraction, the sample was 
resuspended in 150 μl low salt CSK buffer (same as CSK buffer except 50 mM NaCl) 
supplemented with 1 μl/ml Benzonase, and incubated at room temperature for 20 
minutes with occasional agitation. The remaining insoluble material was then collected 
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by centrifugation and the soluble fraction (DNA bound) transferred to a clean tube, whilst 
the insoluble was resuspended in Laemmli sample buffer and boiled. Equivalent amounts 
to the whole cell extract were analysed by Western blot (section 2.3.3). 
 
2.8.9. Purification of Strep-tagged PrimPol from human cultured cells 
2.8.9.1 Small scale affinity purification  
For small scale affinity purification of soluble Strep-tagged PrimPol from human cultured 
cells, Flp-In T-REx-293 cells engineered for inducible expression of PrimPol-FLAG-Strep 
were seeded in two 175 cm2 flasks and one day before they became confluent, 10 ng/ml 
doxycycline was added to one of the flasks inducing PrimPol expression. Cells were 
harvested by resuspension in PBS and collected by centrifugation (1500 rpm, 5 minutes), 
and the non-induced and induced pellets each lysed in 1 ml lysis buffer (150 mM NaCl, 
30 mM Tris pH 7.4, 0.5 % NP-40, with Roche protease inhibitor cocktail), and place on a 
tumbler at 4 oC for at least 20 minutes. The lysate was cleared by centrifugation (10 000 
g, 10 minutes, 4 oC), 100 μl retained as input, and pre-washed 100 μl Strep-tactin 
(Invitrogen) 1:1 slurry added, before incubation for at least 1 hour on a tumbler at 4 oC 
(can leave overnight). The material bound to the Strep-tactin resin was washed 3 times 
by brief centrifugation (30 seconds, 3000 g, 4 oC), resuspension in an excess of wash 
buffer (same as lysis buffer except 0.1 % NP-40) followed by at least 5 minutes on a 
tumbler at 4 oC. Proteins bound specifically to the Strep-tactin resin were eluted with 200 
μl 2 mM desthiobiotin (in 150 mM NaCl, 30 mM Tris pH 7.4), 3-5 successive elutions 
were performed. The resulting samples were analysed by Western blot (section 2.3.3). 
 
2.8.9.2. Affinity purification for mass-spectrometry analysis 
For the large scale affinity purification of soluble PrimPol for mass-spectrometry analysis, 
thirty 175 cm2 flasks of confluent Flp-In T-REx-293 cells engineered for PrimPol 
expression were used, 1 day before harvesting, PrimPol expression was induced in 15 of 
these flasks by addition of 10 ng/ml doxycycline. Following harvesting and collection, 
cell pellets (~1 g each) were lysed in 15 ml lysis buffer and incubated at 4 oC on a rocker 
for 20 minutes. Input was retained (500 μl) and 1 ml of Strep-tactin resin (packed volume) 
added to the lysate and placed on a rocker for 2 hours at 4 oC. Washes were also 
performed in batch mode and then the Strep-tactin resin was transferred to a gravity 
flow column and washed further. Five successive 500 μl elutions with 2 mM desthiobiotin 
were performed, and each snap frozen with 10% glycerol. Following Western blot 
analysis to determine which affinity purifications were successful, the chosen elutions 
were concentrated using a VivaSpin 10 000 kDa molecular filter before resolving on a 
Bis-Tris 4-20 % gel and colloidal Coomassie staining (Invitrogen). Whole lane gel 
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extraction was performed with each lane being divided into 1-2 mm bands which were 
placed in a 96 well plate before trypsin digestion and mass-spectrometry analysis (in 
collaboration with Mark Sekel, CRUK, Clare Hall). 
 
2.8.9.3. Treatment of purified PrimPol with lambda phosphatase 
PrimPol was affinity purified using Strep-tactin resin as detailed above, except for the 
addition of PhosSTOP phosphatase inhibitor cocktail (Roche) in the lysis buffer. 
Following 3 washes in wash buffer, the material bound to the Strep-tactin resin was 
washed with protein metallophosphatase (PMP) buffer (New England Biolabs), and then 
divided between 3 clean eppendorf tubes. To each, PMP buffer supplemented with 1 
mM MnCl2 was added with either 400 U Lambda Protein Phosphatase (New England 
Biolabs) and PhosSTOP, just the Lambda Protein Phosphatase, or neither of the two. 
Following a 20 minutes incubation at 30 oC with agitation, the resin was collected by 
centrifugation and boiled in Laemmli sample buffer before analysis by Western blot 
(section 2.3.3).  
 
2.9. Yeast two-hybrid methods 
The Two-Hybrid Matchmaker 2 System (Clontech) using the S. cerevisiae Y190 strain 
was used, in conjunction with pGBKT7 (containing the GAL4 DNA binding domain) and 
pACT2 (containing the GAL4 DNA activation domain) vectors. Plasmid constructs used in 
the yeast two-hybrid assay, and the primers used to generate these constructs, are 
detailed in Tables 2.10 and 2.11 respectively. 
 
2.9.1. Yeast culture 
Y190 was grown in Yeast Extract medium (YE; 0.5 % (w/v) yeast extract, 3 % (w/v) 
glucose, 0.02 % (w/v) adenine, and 0.1 % (w/v) uracil, histidine, arginine, and leucine) or 
on YEA plates (YE medium solidified with 2.5 % granulated agar) at 30 oC. For short term 
storage plates of yeast were stored at 4 oC, however for long term storage glycerol 
stocks were made. A single colony was resuspended in growth medium (YE) and 50 % 
glycerol added to a final concentration of 25 % before transferring to -80 oC. To restart a 
culture, a small proportion of the glycerol stock was streaked onto plates (YEA) and 
incubated at 30 oC for 3-5 days. 
 
2.9.2. Yeast transformation 
One millilitre of YE was inoculated with a few colonies of Y190, vortexed vigorously to 
disperse clumps, and transferred to 50 ml of YE to be incubated overnight at 30 oC with 
shaking (250 rpm) until stationary phase (OD600 > 1.5). The culture was then diluted to an 
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OD600 of 0.05 in 100 ml of YE and returned to the incubator for a further 3-4 hours until 
an OD600 of 0.2 was reached. The cells were collected by centrifugation (2500 rpm, 5 
minutes) and resuspended in 10 ml sterile TE (10 mM Tris pH 7.5, 1 mM EDTA) before 
centrifugation. The cells were then resuspended in 0.5 ml freshly prepared sterile LiAc-
TE (0.1 M lithium acetate, 10 mM Tris pH 7.5, 1 mM EDTA) and kept on ice. 
 
To 5 μg of each plasmid (pGBKT7 and pACT2) and 50 μg carrier DNA (herring 
sperm DNA denatured at 90 oC for 20 minutes), 100 μl competent yeast cells were added 
and mixed well by vortexing. To this mixture, 600 μl of sterile PEG LiAc-TE (40 % (w/v) 
PEG 3350 in LiAc-TE) was added and vortexed at high speed for 10 seconds. Following 
a 30 minutes incubation at 30 oC with shaking, 70 μl 100 % DMSO was added and 
mixed by inversion, the mixture heat-shocked at 42 oC for 15 minutes, before being 
chilled on ice for a further 1-2 minutes. The cells were collected by centrifugation (3000 
rpm, 5 minutes), resuspended in 500 μl TE, and 100 μl plated on yeast minimal medium 
plates (YMM; yeast nitrogen base (YNB), 10 % glucose, 2.5 % granulated agar) 
supplemented with 20 mg/ml adenine and histidine (to select for pGBKT7 and pACT2). 
Colonies grew over 2-3 days in a 30 oC incubator. 
 
2.9.3. Detection of interaction 
Colonies of yeast cells transformed with both pGBKT7 and pACT2 were picked and 
resuspended in 20 μl sterile TE, vortexed to disperse clumps. Half was spread on YMM 
plates supplemented with adenine and histidine and the other half on YMM plates 
supplemented with adenine and 25 mM 3-amino-1, 2, 4-triazole (3-AT), a competitive 
inhibitor of the yeast HIS3 protein therefore inhibiting low-level leaky expression (Durfee 
et al., 1993). At least 4 colonies were streaked per plate. Following 2-3 days at 30 oC, the 
growth of cells in the absence of histidine (3-AT plates) indicated a potential interaction 
of the proteins cloned in pGBKT7 and pACT2.  A liquid X-Gal assay was also performed 
to detect a possible interaction; first, the cells re-streaked on YMM plates containing 
adenine and histidine were resuspended in 150 μl Z buffer (60 mM Na2HPO4, 60 mM 
NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7) and lysed by 3 cycles of freeze-thawing in 
liquid nitrogen. To this, 150 μl Z buffer containing X-Gal and β-mercaptoethanol was 
added and colour was allowed to develop at 30 oC. If the mixture turned blue this 
indicated a potential interaction. 
 
2.10. Bioinformatics 
Gene sequences were retrieved via the National Centre for Biotechnology Information 
(NCBI) (Sayers et al, 2009) from GenBank (Benson et al, 2009). Typanosomatid gene 
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sequences were retrieved from TriTryp database (Aslett et al, 2009). Multiple sequence 
alignments were generated using ClustalW2 (Larkin et al, 2007), TCoffee (Notredame et 
al, 2000), MUSCLE (Edgar, 2004), and MAFFT (Katoh et al, 2009) in the alignment editor 
JALview (Waterhouse et al, 2009). Phylogenetic trees were generated using ClustalW2 
and edited using iTOL (interactive tree of life; Letunic and Bork, 2011). ProtParam 
(Gasteiger et al, 2005) was used for computation of physical and chemical parameters of 
proteins, and various other programs on the ExPASy server (Gasteiger et al, 2003). 
 
 
 
! 60!
 
 
 
Chapter 3 
 
The African trypanosome contains two PrimPol-like 
proteins and one is essential for completion of DNA 
replication 
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3.1. Introduction 
Eukaryotic genomes encode numerous DNA polymerases required for the replication and 
maintenance of the genome (Lange et al., 2011). In contrast, with the exception of 
trypanosomatid kinetoplast DNA replication, only a single DNA primase has been 
characterised to date, being Prim1 of the Pol α-Prim complex. Prim1 is the reference 
member of the AEP superfamily and is essential for the initiation of DNA replication in all 
eukaryotes analysed so far (Muzi-Falconi et al., 2003). In archaea and prokaryotes, AEPs 
have been shown to be versatile polymerases capable of a number of nucleotidyl 
transferase activities, and in some bacteria function in DNA break repair (Lao-Sirieix et 
al., 2005; Brissett and Doherty, 2009). Currently unpublished work in the laboratories of 
Aidan Doherty and collaborator Luis Blanco (CBMSO, Madrid) has identified an 
additional eukaryotic AEP-like enzyme, the human protein CCDC111, which was 
previously reported to be a putative member of the AEP superfamily (Iyer et al., 2005). 
Preliminary experiments have shown that recombinant human CCDC111 is a versatile 
enzyme in vitro, being capable of both primase and polymerase activities, and so the 
protein was renamed PrimPol. To complement the characterisation of human PrimPol 
(Chapters 5-7) it was decided to study PrimPol in a relatively ‘simpler’ eukaryotic model 
organism. The African trypanosome was chosen (for reasons later explained) and this is 
the topic of the current chapter. 
 
T. brucei, the African trypanosome, along with the closely related T. cruzi and 
Leishmania’s, are protozoan parasites of significant medical importance (World Health 
Organisation, 2008). T. brucei is the causative agent of human African trypanosomiasis, a 
typically fatal condition that is endemic in sub-Saharan Africa (Brun et al., 2010). In 
addition to their medical importance, trypanosomatids also present a unique evolutionary 
perspective, as they are among the earliest diverging organisms from the eukaryotic tree 
(Simpson et al., 2006). Replication of the nuclear genome in trypanosomatids is less well 
understood than replication of its mitochondrial counterpart, although current knowledge 
is advancing (Tiengwe et al., 2012b), and all the major components of the higher 
eukaryotic replication machinery are present in trypanosomatid genomes suggesting 
similar mechanisms may exist (El-Sayed et al., 2005). Most conventional DNA repair 
pathways appear to operate in trypanosomatids (Passos-Silva et al., 2010), however, 
consistent with early divergence, the replication origin licensing machinery resembles 
that of archaea (Godoy et al., 2009; Tiengwe et al., 2012a) and the nonhomologous end-
joining break repair pathway does not appear to operate (Burton et al., 2007; Glover et 
al., 2008). 
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3.2. Trypanosomatid genomes encode two PrimPol-like proteins 
To identify PrimPol homologues a Position-Specific Iterated (PSI)-BLAST search (Altchul 
et al., 1997) was performed using the human PrimPol (CCDC111) sequence as query. As 
previously reported (Iyer et al., 2005), PrimPol homologues were readily identified in a 
broad range of multicellular and unicellular eukaryotes, including animals, plants, and 
protists. PrimPol was not identified in some animals such as Drosophila and C. elegans, 
and was only identified in one fungus, the parasitic B. dendrobatidis. Notably, a second 
group of lower scoring but significant hits were identified in the genomes of 
trypanasomatids, which were not previously reported by Iyer and colleagues (2005). The 
sequences of a range of PrimPol homologues were aligned (see Appendix for full 
alignment) and subjected to phylogenetic analysis, which confirmed that this second 
group of proteins were divergent members of the PrimPol family (Figure 3.1). As a result, 
this group of PrimPol homologues were named PrimPol2 and the previously identified 
trypanosomatid PrimPol homologues were named PrimPol1 (Figure 3.1). As 
trypanosomatids are amongst the earliest diverging eukaryotic organisms that are readily 
amenable to genetic manipulation, they appear to represent an excellent model system 
to characterise these novel enzymes.  
 
3.2.1. PrimPol1 and PrimPol2 in the African trypanosome T. brucei 
The PrimPol homologues of the African trypanosome, T. brucei, were termed TbPrimPol1 
(Tb927.5.4070) and TbPrimPol2 (Tb927.10.2520). TbPrimPol1 is 608 amino acids in 
length and has ~16 % identity with human PrimPol, which is slightly shorter at 560 amino 
acids. TbPrimPol2 is 732 amino acids long and shares ~11 % identity with its human 
counterpart. Despite their sequence divergence from human PrimPol and from each 
other, sharing ~10 % identical residues, both TbPrimPol1 and 2 contain the 
characteristic domains of the PrimPol family (Figure 3.2). The TbPrimPol1 and 2 amino-
termini contain the catalytic AEP domain comprised of three highly conserved motifs: 
motif I is hhhDhE (where ‘h’ is a hydrophobic residue), motif II SxH, and motif III hD  
(Figure 3.3a). Structural and site-directed mutagenesis studies of AEPs has 
demonstrated that these motifs are essential for catalysis; motif I and III are required for 
binding of divalent metal ions and motif II is required for nucleotide binding (Copeland 
and Tan, 1995; Augustin et al., 2001; Ito et al., 2003; Lao-Sirieix and Bell, 2004). Unlike 
other PrimPol family members, TbPrimPol2 does not contain the variation in motif I of the 
catalytic AEP domain (DxE), which is also shared by the archaeal pRN1-PrimPol (Lipps et 
al., 2003), but rather resembles the majority of AEP family members, containing DxD 
(Figure 3.3a). Carboxyl-terminal to the AEP domain, TbPrimPol1 and 2 also contain the 
CHC2 zinc finger motif with homology to the herpesviral UL52 primase (Figure 3.3b). 
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Although TbPrimPol1 and 2 are divergent from higher eukaryotic PrimPol’s they are 
relatively well conserved among trypanosomatids; the T. cruzi and L. major homologues 
share 50 and 36 % identity with their T. brucei PrimPol1 counterpart, and 44 and 34 % 
with their PrimPol2 counterpart respectively (Figures 3.4 and 3.5).  
 
3.3. Generation of strains to study the cellular roles of TbPrimPol1 and 2 
In order to explore the cellular roles of TbPrimPol1 and 2 in the African trypanosome, 
tetracycline-inducible RNAi strains and in situ epitope-tagged strains were first 
generated for each of these novel enzymes. These were made in bloodstream form 
trypanosomes (the pathogenic life cycle stage) specifically the Lister 427 strain (MiTat 
1.2, clone 221a) and its transgenic derivative the 2T1 strain (Alsford et al., 2005), using 
constructs developed by Alsford and Horn (2008).  
 
3.3.1. TbPrimPol1 and 2 inducible RNAi strains 
To generate inducible RNAi strains (overview in Figure 3.6), first a DNA target sequence 
of 400-600 bases was selected from each of the TbPrimPol1 and 2 genes using RNAit 
software (Redmond et al., 2003). Selected sequences will have little sequence similarity 
to other genes within the T. brucei genome and therefore should specifically target either 
TbPrimPol1 or 2 mRNA. A 401 base pair target sequence was selected for TbPrimPol1 
that corresponds to bases 1292-1693 of the 1827 base pair open reading frame. For 
TbPrimPol2 a 532 base pair target sequence was selected, corresponding to bases 859-
1391 of the 2199 base pair open reading frame. These target sequences were amplified 
from genomic DNA (see Table 2.4 for primers) and cloned individually in a head-to-head 
conformation in the inducible RNAi vector pRPaiSL, generating constructs 
pRPaiSL:TbPrimPol1 and pRPaiSL:TbPrimPol2 (Table 2.3). These constructs were 
linearised and transfected into the 2T1 strain, which in addition to constitutively 
expressing the Tet repressor, also contains a tagged ribosomal RNA locus for targeted 
integration (Alsford et al., 2005). This targeted integration eliminates variable expression 
and position effects that can be observed following random integration within the 
genome (Alsford et al., 2005). Correctly integrated transformants were selected by 
antibiotics and should have tetracycline-inducible expression of stem-loop RNA to target 
the destruction of either TbPrimPol1 or 2 mRNA, thus knocking down protein levels. Two 
inducible RNAi clones were generated for TbPrimPol1, and 3 inducible RNAi clones were 
generated for TbPrimPol2. 
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3.3.2. TbPrimPol1 and 2 in situ tagged strains  
For the purpose of determining the sub-cellular localisation of TbPrimPol1 and 2, and for 
monitoring protein level following RNAi induction, in situ epitope tagged strains were 
generated (overview in Figure 3.7). This is the addition of an epitope tag to one of the 
chromosomal copies of TbPrimPol1 or 2, which is facilitated by the high frequency of 
homologous recombination of tagging cassettes into target genes observed in T. brucei 
(Lee et al., 1990; ten Asbroek et al., 1990; Eid and Sollnerwebb, 1991). DNA fragments of 
977 and 645 base pairs corresponding to the 3’ terminus of the TbPrimPol1 and 2 genes 
respectively, were amplified from genomic DNA (see Table 2.4 for primers) without their 
stop codon and cloned in frame with the coding sequence for 12 consecutive c-Myc 
epitopes in the tagging vector pNATx12M, generating constructs pNATx12M:TbPrimPol1 and 
pNATx12M:TbPrimPol2 (Table 2.3). These constructs were linearised and transfected into 
both wild-type and the cognate inducible RNAi strains. Correct integration will result in 
the addition of 12 c-Myc epitopes to the carboxyl-terminus of one of the chromosomal 
copies of TbPrimPol1 or 2, and therefore expression of TbPrimPol1Myc or TbPrimPol2Myc 
will be under their endogenous transcriptional control. Four in situ Myc-tagged clones 
were generated for TbPrimPol1, including 2 in the cognate inducible RNAi strain, and 3 
tagged clones were generated for TbPrimPol2, with one in the cognate RNAi strain. 
 
3.3.3. Confirmation of TbPrimPol1 and 2 in situ tagged and RNAi strains 
To test expression of recombinant TbPrimPol1 and 2 and RNAi induction, the in situ 
tagged RNAi strains were grown in the presence or absence of tetracycline and the 
lysates prepared from these cells analysed by Western blot. Natively tagged 
TbPrimPol1Myc has a predicted molecular weight of 85.6 kDa (68 kDa without tag) but 
expressed as a species of 100 kDa when visualised by Western blot analysis with an anti 
c-Myc antibody (Figure 3.8a). This larger species was observed in all tagged clones (not 
shown) and 24 hours after addition of tetracycline to the culture media of the RNAi cells, 
a substantial reduction in this species was observed (Figure 3.8a). Natively tagged 
TbPrimPol2Myc has a predicted molecular weight of 99.4 kDa (82 kDa without tag) but 
expressed as a larger species of approximately 125 kDa when visualised by Western blot 
analysis (Figure 3.8b). This species was detected in all tagged clones (not shown) and 
just 8 hours after addition of tetracycline to the culture media of the RNAi cells, the 
specific depletion of this species was observed (Figure 3.8a). This confirms the 
successful in situ tagging and RNAi-mediated knockdown of TbPrimPol1 and 2. 
 
 
!"#$%&'()*)'+&,&%-./,'/0'-,'!"#$!%&',-.1&'-22&2&'3-##",#'43%-",'",''(#)*&+,!)'
!5"#$#%&#'(#)*# +,-./0#/1# 23,#-,0,#/1# .02,+,42# .4#5678.9,:#1+/6#-,0/6.;#<=$#50:#;8/0,:# .02/#
7=$>?&@A# .0# 1+56,#B.23#&@# ;/04,;CDE,# ;FAG;#,7.2/7,4H# !6"# >3,#78546.:# .4# 8.0,5+.4,:#C4.0-#5#
C0.IC,# +,42+.;D/0#4.2,#B.23.0# 23,#;8/0,:#)*# +,-./0#;+,5D0-#5#;/042+C;2#B.23# 2,+6.058# +,-./04#
;/++,47/0:.0-#2/#23,#-,0,#/1#.02,+,42H#!7"#J/++,;2#.02,-+5D/0#B.88#+,4C82#.0#23,#5::.D/0#/1#23,#
;/:.0-#4,IC,0;,#1/+#&@#;/04,;CDE,#;FAG;#,7.2/7,4#2/#23,#JF2,+6.0C4#50:#23,#)*#K>L#B.88#(,#
+,785;,:#(G#!"##-,0,# !!"#M#(854D;.:.0,# +,4.4250;,"M#588/B.0-# 4,8,;D/0#/1# 2+5041/+65024H#>3,#
-,0,# /1# .02,+,42# 0/B# ;/025.0.0-# 5# JF2,+6.058# ;FAG;# 25-# B.88# (,# C0:,+# 23,# +,-C85D/0# /1# .24#
,0:/-,0/C4#7+/6/2,+#!$841/+:#50:#N/+0M#@OOP"H#
7=$>?&@A#
)*#/1#Q,0,#/1#R02,+,42# &@#?#;FAG;# !"##
R02,+-,0.;#+,-./04#K0.IC,#+,42+.;D/0#4.2,#
Q,0,#/1#R02,+,42#
7=$>?&@A#
&@#?#;FAG;# !"##
R02,+-,0.;#+,-./04#JC2#
Q,0,#/1#R02,+,42# &@#?#;FAG;# !"##
R0;/678,2,#SLT#
5'
6'
7'
!"
#"
!!!"!!!!!#$!
%&'()!*!+,-!
.&&/0))1,!
023454675!
#8"!4!
98"!4!
9""!4!
8"!4!
:;!4!
;8!4!
<=0!
+>?(1/?&@9675!
"!!!!!A!!!!#$!
%&'()!*!+,-!
#8"!4!
98"!4!
9""!4!
8"!4!
:;!4!
;8!4!
<=0!
.&&/0))1,!
023454675!
+>?(1/?&@#675!
$%&'()"*+,+"-./%0.123"24"567(%872/9".30":"!"#$!%&";.&&)0".30"<=!%">;(.%3>+"
B,C(,),2-03D,! !"#$!%&#-0EE,F!+>?(1/?&@9675!G!H!02F!+>?(1/?&@#675!G#H! 12F'51>@,!BIJ1!)-(012)!
K,(,! E(&K2! 12! -L,!C(,),25,!&M! 9!NEO/@! -,-(0575@12,! M&(! -L,!3/,)! 12F150-,F! 02F! 5,@@! @7)0-,)!
C(,C0(,F! 02F! 020@7),F! >7! P,)-,(2! >@&-! K1-L! 02! 023454675! 023>&F7Q! R7)0-,)! K,(,! 0@)&!
(,)&@D,F!>7!S=S4?JTU!02F!.&&/0))1,!)-012,F!0)!0!@&0F12E!5&2-(&@Q!
! 65!
3.4. TbPrimPol2 is an essential protein in bloodstream form T. brucei   
It was first investigated whether TbPrimPol1 or 2 were required for cell proliferation. 
Cultures of RNAi strains were grown in the presence or absence of tetracycline and the 
cell density monitored over time using a haemocytometer, with the cultures being diluted 
to their starting density every 24 hours. No proliferative defect was observed following 72 
hours TbPrimPol1 RNAi (Figure 3.9a), however, in stark contrast, a severe proliferative 
defect was observed following TbPrimPol2 RNAi (Figure 3.9b). This defect was clearly 
visible after 24 hours and was ultimately lethal after 48 hours (Figure 3.9b). Thus, whilst 
TbPrimPol1 was dispensable for normal cell proliferation in bloodstream form T. brucei, 
TbPrimPol2 was essential. As a result this chapter largely focuses on the essential 
protein, TbPrimPol2. 
 
3.5. TbPrimPol2 is a nuclear protein 
The sub-cellular localisation of TbPrimPol2 was next investigated. The TbPrimPol2 in situ 
Myc-tagged cells were fixed and subjected to immunofluoresence analysis with an anti-
c-Myc antibody and DAPI counterstaining, which in the African trypanosome allows 
visualisation of both the nuclear and mitochondrial kinetoplast genome. TbPrimPol2Myc 
immunofluoresence was observed in the nuclei of cells (Figure 3.10) suggesting this is 
where its essential role takes place; however, it was not detected in all cells. The sub-
cellular localisation of the dispensable TbPrimPol1 was also investigated but numerous 
attempts failed to detect any TbPrimPol1Myc immunofluoresence.  
 
3.6. TbPrimPol2 is expressed in G2/M phase cells 
Given that TbPrimPol2Myc was only detected in a sub-population of cells, this prompted 
the question of whether TbPrimPol2 expression was cell cycle regulated. Cell cycle stage 
can be determined relatively easily in an unperturbed African trypanosome population 
since the mitochondrial kinetoplast genome is visible by DAPI staining and divides in a 
cell cycle dependant manner, preceding nuclear mitosis (Figure 3.11a). Thus, a cell with 
1 nucleus and 1 kinetoplast (1n1k) represent G1/S, 1 nucleus and 2 kinetoplasts (1n2k) 
represent G2/M, and 2 nuclei and 2 kinetoplasts (2n2k) represent a post-mitosis but pre-
cytokenesis cell (Woodward and Gull, 1990; Siegel et al., 2008). TbPrimPol2Myc was 
detectable by immunofluorescence in ~10 % of cells (Figure 3.11b), with the majority 
(~7.5 %) being 1n2k cells. Around 1.5 % of cells with detectable TbPrimPol2Myc were 
1n1k, and ~1 % were 2n2k. This is a striking result for a DNA synthetic enzyme given 
that 1n2k cells (which constitute ~15 % of an asynchronous population) are indicative of 
G2/M phase, and DNA replication is advanced, if not complete, in these cells. This 
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suggests that the role of TbPrimPol2 may be distinct from that of the canonical DNA 
primases, required for DNA replication initiation and progression through S-phase. 
Indeed, the accumulation of TbPrimPol2 at the G2/M phase of the cell cycle suggests a 
late- or post-DNA replication role. 
 
3.7. TbPri, the putative replicative DNA primase in T. brucei 
Since TbPrimPol2 is a novel AEP with an essential nuclear function, it was decided to 
compare TbPrimPol2 and the canonical replicative DNA primase, required for de novo 
synthesis of RNA primers needed to initiate DNA replication. The trypanosomatid 
genomes encode a putative replicative DNA Primase (El-Sayed et al., 2005), which in 
higher eukaryotes is known to exist as a heterodimer composed of a small catalytic 
subunit (Prim1) and large accessory subunit (Prim2), which exists associated with Pol α 
(Muzi-Falconi et al., 2003). It was decided to study the large subunit (Tb927.10.3110) that 
will be referred to as TbPriL (T. brucei Primase Large subunit) in keeping with the 
archaeal nomenclature, as a recently identified kinetoplastid-specific primase was 
named Pri2 (Hines and Ray, 2011). 
 
3.7.1. Generation of TbPriL in situ tagging and inducible RNAi strains 
To generate an inducible RNAi strain for TbPriL (overview in Figure 3.6), a 775 base pair 
target sequence (corresponding to bases 459-1234) was selected from the 1734 base 
pair open reading frame of TbPriL using RNAit software (Redmond et al., 2003). This 
target sequence was amplified from genomic DNA (see Table 2.4 for primers) and cloned 
in a head-to-head conformation in the RNAi vector pRPaiSL, generating the construct 
pRPaiSL:TbPriL (Table 2.3). To generate a TbPriL in situ epitope tagged strain (overview in 
Figure 3.7), a DNA fragment of 754 base pairs corresponding to the 3’ terminus of the 
TbPriL open reading frame was amplified from genomic DNA (see Table 2.4 for primers) 
without its stop codon, and cloned in frame with the coding sequence for 12 consecutive 
c-Myc epitopes in the tagging vector pNATx12M, generating the construct 
pNATx12M:TbPriL (Table 2.3). These constructs were used as described previously 
(section 3.3.1 and 3.3.2) to generate 3 TbPriL inducible RNAi clones and 4 in situ Myc-
tagged clones, including 2 RNAi clones with a native allele tagged. 
 
3.7.2 Confirmation of TbPriL in situ tagged and RNAi strains 
To test expression of in situ Myc-tagged TbPriL and RNAi induction, the inducible RNAi 
cells with a native allele tagged were grown in the presence and absence of tetracycline 
and the lysates prepared from these cells analysed by Western blot. TbPriLMyc has a 
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predicted molecular weight of 82.8 kDa (65 kDa without tag) but expressed 
predominantly as a single species of approximately 100 kDa (Figure 3.12). This larger 
species was observed in all tagging clones (not shown) and 48 hours after the addition of 
tetracycline to the cell media of the RNAi cells, a substantial reduction of this species 
was observed (Figure 3.12a). This confirms the successful in situ Myc-tagging of TbPriL 
and RNAi-mediated knockdown. 
 
3.7.3. TbPriL is an essential, nuclear protein in bloodstream form T. brucei 
It was first investigated whether TbPriL was required for cell proliferation. Cultures of 
RNAi cells were grown in the presence and absence of tetracycline and the cell density 
monitored over time as described previously. RNAi knockdown of TbPriL resulted in a 
severe growth defect, much like TbPrimPol2, that was ultimately lethal after 48 hours 
(Figure 3.13). Is to be noted that although the growth defect observed in TbPrimPol2 
knockdown cells appears more severe than that of TbPriL  (Figure 3.9b and 3.13, 
compare 24 hours), TbPrimPol2 knockdown was much more efficient (Figure 3.8b and 
3.12, compare 8 hours) and at a comparable time point, such as 36 hours after RNAi 
induction, the growth defects look similar. The sub-cellular localisation of TbPriL was 
next determined using immunofluorescent microscopy. TbPriLMyc was detected in the 
nuclei of cells (Figure 3.14) as to be expected as a component of the replicative DNA 
primase. Thus, as expected, TbPrL is an essential, nuclear protein in bloodstream form 
T. brucei. 
 
3.8. TbPrimPol2’s cellular role is distinct from canonical DNA primases 
It was next investigated whether the severe growth defect that followed TbPrimPol2 and 
TbPriL knockdown was associated with aberrant cell cycle progression.  
 
3.8.1. Depletion of TbPrimPol2 arrests cells with 1 nucleus and 2 kinetoplasts 
As previously described, a useful cytological tool to determine cell cycle phase in T. 
brucei is the division of the mitochondrial kinetoplast genome (Figure 3.11a). Cultures of 
TbPrimPol2 and TbPriL RNAi strains were grown in the presence of tetracycline and 
analysed by DAPI staining and fluorescence microscopy to determine the cell cycle 
distribution. In uninduced cultures, the cell cycle distribution was as expected in an 
asynchronous population; ~80 % of cells were 1n1k (G1/S), ~15 % were 1n2k (G2/M), 
and the remainder were 2n2k (post-M). However, following 24 hours knockdown of either 
TbPriL or TbPrimPol2, the number of 1n1k cells was reduced to 10-20 %, and the 
number of 1n2k cells increased to 80-90 % (Figure 3.15a and b). The beginning of this 
shift in cell cycle distribution was visible just 8 hours after TbPrimPol2 RNAi induction 
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(Figure 3.15b), which is just over one cell division. Such a striking cell cycle arrest 
following just 24 hours RNAi is unprecedented in bloodstream form T. brucei, and 
strongly supports an essential function of both TbPrimPol2 and TbPriL in cell cycle 
progression, most likely due to defects during nuclear DNA replication. It is also of note 
that both TbPriL and TbPrimPol2 knockdown was associated with cells having grossly 
abnormal morphologies, which is not uncommon for lethal RNAi’s, and the nuclei of 
these cells were also severely distorted (Figure 3.16).  
 
3.8.2. Depletion of TbPrimPol2 arrests cells with 4n DNA content 
Accumulation of 1n2k cells is consistent with a defect in nuclear DNA replication. To 
identify the nature of the replication defect, the DNA content of the cells before and after 
knockdown was determined using PI staining of DNA coupled with flow cytometry 
analysis. In uninduced cultures of TbPrimPol2 and TbPriL RNAi strains, the cell cycle 
distribution was consistent with that of unperturbed cells (Figure 3.17): ~70 % have a 
DNA content of 2n corresponding to G1, ~15% have 4n DNA content being G2, and the 
remainder between the two are S-phase cells. Twenty-four hours of TbPriL knockdown 
prevented cells from fully duplicating their genome and arrested them in S-phase (Figure 
3.17). This result in consistent with the established function of the replicative DNA 
Primase from other eukaryotes and suggests that this proteins essential role is 
conserved in trypanosomatids. In striking contrast, 24 hours of TbPrimPol2 knockdown 
resulted in almost all cells stalling with 4n DNA content (Figure 3.17). These data 
demonstrate that TbPrimPol2 is performing a distinct role from other eukaryotic 
primases. TbPrimPol2 is not required for initiation or progression of S-phase as 
knockdown cells can efficiently duplicate the majority, if not all, of their DNA. However, 
these cells arrest prior to cytokenesis in late-S-G2/M. This phenotype corresponds with 
the earlier observation that TbPrimPol2 accumulates in G2/M cells (Figure 3.11b), and 
indicates that TbPrimPol2’s essential function occurs after the bulk of DNA synthesis. 
 
3.9. TbPrimPol2 depletion results in the accumulation of DNA damage 
The results so far indicate an essential function for TbPrimPol2 that is distinct from 
previously characterised eukaryotic primases, in that it is required for a process that 
occurs after the majority of DNA replication takes place. It was next investigated whether 
the cell cycle arrest in TbPrimPol2 (and TbPriL) knockdown cells coincided with the 
accumulation of damaged DNA, as this could explain the cell cycle arrest.  
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3.9.1 TbPrimPol2 depletion causes a small increase in nuclear TUNEL staining 
It was first attempted to detect DNA damage using the Terminal deoxynucleotidyl 
transferase (TdT) dUTP Nick End Labelling (TUNEL) method. TdT catalyses 
polymerisation of nucleotides to free 3’ hydroxyl ends of DNA in a template-independent 
manner. In the TUNEL assay fixed cells are incubated with TdT and fluorescently labelled 
nucleotides, and so TdT will fluorescently label free DNA ends that are much more 
frequent when DNA is damaged. Detection of the fluorophore by fluorescence 
microscopy allows the visualisation of cells with DNA damage. In an uninduced culture of 
TbPrimPol2 or TbPriL RNAi strains almost no nuclei were positive for TUNEL staining 
(Figure 3.18). Twenty-four hours after TbPriL RNAi induction around 2 % of cells 
contained nuclear TUNEL staining (Figure 3.18). A larger increase was observed in 
TbPrimPol2 knockdown cells, with around 10 % of cells containing nuclear TUNEL 
staining (Figure 3.18), suggesting the presence of damaged DNA in these cells. However, 
this is only a small proportion of cells and is not consistent with the lethality of 
TbPrimPol2 knockdown. 
 
3.9.2 Depletion of TbPrimPol2 triggers assembly of Rad51 foci 
A well-known phenomenon is the assembly of DNA repair and signalling proteins into 
foci, visible by immunofluorescence microscopy at sites of DNA damage. One such DNA 
repair enzyme is the recombinase Rad51 that plays a central role in homologous 
recombination, which repairs DNA double-strand breaks in addition to supporting 
genome replication (Li and Heyer, 2008). Cultures of TbPrimPol2 and TbPriL inducible 
RNAi strains were grown in the presence or absence of tetracycline and analysed by 
immunofluoresence microscopy to detect Rad51. In uninduced cells, a single Rad51 
focus was typically detected in ~1 % of nuclei (Figure 3.19), as expected (Proudfoot and 
McCulloch, 2005; Glover et al., 2008). Following 24 hours of TbPrimPol2 knockdown, 
almost 90 % of cells displayed multiple sub-nuclear Rad51 foci (Figure 3.19). Indeed, 
almost 15% of cells scored positive for Rad51 foci after only 8 hours TbPrimPol2 
knockdown (Figure 3.19). TbPriL knockdown also resulted in the assembly of Rad51 foci, 
but to a lesser extent. In this case, ~30 % of cells contained multiple sub-nuclear foci 
after 24 hours of knockdown (Figure 3.19). The accumulation of Rad51 foci following 
TbPrimPol2 depletion indicates the accumulation of DNA damage in the vast majority of 
these cells, rather than only in a small proportion as concluded from the TUNEL method. 
It is possible that the DNA damage caused by either TbPrimPol2 or TbPriL knockdown 
does not result in free 3’ termini of DNA, or at least 3’ termini that can be extended by 
TdT. The accumulation of irreparable DNA damage following TbPrimPol2 knockdown is 
likely the cause of cell cycle arrest and cell death. 
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3.10. Over-expression of TbPrimPol2 does not perturb cell proliferation 
It was also investigated whether TbPrimPol2 over-expression perturbed cell growth, as 
was observed for TbPrimPol2 depletion. A T. brucei strain was made with inducible over-
expression of Myc-tagged TbPrimPol2. The TbPrimPol2 open reading frame without its 
stop codon was amplified from genomic DNA (see Table 2.4 for primers) and cloned in 
frame with the coding sequence for 6 consecutive c-Myc epitopes in the vector pRPai6M, 
generating construct pRPai6M:TbPrimPol2 (Table 2.3). Transfection of this construct into 
the previously described 2T1 strain (see section 3.3) results in the stable integration of 
the expression construct into the tagged genomic locus, allowing tetracycline-inducible 
expression of Myc-tagged TbPrimPol2. Two over-expression clones were generated; 
inducible Myc-tagged TbPrimPol2 (TbPrimPol2iMyc), with a predicted molecular weight of 
90 kDa, expressed as a species of approximately 120 kDa following a 24 hour 
tetracycline induction (Figure 3.20a). Over-expression was not associated with a growth 
defect after 72 hours (Figure 3.20b). 
 
3.11. Attempt to delete the un-tagged TbPrimPol2 allele in the in situ 
tagged strain 
Detection of TbPrimPol2 has thus far relied on an in situ Myc-tag at one native allele, 
however it is not known whether addition of this carboxyl-terminal Myc tag affects 
TbPrimPol2 function. To determine whether this was the case, it was decided to delete 
the entire allele encoding for the un-tagged TbPrimPol2, producing a strain that 
expresses only the Myc-tagged protein. A 527 base pair DNA fragment from the 5’ un-
translated region (UTR) of the TbPrimPol2 gene, and a 545 base pair fragment from the 
3’UTR, were amplified from genomic DNA (see Table 2.4 for primers) and cloned flanking 
the PAC gene (puromycin resistance) in the vector pPAC BS-KS, generating the 
construct pPAC BS-KS:TbPrimPol2 (Table 2.3) (Figure 3.21a). This construct was 
transformed into the TbPrimPol2 in situ tagged RNAi strain and puromycin clones 
selected. Five clones were produced and genomic DNA was prepared from these cells 
and screened by PCR using a forward primer in the 5’ UTR and reverse primer in the 3’ 
UTR (Table 2.4). In all clones the wild-type un-tagged PrimPol allele was visible and the 
Myc-tagged allele was deleted (Figure 3.21b). No further attempts were made to delete 
the un-tagged TbPrimPol2 allele. 
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3.12. Discussion 
PrimPol (CCDC111) is a novel eukaryotic primase-polymerase that was originally 
identified as a member of the AEP superfamily (Iyer et al., 2005). The aim of this chapter 
was to complement the study of higher eukaryotic PrimPol (Chapters 5-7) by 
characterising PrimPol in a relatively ‘simple’ eukaryotic model organism. A search of the 
available eukaryotic genomes identified PrimPol homologues in a wide range of 
eukaryotes, as previously reported by Iyer et al. (2005), but in addition, identified a 
second group of PrimPol-like proteins in trypanosomatids. Characterisation of these two 
PrimPol homologues in the important human pathogen T. brucei revealed that whilst one 
of them was dispensable for cell survival, the other was essential and required for a role 
distinct from previously characterised eukaryotic primases. 
 
Several pieces of data suggest that TbPrimPol2’s essential role occurs following 
the bulk of DNA synthesis in the nucleus. Native allele tagging of TbPrimPol2 revealed 
this enzyme localised to the nuclei of G2/M cells, in which genome duplication will be 
advanced, if not complete. RNAi-mediated depletion of TbPrimPol2 arrested cells with a 
ploidy indistinguishable from 4n with an accumulation of DNA damage, as suggested by 
assembly of Rad51 foci in almost all cells, and this ultimately led to cell death. These 
data are consistent with a late- or post-DNA replication role, which is in stark contrast to 
the role previously described for archaeal and eukaryotic primases, being the synthesis 
of RNA primers needed to initiate DNA replication. In the nucleus of eukaryotes, this is a 
role ascribed to the heterodimeric replicative DNA Primase which exists associated to 
Pol α (Pol α-Prim complex). As would be expected, the putative canonical replicative 
DNA Primase in T. brucei localised to the nucleus and upon RNAi-mediated knockdown, 
caused cells to irreversibly arrest in S-phase. This presumably was due to the inability of 
these cells to efficiently initiate DNA synthesis at replication origins and Okazaki 
fragments, and therefore S-phase progression was severely impeded, consistent with its 
described role in higher eukaryotic species (Muzi-Falconi et al., 2003). The phenotype 
resulting from knockdown of the replicative DNA Primase is clearly distinct from the 
phenotype observed following TbPrimPol2 knockdown, as instead of being required for 
S-phase initiation and progression, this novel enzyme is required for a process that 
occurs following the majority of DNA synthesis. 
 
Further insights into the role of PrimPol2 in T. brucei were gained from work 
performed in the laboratory of David Horn (LSHTM, London) by Lucy Glover using the 
strains generated in this chapter. Following knockdown of either TbPrimPol2 or TbPriL 
almost all cells contained multiple sub-nuclear foci of the phosphorylated histone H2A 
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(!H2A) (Figure 3.22); a DNA damage signalling protein that is recruited early on at sites of 
damage, being the trypansomatid equivalent of the higher eukaryotic histone variant 
!H2AX (Glover and Horn, 2012). This provides further evidence for the accumulation of 
DNA damage in the absence of TbPrimPol2 (and TbPriL), supporting the observation of 
Rad51 foci in almost all TbPrimPol2 knockdown cells. It is interesting that despite the 
apparent abundance of DNA damage following TbPrimPol2 depletion, only a modest 
level of TUNEL staining was observed, suggesting that the possible DNA damage/lesion 
does not provide 3’ ends compatible with TdT extension. Whatever this DNA damage 
may be it is clear that it is irreparable, either due to sheer abundance or the nature of the 
damage, despite the attempted repair of these lesions by homologous recombination, 
indicated by assembly of Rad51 foci. In addition, further experiments demonstrated that 
following treatment of cells with the alkylating agent methyl methanesulfonate (MMS), a > 
9-fold increase in TbPrimPol2Myc detection was observed, which was a result of 
TbPrimPol2Myc re-localising into sub-nuclear foci that represented sites of DNA damage, 
as they co-localised with !H2A (Figure 3.23). This clearly establishes a role for 
TbPrimPol2 in the DNA damage response. The DNA lesions caused by MMS treatment 
can stall the replication machinery, and as a result, are substrates for BER and DNA 
damage tolerance pathways (reviewed in Fu et al., 2012). Both of these processes can 
occur specifically after DNA replication (Otterlei et al., 1999; Ulrich, 2011) and so a role 
for TbPrimPol2 in one of these processes is highly possible, especially in response to 
endogenously occurring DNA damage, this is investigated further in the following 
chapter. 
 
Although various pieces of data are indicative of a late- or post-DNA replication 
TbPrimPol2 function, it is possible that TbPrimPol2 could function during S-phase. As 
previously detailed, immunfluorescent detection of TbPrimPol2Myc increases following 
induction of DNA damage (Figure 3.23), and so it is possible that the G2/M detection of 
TbPrimPol2 in unperturbed cells could reflect these cells containing more DNA damage, 
being accrued during S-phase, rather than cell cycle regulation of TbPrimPol2 
expression. The cell cycle arrest observed in TbPrimPol2 knockdown cells could also be 
consistent with an S-phase role, with the effects of TbPrimPol2 depletion only becoming 
apparent following bulk DNA synthesis.  However, comparison of the phenotype 
observed following TbPriL knockdown with TbPrimPol2 knockdown could be 
informative. Given that TbPriL is a component of the replicative DNA Primase complex 
involved in S-phase initiation, defects would be expected to arise at the replication fork 
following TbPriL depletion. Consistent with this, it has been reported in T. brucei that 
problems arising during replication result in the assembly of !H2A foci (Glover and Horn, 
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2012) but not Rad51 foci (Glover et al., 2008), which is what was observed following 
TbPriL knockdown (Figure 3.13 and 3.22). In contrast, TbPrimPol2 knockdown results in 
the vast majority of cells presenting both !H2A (Figure 3.22) and Rad51 foci (Figure 3.13), 
consistent with a DNA repair defect that occurs downstream of TbPriL function, not at 
the replication fork. This would be in line TbPrimPol2 functioning after replication fork 
progression. 
 
The PrimPol homologue that shares marginally more percentage identity with 
human PrimPol, TbPrimPol1, was dispensable for normal cell proliferation. Attempts to 
determine TbPrimPol1’s sub-cellular localisation proved unsuccessful, perhaps due to 
low-level expression and/or a dispersed sub-cellular localisation, and, unlike TbPrimPol2, 
treatment of cells with MMS did not enhance immunofluorescent detection of 
TbPrimPol1 (Lucy Glover and David Horn, personal communication). However, a small 
increase in the proportion of cells with sub-nuclear !H2A foci following TbPrimPol1 
knockdown was observed (Figure 3.23), suggestive of a nuclear role for this enzyme 
also. It would be interesting to determine whether TbPrimPol1 (and TbPrimPol2?) had 
any function in kDNA replication, as it is not uncommon for proteins to be localised to 
both compartments. But considering that the mitochondria of T. brucei already contain 
two AEP primases, which have been demonstrated to be required for kDNA replication 
(Hines and Ray, 2010; Hines and Ray, 2011), this may not be the case. Further work 
would be required to elucidate the role of the dispensable TbPrimPol1. 
 
DNA replication enzymes are potential targets for anti-trypanosomal drugs. The 
phenotype observed following TbPriL depletion was both rapid and lethal, as was the 
case for TbPrimPol2 also. Whilst other eukaryotes contain one essential AEP (the 
replicative DNA Primase), trypanosomes have evolved a DNA replication mechanism that 
requires two essential AEPs: the replicative DNA Primase to initiate DNA replication and 
TbPrimPol2, which is essential to complete DNA replication. This indicates that it is not 
only the mechanism of DNA replication initiation that has diverged in this parasite (Godoy 
et al., 2009; Tiengwe et al., 2012a), but a downstream process also. The TbPrimPol2-
dependant pathway poses a particularly attractive target for anti-trypanosomal drugs 
given that this pathway appears specific to trypanosomes, as higher eukaryotic PrimPol 
is not an essential protein (Julie Bianchi, Laura Bailey, Aidan Doherty, personal 
communication); further efforts could explore this topic. 
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Chapter 4 
 
PrimPol1 and 2 in the African trypanosome are 
trans-lesion synthesis DNA polymerases 
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4.1. Introduction 
Chapter 3 established that a PrimPol homologue in the divergent eukaryote and 
important human pathogen T. brucei was essential for survival. RNAi depletion of this 
homologue, called TbPrimPol2, caused the accumulation of DNA damage to the nuclear 
genome that resulted in an irreversible cell cycle arrest following the bulk of DNA 
synthesis. Further work in the laboratory of David Horn (LSHTM, London) demonstrated 
that TbPrimPol2 had a role in the DNA damage response, as it re-localised to sites of 
alkylation DNA damage. It was hypothesised that TbPrimPol2 may function in post-
replication repair, a DNA damage tolerance process that occurs after replication fork 
progression and requires specialised DNA polymerases. The aim of the current chapter 
was to characterise the in vitro activities of TbPrimPol2 (and 1), in particular whether 
these novel enzymes were capable of TLS, which would be consistent with a role in 
post-replication repair in the African trypanosome.  
  
4.2. Cloning the T. brucei PrimPol1 and PrimPol2 genes 
In order to characterise the enzymatic activities of TbPrimPol1 and 2 in vitro, the 
corresponding genes must first be cloned into an appropriate expression vector. The 
1827 base pair open reading frame corresponding to TbPrimPol1 (Tb927.5.4070), and 
the 2199 base pair open reading frame corresponding to TbPrimPol2 (Tb927.10.2520) 
were amplified from T. brucei (Lister 427 strain) genomic DNA (using primers in Table 2.6) 
and cloned individually into the E. coli expression vector pET28a, generating constructs 
pET28a:TbPrimPol1 and pET28a:TbPrimPol2 (Table 2.5). Each was cloned in frame with 
an amino-terminal 6-histidine tag and expression of these fusions was under the control 
of an IPTG-inducible promoter (Figure 4.1a).  
 
4.3. Expression of recombinant TbPrimPol1 and 2 in E. coli 
The TbPrimPol1 and TbPrimPol2 expression constructs were transformed into B834 
(DE3) pLysS (B834s) E. coli, the parental strain of the widely used BL21 with the addition 
of the pLysS plasmid encoding the bifunctional T7 lysozyme protein, which reduces 
leaky expression in addition to aiding cell lysis (Inouye et al., 1973; Moffatt and Studier, 
1987; Studier, 1991). Cultures were grown with the addition of zinc to stabilise the 
putative zinc finger motif of the TbPrimPol’s and expression was induced by addition of 
IPTG. Cells were then lysed and the soluble and insoluble fraction separated by 
centrifugation before analysis by Western blot with an anti-His antibody. HisTbPrimPol1 
has a predicted molecular weight of 70382.3 Da and following addition of IPTG a species 
of approximately 70 kDa was detected, but was largely in the insoluble cell lysate (Figure 
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4.1b). HisTbPrimPol2 had a predicted molecular weight of 84146 Da and following 
addition of IPTG a species of approximately 85 kDa was detected, again largely in the 
insoluble cell lysate (Figure 4.1b). Although both TbPrimPol1 and 2 expressed well 
following IPTG induction, further optimisation was required to improve the amount of 
soluble protein produced.  
 
A number of strategies were attempted to improve the yield of soluble protein; 
such as the use of E. coli strains that express addition tRNAs used in eukaryotes but 
rarely used in E. coli (e.g. Rosetta derivatives), and strains which enhance correct protein 
folding (e.g. SHuffle). However none proved successful (not shown), and so expression 
conditions were further optimised in B834s, which have been reported to produce 
significantly higher amounts of some target proteins when compared to BL21 strains 
(most strains attempted were BL21 derivatives) (Doherty et al., 1995). Various induction 
times and temperatures were tested, with lower temperatures for shorter times being 
found to be best, particularly for TbPrimPol2, which started to be degraded after 3 hours 
of expression (Figure 4.2a). Optimal conditions were a 3 hour induction at 25 oC, which 
produced some soluble TbPrimPol1 and 2 (Figure 4.2b). It was decided to purify this 
soluble protein, at least initially, rather than re-folding the insoluble protein, in order to 
prevent characterisation of mis-folded protein.  
 
4.4. Purification of recombinant TbPrimPol1 and 2  
Cultures of E. coli B843s transformed with either the TbPrimPol1 or TbPrimPol2 
expression construct were grown until exponential phase and induced for expression by 
addition of 1 mM IPTG for 3 hours at 25 oC. The soluble cell lysate was prepared and 
subjected to Ni2+-NTA agarose affinity chromatography, which will selectively bind the 6-
histidine tag fused to both the TbPrimPol’s. The bound TbPrimPol’s eluted over a range 
of imidazole concentrations (~70 – 300 mM, not shown), and so to concentrate the 
elution as much as possible, a single elution of 300 mM imidazole was performed. This 
successfully eluted TbPrimPol1 and 2, resolving with an apparent molecular mass of ~70 
and ~85 kDa respectively on an SDS-polyacrylamide gel (Figure 4.3), which was in 
agreement with their predicted molecular masses. Both TbPrimPol’s co-eluted with a 
substantial amount of a ~70 kDa E. coli contaminant (Figure 4.3a and b) and so further 
purification was required.   
 
Anion exchange chromatography was first tried to remove the E. coli 
contaminant, which separates proteins on the basis of charge, however both TbPrimPol1 
or 2 and the contaminant had the same elution profile (not shown). Rather it was heparin 
!""""#"""""$"""""%"""""&"""""'"""#("""")*+,-".*-/"01234567+89*6"
:694(4;5-"
<*
*=
:-
-5
>"
?!4"
'?4"
#!!4"
@'4"
'!4"
AB:"
C)*D>"8>DD">E/,:8/"
;5-2F1,5=1*D$"
!"#$%&'()*)"+,-."/"0#'&1,%&//"20'23'%&42.5"0607'859%".92:;'60<'*'"0'!"#$%&')'
G=H" I" 8+D/+,>" *J" !"# $%&'" -/,:56" K?%&-L" /,:6-J*,=>7" M5/)" .N2$?:O2F1,5=1*D$L" M:-" P,*M6" /*"
>E.*6>69:D" .):->" GQRB(!!H" :67" /)>6" #"=S" 0123" :77>7" /*" 567+8>" ;5-2F1,5=1*D$" >E.,>--5*6"
F>J*,>"568+F:9*6":/"$'"*<T"U:=.D>-"*J"/)>"8+D/+,>"M>,>"/:A>6":/"/)>"9=>-"56758:/>7":67"/)>"
>V+5W:D>6/" *J" !T#'"RB(!!" GQ&!" XPH"M:-" -+FY>8/>7" /*" UBU41I3N"M5/)" <**=:--5>" -/:5656P" :67"
C>-/>,6" FD*/" :6:DZ-5-" M5/)" :6" :694(;5-" :69F*7ZT" G>H" <+D/+,>-" *J" K?%&-L" /,:6-J*,=>7" M5/)"
>5/)>,".N2$?:O2F1,5=1*D#"*,".N2$?:O2F1,5=1*D$L"M>,>"567+8>7"M5/)"#"=S"0123":/"$'"*<"J*,"%"
)*+,-T"<>DD-"M>,>"/)>6"DZ->7":67"/)>"-*D+FD>":67"56-*D+FD>"J,:89*6-",>-*DW>7"FZ"UBU41I3N":67"
<**=:--5>"-/:56>7L"*,":6:DZ->7"FZ"C>-/>,6"FD*/"M5/)":6":694(;5-":69F*7ZT""
='
>'
AB:"
@'4"
'!4"
#!!4"
<**=:--5>"
:694(4;5-"
;5-2F1,5=1*D$"
;5-2F1,5=1*D#"
@'4"
!"#$
%&&#$
'()$
*+,-$ ./0)123$
!"#$
"&#$
.2456712879:;$
.2456712879:%$
!"#$%&'()*)'+$%",-./01'02'%&-034"1.15'64+%"3+078'.19':'2%03'!"#$%&'#
,$ <$ =$ >?:@?1/$ 9A$ !"# $%&'$ BC<D4$ @1)34A918/E$ F2@G$ /2@G/1$ 0H5;C)I56712879:;$ J;K$ 91$
0H5;C)I56712879:%$ J<K$ F)4$ L19F3$ @9$ /M093/3N):$ 0G)4/$ )3E$ 23E?>/E$ 6O$ )EE2N93$ 9A$ %$8+$
*75P$ )3E$ 23>?6)@/E$ A91$ <$ G9?14$ )@$ ;"$ 9-Q$ 5G/$ >/::4$ F/1/$ :O4/E$ )3E$ @G/$ 49:?6:/$ A1)>N93$
4?6R/>@/E$$@9$S2;T#S5,$)L)194/$>G198)@9L1)0GOQ$B9?3E$.2456712879:%$)3E$;$F/1/$F)4G/E$)3E$
@G/3$ /:?@/E$F2@G$ <&&$8+$ 282E)U9:/V$ E2:?@/E$ %&#A9:E$ @9$ 1/E?>/$ 4):@$ >93>/3@1)N93V$ )3E$ @G/3$
4?6R/>@/E$@9$G/0)123$)W32@O$>G198)@9L1)0GOV$4?>>/44A?::O$/:?N3L$.2456712879:%$)3E$;$F2@G$&Q"$
+$ S)-:Q$ X)80:/4$ A198$ /)>G$ 0?12Y>)N93$ 4@/0$ F/1/$ )3):O4/E$ 6O$ X(X#7,PH$ )3E$ -998)442/$
4@)2323LV$1/01/4/3@)NZ/$L/:4$A198$.2456712879:%$)3E$;$0?12Y>)N93$4G9F3Q$
;'
<'
! 77!
affinity chromatography that succeeded, which selects for DNA binding proteins as it is a 
phosphate mimetic. The Ni2+-NTA eluate was first diluted at least 10-fold to reduce the 
salt concentration and then applied to a heparin chromatography column. Both 
TbPrimPol1 and 2 and the E. coli contaminant bound to the column but the contaminant 
was eluted with a low salt wash, whilst both TbPrimPol1 and 2 eluted at 0.5 M NaCl 
(Figure 4.3a and b). The typical yield of purified recombinant TbPrimPol1 and 2 was 0.25 
mg and 0.1 mg respectively from a 3 litre culture. 
 
4.5. Production of catalytically inactive TbPrimPol1 and 2 mutants 
To be certain that the observed enzymatic activities were intrinsic properties of either 
TbPrimPol1 or 2, catalytically inactive mutants were made. Residues essential for 
catalysis in TbPrimPol1 and 2 can be predicted based on previous studies of AEP family 
members (Copeland and Tan, 1995; Augustin et al., 2001; Ito et al., 2003; Lao-Sirieix and 
Bell, 2004). The aspartic and glutamic acid residues in motif I of the AEP catalytic 
domain, predicted to be required for divalent metal binding which is essential to 
polymerase activity, were selected to be mutated to alanines; D165A E167A in 
TbPrimPol1 (TbPrimPol1 AxA) and D193A D195A in TbPrimPol2 (TbPrimPol2 AxA) 
(Figure 4.4). Complementary primers were designed (Table 2.6) to introduce these 
mutations into the TbPrimPol1 and 2 expression constructs by site-directed mutagenesis 
PCR, generating constructs pET28a:TbPrimPol1-AxA and pET28a:TbPrimPol2-AxA 
(Table 2.5). TbPrimPol1 and 2 AxA were expressed and purified in a similar manner to 
their wild-type counterparts (Figure 4.5). 
 
4.6. TbPrimPol1 and 2 are DNA-dependant DNA polymerases 
It was investigated whether TbPrimPol1 and 2 were capable of DNA polymerase activity 
using the primer extension assay. Primer extensions employ a DNA oligonucleotide 
primer containing a fluorescent moiety at the 5’ end annealed to a longer DNA 
oligonucleotide template, yielding double-stranded DNA with a 5’ over-hang (Figure 4.6). 
Addition of dNTPs to the 3’ end of the labelled primer by a DNA polymerase, in order to 
replicate the DNA template, will result in labelled products of decreasing electropheretic 
mobility. Incubation of the primer-template substrate with reaction buffer containing 
magnesium and either TbPrimPol1 and 2 or dNTPs resulted in no extension of the 
labelled primer (Figure 4.6, lanes 1, 2, and 7). However, following addition of both, full 
extension of the primer was observed (Figure 4.6, lanes 3-5 and 8-10). Mutation of active 
site residues of TbPrimPol1 and 2 resulted in no extension of the labelled primer (Figure 
4.6, lanes 6 and 11), indicating the DNA-dependant DNA polymerase activity was an 
intrinsic property of both TbPrimPol1 and 2. The majority of reaction products 
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synthesised by TbPrimPol1 and 2 were intermediates, even at high enzyme 
concentrations (Figure 4.6, lanes 5 and 10) suggesting these enzymes are of low 
processivity, requiring multiple binding events to the primer-template substrate in order 
to fully extend the primer. 
 
4.7. TbPrimPol1 and 2 are trans-lesion synthesis DNA polymerases 
It was next tested whether TbPrimPol2 (and 1) could perform TLS, as this would be 
consistent with a role for this enzyme in post-replication DNA damage tolerance. The 
previously described primer extension assay was employed using oligonucleotide 
templates containing site-specific replication-blocking DNA lesions, so that in order for 
TbPrimPol1 and 2 to fully extend the primer, they must perform TLS. 
 
4.7.1 Extension opposite a templated T-T CPD 
Well-characterised examples of DNA lesions that block replicative DNA polymerases are 
those caused by UV irradiation, such as CPDs and 6-4 photoproducts (Rastogi et al., 
2010). A DNA oligonucleotide template was synthesised containing a site-specific cis-
syn thymine-thymine (T-T) CPD and annealed to a shorter labelled DNA primer for use in 
a primer extension assay (Figure 4.7a). To be sure that the DNA lesion was a block for 
replicative DNA polymerases, a primer extension reaction was first performed with a 
replicative family-B polymerase, using the replicative polymerase from the archaeon 
Thermococcus gorgonarius Tgo-Pol (exo-) (gift from Stanislaw Jozwiakowski, GDSC, 
Brighton). Consistent with a CPD being a replication blocking lesion (Svoboda and Vos, 
1995; Lopes et al., 2006), Tgo-Pol was unable to fully extend the primer annealed to the 
CPD containing template and incorporated a single base opposite the 3’ T of the lesion 
(Figure 4.7a, lane 7). To ensure the integrity of the template beyond the CPD lesion, a 
modified Tgo-Pol was used that contains the Pol ζ finger domain (Tgo-Z3 Pol) (gift from 
Stanislaw Jozwiakowski; Jozwiakowski and Connolly, 2011). This polymerase was able 
to completely replicate the CPD containing template, performing TLS of the lesion, and 
more importantly ensuring the integrity of the DNA template after the CPD lesion (Figure 
4.7a lane 8). TbPrimPol1 and 2 were able to fully extend the labelled primer annealed to 
the undamaged template (Figure 4.7a, lanes 2 and 3). However, when the primer was 
annealed to the CPD containing template, both TbPrimPol1 and 2 stalled one base prior 
to the 3’ T of the lesion (Figure 4.7a, lanes 5 and 6). Together, these data indicate that 
TbPrimPol1 and 2 are incapable of reading through a templated T-T CPD. 
 
 TLS can occur by a two-step mechanism, in which one polymerase first 
incorporates opposite the lesion and a second polymerase extends from this 
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(mis)matched terminus (Sale et al., 2012). A possible extender role for TbPrimPol1 and 2 
in CPD bypass was next investigated. A labelled primer was designed and annealed to 
the CPD template so that a 3’ terminal adenine (A) was opposite the 3’ T of the dimer 
(Figure 4.7b). Whilst capable of fully extending from this primer terminus annealed to a 
non-damaged template (Figure 4.7, lanes 2 and 3), TbPrimPol1 and 2 were completely 
incapable of extending from this primer terminus when annealed opposite a CPD (Figure 
4.7b, lanes 5 and 6), indicating TbPrimPol1 and 2 cannot incorporate opposite the 5’ T of 
a CPD. A second substrate was designed with two 3’ terminal adenosines (AA) and 
annealed opposite both thymines of the templated CPD (Figure 4.7c). The control 
polymerase Tgo-Pol was completely incapable of extending the primer annealed to the 
damaged template (Figure 4.7c, lane 2), indicating that this primer terminus when 
annealed to a CPD lesion is a replication block. TbPrimPol1 and 2 were capable of fully 
extending the primer annealed to the CPD containing template strand (Figure 4.7, lanes 
13-15 and 17-19), however extension was less efficient than on the undamaged template 
(Figure 4.7 lanes 4-6 and 8-10). The observed TLS activity of TbPrimPol1 and 2 was an 
intrinsic property of the enzymes as no extension was observed from the catalytically 
dead mutants (Figure 4.7, lanes 16 and 20). In conclusion, although TbPrimPol1 and 2 
could not read-through a T-T CPD, or incorporate opposite the 5’ T of the lesion, they 
could extend from a terminal A-A paired with the CPD lesion, thus performing TLS. 
 
4.7.2. Error-prone bypass of a templated T-T 6-4 photoproduct 
The ability of TbPrimPol1 and 2 to replicate DNA containing a 6-4 photoproduct was next 
investigated. The 6-4 photoproduct is a potent replication-blocking lesion that highly 
distorts the DNA double helix (Rastogi et al., 2010). An oligonucleotide template 
containing a site-specific T-T 6-4 photoproduct (gift from Alan Lehmann, GDSC, 
Brighton) was annealed to a shorter labelled primer and used in a primer extension 
assay. Consistent with a 6-4 photoproduct being a replication blocking lesion, the 
control polymerase Tgo-Pol was unable to efficiently extend the primer annealed to the 
DNA lesion containing template, weakly inserting a single nucleotide (Figure 4.8, lane 2). 
TbPrimPol1 and 2 however, were able to insert nucleotides opposite the T-T 6-4 
photoproduct and extend from these nucleotides a total of 6 bases (Figure 4.8, lanes 13-
15 and 17-19), performing TLS of a 6-4 photoproduct. This striking activity was intrinsic 
to TbPrimPol1 and 2 as no extension was observed with the catalytically dead mutants 
(Figure 4.8, lanes 16 and 20). 
 
 As TbPrimPol1 and 2 can read-through a 6-4 photoproduct, it was next 
investigated whether this bypass was error-free or mutagenic. Primer extension assays 
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were carried out but rather than supplementing the reaction with all four dNTPs, each 
dNTP was supplied separately. On an undamaged template, both TbPrimPol1 and 2 
correctly incorporated two A’s opposite an undamaged T-T (Figure 4.9). In the presence 
of a T-T 6-4 photoproduct TbPrimPol1 and 2 incorporated T opposite the 3’ T of the 
lesion (Figure 4.9). A second substrate was annealed with a 3’ terminal T opposite the 3’ 
T of the templated lesion to determine what TbPrimPol1 and 2 insert opposite the 5’ T. 
Both enzymes inserted C or G opposite the 5’ T with similar efficiency (Figure 4.9). This 
choice of incorporation can also be seen in the previous read-through experiments 
(Figure 4.8, lanes 13-15). In conclusion, TbPrimPol1 or 2-dependant bypass of a T-T 6-4 
photoproduct is error-prone.  
 
4.7.3. Incorporate opposite a 3MeA analogue 
Replication blocking DNA lesions can also arise from alkylation damage, which can result 
from both environmental factors and endogenous sources such as metabolic processes 
(Fu et al, 2012). One such DNA lesion is caused by the methylation of adenine, producing 
3-methyladenine (3MeA), which accounts for ~20 % of base damage caused by SN2 
methylating agents (Hoffmann, 1980). 3MeA is an inherently unstable lesion and so an 
oligonucleotide template with a site-specific stable analogue of 3MeA, 3-deaza 3-
methyladenine (3dMeA) (gift from Roger Woodgate, NIH, Maryland) (Plosky et al., 2008), 
was annealed to a labelled primer and used in a primer extension assay. Consistent with 
previous studies demonstrating 3dMeA is a replication blocking lesion (Plosky et al., 
2008), the control polymerase Tgo-Pol was completely incapable of extending the 
labelled primer annealed to the 3dMeA containing template (Figure 4.10, lanes 1 and 2). 
In contrast, both TbPrimPol1 and 2 were able to extend the labelled primer annealed to 
the 3dMeA-containing template by a single base, incorporating opposite the 3dMeA 
lesion (Figure 4.10, lanes 13-15 and 17-19). No extension was observed from the 
catalytically dead mutants (Figure 10, lanes 16 and 20), indicating this TLS activity was 
an intrinsic property of TbPrimPol1 and 2. It was next investigated whether the 
TbPrimPol1 or 2-dependant incorporation opposite a 3dMeA lesion was error-free or 
error-prone using the previously described single incorporation primer extension assays. 
In both the absence and presence of a templated 3dMeA, TbPrimPol1 and 2 correctly 
inserted a T, although this insertion was less efficient opposite the damaged base (Figure 
4.11). This indicates that TbPrimPol1 and 2 incorporation opposite a 3dMeA is error-free. 
 
4.7.4. Bypass of a templated 8-oxo-guanine 
A common source of endogenous DNA damage are free-radical and non-radical 
oxidants that can modify individual bases, causing lesions such as 8-oxo-G, or cause 
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damage to the sugar backbone causing abasic sites. Although a templated 8-oxo-G 
does not majorly distort the DNA helix (McAuley-Hecht et al., 1994, Lipscombe et al., 
1995) it can result in stalling or decreased processivity of replicative polymerases, and it 
has been suggested that a polymerase switch mechanism, such as exists for UV 
photoproducts, may also exist for 8-oxo-G (McCulloch et al., 2009). In yeast, bypass of 
8-oxo-G has been suggested to occur in a post-replicative manner (de Padula et al., 
2004). 8-oxo-G is a mutagenic lesion, as replicative polymerases readily mis-incorporate 
A opposite a templated 8-oxo-G (reviewed in Berquist and Wilson, 2012). An 
oligonucleotide template containing a site-specific 8-oxo-G was used in a primer 
extension assay (Figure 4.12). The control polymerase Tgo-Pol was capable of fully 
extending the labelled primer annealed to the 8-oxo-G containing template, however 
significant stalling was observed at the lesion (Figure 4.12, lane 2). Both TbPrimPol1 and 
2 could fully extend the labelled primer also, however, a small decrease in processivity 
was observed when the primer was annealed to the 8-oxo-G containing template (Figure 
4.12, lanes 13-15 and 17-19). No extension was observed with the TbPrimPol1 and 2 
catalytic mutants confirming that the TLS activity observed was an intrinsic property of 
TbPrimPol1 and 2 (Figure 4.12, lanes 11 and 20). It was next investigated whether 
TbPrimPol1 and 2-dependant bypass of an 8-oxo-G was error-prone or error-free. A 
substrate was annealed so that the 3’ terminus of the labelled primer was annealed to 
the base 3’ of the 8-oxo-G lesion. Single incorporation primer extension experiments 
revealed that both TbPrimPol1 and 2 incorporated A and C opposite a templated 8-oxo-
G with similar efficiencies (Figure 4.13), suggesting TbPrimPol1 and 2 dependant bypass 
of a templated 8-oxo-G can be error-prone and error-free. 
 
4.7.5. Stall prior to a templated abasic site 
The ability of TbPrimPol1 and 2 to perform TLS of an abasic site was next tested. In 
addition to arising directly from DNA damage, abasic sites are also a common 
intermediate in BER, and can often be more harmful that the original base modification. 
An oligonucleotide with a site-specific abasic site was annealed to a shorter labelled 
primer and used in a primer extension assay. TbPrimPol1 and 2 were incapable of fully 
extending the labelled primer annealed to the abasic site-containing template, both 
stalling one base prior to the DNA lesion (Figure 4.14a), indicating TbPrimPol1 and 2 
cannot read-through an abasic lesion. It was next investigated whether TbPrimPol1 and 
2 could function as an extender in abasic site bypass. First, a substrate was annealed 
with a 3’ terminal A opposite the abasic lesion and the ability of TbPrimPol1 and 2 to 
extend the labelled primer was tested. Both enzymes were completely incapable of 
extending the labelled primer (Figure 4.14b). A second substrate was tested with a 3’ 
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terminal C annealed opposite the abasic site, and again no extension of the labelled 
primer was observed (Figure 4.14c). Both TbPrimPol1 and 2 did weakly extend the 
primer annealed to the non-damaged template, extending from a T:C mismatch (Figure 
4.14c), although this mismatch has been shown not to cause significant difficulty to DNA 
polymerases (Johnson and Beese, 2004) In conclusion, TbPrimPol1 and 2 cannot 
perform TLS of an abasic site in vitro. 
! 83!
4.8. Discussion  
The data presented in this chapter demonstrates that TbPrimPol1 and 2 are DNA-
dependant DNA polymerases in vitro, and are capable of TLS of replication blocking 
lesions (summarised in Table 4.1). Both TbPrimPol1 and 2 were capable of extension 
from bases opposite a T-T CPD, could remarkably catalyse error-prone read-through of 
a T-T 6-4 photoproduct, in addition to correctly inserting a single dT opposite a 3dMeA, 
and reading-through an 8-oxo-G incorporating dA and dC equally. TbPrimPol1 and 2 
could not read-through a T-T CPD or read-through and extend from an abasic site. 
These data suggest that TbPrimPol1 and 2 could function in TLS damage tolerance in 
the African trypanosome, whether reading-through, extending, or inserting opposite a 
DNA lesion. 
 
 The AEP superfamily is proving to be an extremely adaptable group of 
polymerases. In archaea and eukaryotes primases are required for the essential role of 
initiating DNA synthesis, and so it was widely accepted that AEPs are DNA-dependant 
RNA polymerases specialised in primer synthesis (Frick and Richardson, 2001). This was 
first questioned following the discovery of AEPs in prokaryotes (Koonin et al., 2000; 
Weller and Doherty, 2001), which use the evolutionarily unrelated DnaG Primase for 
replication, and further questioned with the discovery of versatile archaeal primase-
polymerases (Bocquier et al., 2001; Lipps et al., 2003). These prokaryotic and archaeal 
AEPs possess a number of nucleotidyl transferase activities and some have been shown 
to play distinct roles in DNA metabolism, such as DNA break repair in prokaryotes 
(Pitcher et al., 2007b; Brissett and Doherty, 2009). This diversity of AEPs is now 
extended into eukaryotes with the demonstration that PrimPol is capable of TLS of 
potent replication blocking DNA lesions. This activity is most likely attributed to the 
spacious and flexible AEP active site (Lipps et al., 2004; Pitcher et al., 2007a), which like 
Y-family polymerases is capable of accommodating major helix-distorting DNA lesions 
that the replicative polymerases cannot. It is because of the inherent adaptability of the 
AEP catalytic centre that these polymerases provide a good evolutionary candidate to 
overcome a range of DNA metabolic problems. 
 
TbPrimPol2 is expressed in the nuclei of G2/M cells, which will have completed 
the bulk if not all of DNA synthesis, and RNAi depletion of TbPrimPol2 leads to the 
accumulation of DNA damage and an irreversible cell cycle arrest following DNA 
replication (Chapter 3). It was hypothesised that this late- or post-DNA replication role 
could be post-replication repair, a DNA damage tolerance process that occurs following 
replication fork progression (Ulrich, 2011; Daigaku, 2012), and TLS activity of TbPrimPol2 
DNA adduct! Trans-lesion synthesis?! Error prone/free?!
CPD! extension from dAdA! -!
6-4 PP! read-through! error-prone!
3dMeA! insertion! error-free!
Abasic site! stall prior! -!
8-oxo-G! read-through! both!
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is entirely consistent with this hypothesis. Thus, the following model is proposed for the 
function of TbPrimPol2 (Figure 4.15). In every cell during each cell cycle, despite 
proficient DNA repair mechanisms, the replication machinery will inevitably encounter 
abnormal or damaged DNA templates, as a result of endogenous processes and 
environmental insults. This will result in stalling of the replication fork and so several 
mechanisms exist to overcome this problem. The DNA lesion can be bypassed at the 
fork by TLS or template switching, and also bypassed in a post-replicative manner. 
Replication initiated from adjacent origins can converge on the stalled fork allowing 
completion of the bulk of DNA synthesis, and replication can re-initiate downstream of 
the lesion by Okazaki fragment synthesis on the lagging strand and by re-priming on the 
leading strand (Heller and Marians, 2006; Lopes et al., 2006). This will result in a daughter 
strand with a single-stranded gap opposite the DNA lesion (post-replication gap). The 
current data suggests TbPrimPol2 is responsible for filling these gaps using its TLS 
activity, which it does following the bulk of DNA synthesis in late-S/G2 phase (Figure 
4.15), thereby restoring the DNA lesion within the safety of the double helix prior to cell 
division.  The phenomenon of post-replication repair has long been documented in 
bacteria, yeast, and mammals (Rupp and Howard-Flanders, 1968; Lehmann, 1972; Di 
Caprio and Cox, 1981). More recently it has been demonstrated elegantly in budding 
yeast that DNA damage tolerance can be completely separate from DNA replication and 
still be fully operational (Karras and Jentsch, 2010; Daigaku et al., 2010). In fact, in both 
budding yeast and human cultured cells, there is an actual preference for bypassing 
some DNA damage following the bulk of DNA synthesis rather than during DNA 
replication (Callegari and Kelly, 2006; Diamant et al., 2012). In support of this, the Y-
family polymerase REV1 in budding yeast is mainly expressed in G2/M cells, which is 
when it is suggested to perform its critical DNA damage bypass function (Waters and 
Walker, 2006), as could be possible for TbPrimPol2 here. In some instances, damage 
bypass in G2 has been shown to be more mutagenic than bypass during S-phase 
(Diamant et al., 2012), which may be consistent with the increased mutagenicity 
observed during late replication (Stamatoyannopoulos et al., 2009; Lang and Murray, 
2011). It is possible that TbPrimPol2 could contribute to the genetic diversity of T. brucei 
through mutagenic bypass of DNA damage. 
 
According to the model, in cells depleted of TbPrimPol2 the post-replication 
gaps would remain unfilled (Figure 4.15). Post-replication gaps have been shown to 
contribute to checkpoint activation leading to a G2/M arrest (Karras and Jentsch, 2010; 
Daigaku et al., 2010; Callegari et al., 2010), which could be consistent with the 4n arrest 
observed in TbPrimPol2 knockdown cells in the previous chapter. Also, post-replication 
!"#$%&'()*+
,)-.+/0'$$/+
!"#$%&'()*+
-"/0'-0/+
1'2340"-+/0-'*5+
3'#+-"6'%*/+
789-%69)$:+;$$/+
3'#+8<+7=>+
!"#$%&'()&"*+#,#-./#0"1#2**34#
?'#+2*/0'8$"@+
#-)&"//"5+0)+1>A+
B*+04"+'8/"*&"+),+
&4"&.#)%*0+5"$'<@+
3'#+#"-/%/0/+%*0)+
/28/"C2"*0+>D
#4'/"+
1>A+,)-6"5+
&'**)0+8"+
-"#'%-"5+8<+E!+
F+1GH+
6)5%;&'()*+
>D#4'/"+ ?:IJD#4'/"+
5(-6'3#789:8#;"43*#"<#1=3#3>>30?.*#'"*3#"<#$%&'()&"*+#46'(0-#@3**#/'"*(<3'.?"08#
B*+ '$$+ &"$$/+ 52-%*3+ "K"-<+ &"$$+ &<&$"@+ 04"+ 1GH+ -"#$%&'()*+6'&4%*"-<+ L%$$+ %*"K%0'8$<+ "*&)2*0"-+
'8*)-6'$+ )-+ 5'6'3"5+1GH+ 0"6#$'0"/+ 04'0+ -"/2$0+ %*+ 04"+ -"#$%&'()*+ ,)-.+ /0'$$%*3M+ !"#$%&'()*+
&'*+#-)&""5+5"/#%0"+04"/"+5'6'3"5+0"6#$'0"/+8<+-"#$%&'()*+-"/0'-0+N/4)L*+)*+$"'5%*3+/0-'*5O+
)-+ &)*K"-3"*&"+ ),+ '5P'&"*0+ -"#$%&)*/M+ 74%/+ L%$$+ &-"'0"+ '+ /%*3$"D/0-'*5"5+ 3'#+ )##)/%0"+ 04"+
5'6'3"5+ 0"6#$'0"M+ 74"+ #-)#)/"5+ -)$"+ ),+ 789-%69)$:+ %/+ 0)+ ;$$+ %*+ 04"/"+ 3'#/+ 2/%*3+ %0/+ 0-'*/D
$"/%)*+ 1GH+ /<*04"/%/+ '&(K%0<+ N3-""*+ $%*"O@+ 042/+ -"/0)-%*3+ 04"+ '8*)-6'$+ 0"6#$'0"+ %*+ 5)28$"D
/0-'*5"5+1GH+'*5+,'&%$%0'(*3+%0/+$'0"-+-"#'%-M+B,+789-%69)$:D5"#"*5'*0+5'6'3"+0)$"-'*&"+5)"/+
*)0+)#"-'0"@+04"+#)/0D-"#$%&'()*+3'#/+L%$$+#"-/%/0+'*5+"K"*02'$$<+,)-6+5)28$"D/0-'*5+8-"'./+%*+
04"+1GH@+04%/+L%$$+2$(6'0"$<+$"'5+0)+&"$$+5"'04M+
! 85!
gaps would be subject to further DNA metabolic processes, lead to double-strand 
breaks, and be substrates for HR (Elvers et al., 2011), which is in line with !H2A and 
Rad51 foci observed in the absence of TbPrimPol2 (Chapter 3). The phenotype observed 
in TbPrimPol2 knockdown cells has striking similarity to UV exposed REV1-/- or REV3L-/- 
mouse embryonic fibroblasts, which are capable of almost completely replicating their 
DNA, but single-stranded gaps remain encompassing the UV photoproduct that cause 
these cells to irreversibly arrest in G2 (Jansen et al., 2009a and b). One major difference 
between the studies referenced thus far, and the observations reported here, is that the 
phenotype resulting from TbPrimPol2 depletion (arrest, DNA damage, cell death) occurs 
in the absence of external challenges to DNA. This is intriguing as only one other TLS 
polymerase has been reported to be essential for normal cell proliferation, being 
mammalian Pol ζ (Lange et al., 2012). In the absence of Pol ζ, primary mouse fibroblasts 
accumulate replication-dependant strand breaks and chromosome aberrations during a 
single cell cycle, and following further cell divisions ultimately proceed through apoptosis 
(Lange et al., 2012). This again shows similarity to the phenotype observed in 
TbPrimPol2 depleted cells (Chapter 3), and so it’s possible a similar mechanism could be 
taking place here. 
 
The endogenously occurring DNA damage that is responsible for the severe 
phenotype observed in TbPrimPol2 depleted cells is unknown. TbPrimPol2 can bypass 
replication-blocking lesions such as the well-characterised UV photoproducts, but it is 
very unlikely that UV photoproducts occur naturally in these blood-borne parasites. 
However, what I have demonstrated is the inherent adaptability of the PrimPol catalytic 
centre to accept major helix-distorting lesions, such as 6-4 photoproducts, and so it is 
predictable that PrimPol could bypass other DNA lesions, which should be the topic of 
further investigation. Common sources of endogenous DNA damage include ROS, which 
has shown to be a contributing factor to Pol ζ’s essential role in mammalian cells (Lange 
et al., 2012). Also mis-incorporation of ribonucleotides into genomic DNA by the 
replicative polymerases has also been shown to pose a significant problem to replication 
(Reijns et al., 2012), and it has been demonstrated in budding yeast that a Pol ζ-
dependant post-replication repair mechanism is responsible for protecting cells against 
this (Lazzaro et al., 2012), and so TbPrimPol2 may be required for a similar role in T. 
brucei. It is also worth considering that T. brucei may be more susceptible to DNA 
damage; constitutive polycistronic transcription of their genome will involve removal of 
histones that exposes DNA to possible threats, and the non-transcribed strand will be 
transiently single-stranded further exposing the DNA to possible threats. Therefore it is 
conceivable that T. brucei may be more reliant on DNA damage tolerance and repair 
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pathways than other eukaryotes. This may also be the case considering the relatively few 
replication origins T. brucei use to replicate their genome (Tiengwe et al., 2012b), as 
these parasites may be more reliant on damage tolerance to complete genome 
duplication rather than convergence of adjacent replicons. TLS polymerases are also 
important for replicating structured DNA and difficult to replicate regions such as 
chromosomal fragile sites (Bétous et al., 2009; Rey et al., 2009), and so it is possible that 
rather than DNA damage, TbPrimPol2 could be required for replication of these difficult 
to replicate areas of the genome. 
 
 This chapter details the cloning, purification, and initial biochemical 
characterisation of TbPrimPol1 and 2. Further experiments should continue this study 
and define the catalytic capabilities of these novel enzymes, assaying for activities 
displayed by other AEPs, such as DNA-dependant RNA/DNA priming, RNA polymerase, 
and terminal transferase. Additionally, characterising the kinetics and fidelity of these two 
polymerases would be insightful. Given that TbPrimPol2 is an essential enzyme in 
bloodstream form T. brucei, biochemical and structural studies could develop inhibitors 
of this enzyme as a tentative drug target, given that higher eukaryotic PrimPol is not an 
essential enzyme (Julie Bianchi, Laura Bailey, Aidan Doherty, unpublished). Taken 
together, the work I have presented in this chapter and the preceding chapter describe a 
novel role for an AEP. Rather than initiation of DNA replication or DNA repair, the data I 
have presented are consistent with the novel primase-polymerase TbPrimPol2 being 
required for the tolerance of naturally occurring DNA damage in the pathogenic African 
trypanosome.  
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Chapter 5 
 
Localisation of PrimPol in human cells 
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5.1. Introduction 
The human genome is comprised of the DNA in the cell nucleus and mitochondrion. The 
nuclear genome is approximately 3 billion base pairs in length and exists packaged in 23 
chromosome pairs, with only a small fraction of this DNA containing the ~21,000 protein-
coding genes (Lander, 2011). In stark contrast, the mitochondrial genome economically 
compacts 37 genes into a double-stranded circular molecule of just 16,569 base pairs, 
and is dedicated in its entirety to the aerobic production of ATP (Holt, 2009). Whilst to 
date 14 DNA-dependant DNA polymerases are known to be located within the nucleus, 
required for the replication and maintenance of the nuclear genome, only a single DNA 
polymerase, Pol γ, is present within mitochondria. Pol γ is therefore implicated in all DNA 
synthetic processes that occur within this essential organelle, being responsible for both 
the replication and repair of mitochondrial (mt)DNA (Kaguni, 2004). Also in contrast to the 
nucleus, no DNA primase has been characterised in mitochondria. In the 1980’s primase 
activity from mitochondria was documented (Wong and Clayton, 1985) but the protein 
responsible was not identified, and it has subsequently been demonstrated that the 
mitochondrial RNA polymerase (POLRMT) is responsible for priming DNA synthesis (Xu 
and Clayton, 1986; Wanrooij et al., 2008; Fusté et al., 2010). Despite the core DNA 
replication and transcription machineries in mitochondria being distinct from those in the 
nucleus, many proteins involved in DNA repair are shared between these two organelles 
(Kazak et al., 2012). The human gene CCDC111 encodes a putative primase, identified 
by in silico analysis as a member of the AEP superfamily (Iyer et al., 2005). Unpublished 
experiments in the laboratories of Aidan Doherty and collaborator Luis Blanco (CBMSO, 
Madrid) have demonstrated that recombinant human CCDC111 possesses both primase 
and polymerase activities in vitro, and thus the protein was renamed PrimPol. The aim of 
the work presented in this chapter was to determine PrimPol’s sub-cellular localisation, 
as this would no doubt prove a key component in ascertaining the role of this novel 
enzyme in human cells. 
 
5.2. Immunofluorescent detection of PrimPol 
PrimPol lacks any high probability nuclear or mitochondrial localisation target signals 
(Aidan Doherty and Luis Blanco, personal communication). Low probability motifs can be 
identified in a number of prediction programs but they are often located within the 
predicted catalytic domain and are therefore unlikely to be genuine target signals (not 
shown). Immunofluorescent microscopy was first used to empirically determine the sub-
cellular localisation of human PrimPol. A polyclonal antibody raised against insoluble 
human PrimPol produced in E. coli (gift from Luis Blanco, CBMSO, Madrid) was affinity 
purified (Julie Bianchi and Aidan Doherty, unpublished) and used to detect endogenous 
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PrimPol in a number of human cell lines. Initial attempts however generated 
immunofluorescent images of poor quality (not shown), allowing limited conclusions to 
be made. Detection of transiently over-expressed PrimPol was next attempted, which 
was fused to either a green fluorescent protein (GFP) or haemagglutinin (HA) tag (for 
constructs see Table 2.8), but this again gave inconclusive results (not shown; Julie 
Bianchi and Aidan Doherty, unpublished). In an attempt to firmly establish the cellular 
localisation of PrimPol, it was decided to make a cell line stably over-expressing PrimPol 
fused to an epitope tag. 
 
5.2.1. Generation of a stable, inducible PrimPol expression cell line 
To make a cell line stably expressing epitope tagged PrimPol, the Flp Recombinase-
mediated Integration (Flp-In) Tetracycline-Regulated Expression (T-REx) system was 
chosen (overview in Figure 5.1). A derivative of HEK-293 cells (Flp-In T-REx-293) was 
used that contain a single Flp Recombinase Target (FRT) site integrated into a 
transcriptionally active genomic locus. The human PrimPol cDNA with a carboxyl-
terminal HA tag was amplified from pCI-Neo:PrimPol-HA (primers used in Table 2.9) and 
sub-cloned into the tetracycline/doxycycline-inducible expression vector 
pcDNA5/FRT/TO, also containing an FRT site. This generated the construct 
pcDNA5/FRT/TO:PrimPol-HA (Table 2.8) that was subsequently co-transfected into Flp-
In T-REx-293 cells along with a vector expressing Flp recombinase, resulting in the 
inducible PrimPol expression cassette recombining into the single FRT site. Due to this 
targeted integration, rather than selecting clones following antibiotic selection, the entire 
polyclonal population was pooled before testing for expression. A second cell line was 
also generated expressing PrimPol fused to carboxyl-terminal tandem Flag and Strep-
Tag-II epitopes, which was mainly used in later chapters. For this cell line the PrimPol 
cDNA was amplified from pcDNA5/FRT/TO:PrimPol-HA (using primers in Table 2.9) and 
sub-cloned into pcDNA5/FRT/TO:FLAG-Strep-II-Tag (gift from Ian Holt, MRC, 
Cambridge), generating the construct pcDNA5/FRT/TO:PrimPol-FLAG-Strep-II-Tag 
(Table 2.8). The cell line was generated in the same manner as previously described for 
HA-tagged PrimPol. 
 
To test for expression of the PrimPol and HA fusion (PrimPolHA) cells were grown 
in the presence or absence of 10 ng/ml doxycycline for 16-24 hours. Western blot 
analysis with an anti-PrimPol antibody detected endogenous PrimPol in both lysates, but 
cells grown in the presence of doxycycline also contained a slower migrating species of 
approximately 70 kDa, consistent with the predicted molecular weight of PrimPolHA 
(67075.2 Da) (Figure 5.2a). This species was also detected with an anti-HA antibody 
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(Figure 5.2a). Immunofluorescent detection of the HA epitope showed little to no 
immunofluoresence of cells grown in the absence of doxycycline, however in the 
presence of doxycycline, a strong signal was observed throughout the cells (Figure 5.2b), 
consistent with the induction of PrimPolHA expression. Taken together, these data show 
the successful generation of a stable cell line with inducible expression of HA-tagged 
PrimPol. 
 
5.2.2. Immunofluorescent detection of stably expressed recombinant PrimPol 
PrimPol is capable of primase and DNA polymerase activites and therefore would be 
expected to localise to the cell compartments containing DNA, being the nucleus and/or 
the mitochondrion. Cells induced for PrimPolHA expression were counterstained with the 
DNA intercalating dye DAPI and the mitochondrion-specific dye MitoTracker, to visualise 
nuclei and mitochondria respectively, and subjected to immunofluoresence analysis with 
an anti-HA antibody. PrimPolHA immunofluoresence was visible co-localising with both 
nuclei and mitochondria, however the co-localisation was not complete, with some 
cytoplasmic immunofluoresence visible (Figure 5.3). Similar results were also obtained 
with the cell line expressing PrimPol fused to tandem Flag and Strep-Tag-II eptitopes 
(not shown). These data suggest that PrimPol is present in both the nuclei and 
mitochondria of human cells. 
 
5.2.3. Immunofluorescent detection of endogenous PrimPol  
Although recombinant PrimPol over-expressed in human cells localises to nuclei and 
mitochondria, it is important to determine whether this is the case for endogenous 
PrimPol. This was difficult however, due to the limitations of the polyclonal antibody 
available at that time. Soluble human PrimPol was later produced of a high yield and 
purity using insect cells and this protein was used to affinity purify the polyclonal 
antibody, and also to generate a new polyclonal antibody (Julie Bianchi, Andrew Green, 
Aidan Doherty, unpublished), both of which proved much better for immunofluorescent 
detection of endogenous PrimPol. Various cultured human cells were subjected to 
immunofluorescent analysis with an anti-PrimPol antibody. Osteosarcoma 143B and 
U2OS cells, and non-diseased epithelial RPE cells, all gave a punctate PrimPol staining 
pattern throughout the cell (Figure 5.4). Counterstaining of these cells with DAPI and 
MitoTracker, to visualise nuclei and mitochondria respectively, revealed partial co-
localisation of PrimPol with these organelles (Figure 5.4), but to a lesser extent than over-
expressed PrimPol.  
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To determine whether the staining pattern observed was specific to the PrimPol 
protein, cells were transfected with a PrimPol siRNA prior to immunofluorescent staining. 
Western blot analysis of lysates prepared from these cells with an anti-PrimPol antibody 
shows the specific loss of an approximately 65 kDa species corresponding to PrimPol 
(Figure 5.5a). Immunofluorescent analysis of these cells revealed a substantial reduction 
of PrimPol immunofluorescent staining (Figure 5.5b), verifying the staining pattern was 
dependant upon the PrimPol protein. Taken together these data suggest that PrimPol is 
distributed throughout the cytoplasm, with some protein present in nuclei and 
mitochondria. 
 
5.3. PrimPol is a mitochondrial protein 
Immunofluoresence studies of over-expressed and endogenous PrimPol suggest a 
portion of this protein is mitochondrial in human cells. To investigate this further sub-
cellular fractionation experiments were performed on cultured human cells. 
 
5.3.1. PrimPol is present in a mitochondrial preparation 
Intact mitochondria were isolated from HEK-293 cells by differential centrifugation and 
their contents analysed by Western blot, along with the contents of the cytosol. The 
mitochondrial DNA polymerase accessory subunit PolG2 was detected exclusively in the 
mitochondrial preparation (Figure 5.6a), as would be expected, confirming the successful 
isolation of mitochondria. The detection of the cytoskeletal component β-actin was 
intended as a cytosolic marker but, consistent with a recent report (Reyes et al, 2011), it 
was also present in the mitochondrial preparation (Figure 5.6a). Although the majority of 
PrimPol was detected in the cytosolic fraction it was also visible in the mitochondrial 
preparation (Figure 5.6a). A similar result was also observed with mitochondria prepared 
from U2OS cells (not shown), which is consistent with the immunofluorescent studies, 
suggesting a portion of PrimPol is mitochondrial. 
 
5.3.2. PrimPol is retained in protease-treated mitochondria 
To confirm the presence of PrimPol inside mitochondria, rather than the possible 
association with the outer-mitochondrial membrane, a protease protection assay was 
carried out. Whole mitochondria were isolated from U2OS cells and then treated with the 
protease Proteinase K in the absence or presence of the detergent Triton X-100, and the 
remaining proteins analysed by Western blot. The mitochondrial protein PolG2 was 
detected in the mitochondrial preparation and the level of this protein remained the same 
following addition of Proteinase K (Figure 5.7, compare lanes 2 and 3 as more protein 
was loaded in lane 1). Following addition of Triton X-100, which permeabilises the 
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mitochondrial membrane and so exposes the proteins inside the mitochondria to 
Proteinase K, PolG2 was completely degraded (Figure 5.7, lane 4). This indicates that 
PolG2 was present inside the mitochondria as the double mitochondrial membrane 
protected PolG2 from proteolysis. A similar result was observed for PrimPol; PrimPol 
was retained in protease treated mitochondria and completely degraded following 
addition of Triton X-100 (Figure 5.7). Although, following addition of Proteinase K a 
reduction in the level of PrimPol protein was observed (Figure 5.7), indicating that some 
PrimPol protein was present outside the mitochondria. This data is consistent with the 
immunofluorescent studies confirming that some, but not all, PrimPol is present inside 
the mitochondria of cultured human cells. 
 
5.4. PrimPol is a nuclear protein, associating with chromatin 
Immunofluorescent studies also suggested PrimPol was present in the nuclei of human 
cells. Nuclear DNA metabolic processes occur in the context of chromatin, and so 
PrimPol’s presence on chromatin was next tested. A simple method to enrich for 
chromatin is to treat cells with a cytoskeletal buffer containing the detergent Triton X-
100, which permeabilises the cell and organelle membranes releasing the soluble 
proteins inside. A centrifugation step can then separate the Triton X-100 soluble 
components of the cell from the Triton X-100 insoluble components, the latter containing 
cellular sub-structures such as chromatin (Kannouche et al., 2004). Given PrimPol is a 
nucleic acid synthetic enzyme the association of PrimPol with chromatin was tested in 
cells synchronised in S-phase, in addition to an asynchronous cell population. To stall 
cells in early S-phase aphidicolin was used, a reversible inhibitor of the nuclear 
replicative (family-B) DNA polymerases (Wist and Prydz, 1979; Wright et al., 1994). 
 
 SV40-transformed non-diseased human (MRC5) fibroblasts were grown in the 
presence or absence of aphidicolin for 16 hours, and then the aphidicolin was removed 
and the cells allowed to grow for a further 3 hours. Analysis of the DNA content of these 
cells using PI staining and flow cytometery shows that the aphidicolin treatment 
successfully stalled the cells in early S-phase, and removal of the aphidicolin allowed the 
cells to progress synchronously through S-phase (Figure 5.8a). These cells were 
separated into Triton X-100 soluble and insoluble fractions and analysed by Western 
blot. The chromatin component histone H1 was almost exclusively detected in the 
insoluble fractions, indicating the enrichment of chromatin in these samples (Figure 
5.8b). Very little insoluble PrimPol was observed in asynchronous cells, however, a 
marked increase of insoluble PrimPol was observed in cells arrested in early S-phase 
(Figure 5.8b). Release of the early S-phase arrest, allowing cells to progress 
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synchronously through S-phase, led to the level of insoluble PrimPol decreasing to 
almost the level observed in asynchronous cells (Figure 5.8b). This suggests that PrimPol 
does associate with chromatin in S-phase, but during unperturbed DNA replication the 
level of chromatin bound PrimPol may be below the detection limit if present at all. The 
stalling of cells in S-phase with aphidicolin will cause extensive replication fork stalling 
due to the stalled replicative DNA polymerase functionally uncoupling from the MCM-
helicase complex, and under these circumstances chromatin bound PCNA becomes 
mono-ubiquitinated (Kannouche et al., 2004; Chang et al., 2006). In line with this an 
increase in insoluble mono-ubiquitnated PCNA was observed following aphidicolin 
treatment (Figure 5.8b). As it is under these circumstances when PrimPol’s association 
with chromatin is more apparent, it is possible that PrimPol may play a role at stalled 
replication forks. Taken together with the immunofluorescent analysis of over-expressed 
and endogenous PrimPol, these data suggest this novel enzyme is localised to nuclei in 
addition to the mitochondrion. 
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5.5. Discussion 
DNA is found in two locations within human cells, inside nuclei and inside mitochondria, 
and it is within these organelles PrimPol was detected. Immunofluorescent detection of 
endogenous and over-expressed recombinant PrimPol in human cultured cells showed 
PrimPol was present in the nucleus and cytoplasm, with a portion of the latter being 
mitochondrial. Sub-cellular fractionation experiments confirmed that PrimPol was 
present in human mitochondria. PrimPol was also found to associate with chromatin, 
consistent with its presence in nuclei, and its association became much more apparent 
when cells were arrested during DNA replication. This dual localisation of PrimPol is 
achieved despite the apparent lack of localisation target signals, however this is not 
uncommon, a prime example being the replicative primase Prim1, which “piggy backs” 
upon its accessory subunit Prim2 in order to localise to the nucleus (Mizuno et al., 1996). 
The implications of the dual localisation of PrimPol to the nucleus and mitochondrion are 
discussed below. 
 
5.5.1. PrimPol – a novel mitochondrial primase-polymerase in human cells 
PrimPol is capable of both primer synthesis and DNA chain elongation in vitro (Aidan 
Doherty and Luis Blanco, unpublished), but determining its in vivo activity will no doubt 
prove difficult. However, regardless of whether PrimPol is a primase, polymerase, or 
perhaps both in vivo, there are a number of important implications of the work presented 
in this chapter. Firstly, Pol γ is no longer the sole mitochondrial DNA polymerase in 
human cells, and so the assumption that Pol γ is involved in all DNA synthetic processes 
within this organelle needs to be re-addressed. It is well established that Pol γ is the 
mtDNA replicase; inactivation of its 3’-5’ exonuclease proofreading domain in mice 
results in the accumulation of mutations and deletions in mtDNA (Trifunovic et al., 2004), 
and further, deletion of the catalytic subunit results in early developmental arrest during 
embryogenesis due to mtDNA depletion, demonstrating that Pol γ is the only DNA 
polymerase able to maintain mammalian mtDNA (Hance et al., 2005). Pol γ also has a 
fairly well-established role in mitochondrial BER, as this enzyme posses dRP-lyase and 
gap-filling activity required for short-patch BER (Longley et al., 1998) and functionally 
interacts with helicase/nuclease DNA2 and flap-endonuclease FEN1 in long-patch BER 
(Liu et al., 2008; Zheng et al., 2008). The role of Pol γ in other mtDNA metabolic 
processes however, is less well understood. For instance it is inevitable that some DNA 
damage will escape repair and encounter the replication machinery, especially as mtDNA 
replication is constitutive and there is an apparent lack of NER in this organelle (Cline, 
2012), which is required for removing bulky replication blocking lesions from the nuclear 
genome. In the nucleus a group of flexible TLS polymerases exist specifically for this 
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scenario, and it would be assumed that the high fidelity of Pol γ and proofreading activity 
would not be compatible with significant TLS activity. Indeed, lesions which create little 
distortion in the DNA helix such as a templated 8-oxo-G, a common lesion in 
mitochondria due to the close proximity of ROS production, poses a significant block to 
human Pol γ (Graziewicz et al., 2007). Pol γ itself is also a major target of oxidative 
damage in mitochondria, and this has been shown to have detrimental effects on its 
replication and repair capabilities (Graziewicz et al., 2002). Bulky helix-distorting DNA 
lesions such as CPDs caused by UV radiation pose a severe block to Pol γ in vitro 
(Kasiviswanathan et al., 2012), and would therefore be expected to stall DNA replication. 
It is noteworthy that REV3, the catalytic subunit of Pol ζ, and REV1, which are well 
known players in nuclear TLS, are present within yeast mitochondria (Zhang et al., 2006); 
and it is also noteworthy that PrimPol is absent from all but one fungus. In addition to 
damage tolerance, the majority of DNA repair mechanisms identified in the nucleus 
require a DNA polymerase (Lange et al., 2011), and it is possible that with regards to 
mitochondria, this polymerase could by PrimPol. A counter argument for the relative 
simplicity of mtDNA repair mechanisms, rather than the lack of identified proteins 
involved, is that mtDNA is polyploid, and so it is not essential to maintain every copy of 
the mitochondrial genome to allow the mitochondria and cell to function correctly, rather 
only a small population of mtDNA molecules (reviewed in Larson, 2010). 
 
 In addition to being a novel mitochondrial DNA polymerase, PrimPol is also a 
primase. Primase activity was first detected in human mitochondria almost three 
decades ago but the enzyme responsible was not identified (Wong and Clayton, 1985). 
Since then it has become clear that mitochondria do not require a dedicated primase to 
initiate replication. It has been demonstrated that RNA transcripts synthesised by 
POLRMT prime leading strand synthesis (Xu and Clayton, 1996), and more recently that 
POLRMT is also a dedicated lagging strand primase (Wanrooij et al., 2008; Fusté et al., 
2010). Results from these studies, and the fact that the mystery primase identified in 
1985 was associated with structural RNA that was required for primase activity (Wong 
and Clayton, 1986), a feature not yet observed for PrimPol (Luis Blanco and Aidan 
Doherty, personal communication), strongly suggests that PrimPol is not the long sought 
after mitochondrial replicative primase. In addition to initiation of DNA synthesis, 
primases have also been implicated in replication restart. It has been demonstrated in 
bacteria that when a replication fork encounters a blocking DNA lesion, re-priming can 
occur downstream of the lesion to facilitate replication progression (Heller and Marians, 
2006; Yeeles and Marians, 2012). PrimPol could play a similar role in mitochondria, 
although this is highly speculative. 
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5.5.2. PrimPol – a novel primase-polymerase in the nuclei of human cells 
In addition to the impact upon our understanding of mtDNA metabolism, PrimPol was 
also present in the nuclei of human cells. Eukaryotic nuclei already contain a dedicated 
replicative DNA primase that exists associated to the family-B polymerase Pol α, which 
is responsible for initiating DNA synthesis at replication origins and Okazaki fragments 
(reviewed in Muzi-Falconi et al., 2003). Given that each subunit of the Pol α-Prim 
complex is essential for cell viability (Lucchini et al., 1987; Foiani et al., 1989; Sugino, 
1995; Muzi-Falconi et al., 2003) it is unlikely that PrimPol plays a similar role in DNA 
replication. The only other foreseeable role for a primase is to restart DNA synthesis 
when replication stalls, as demonstrated in E. coli (Heller and Marians, 2006; Yeeles and 
Marians, 2012) and suggested to occur in yeast (Lopez et al., 2006; reviewed in Lehmann 
and Fuchs, 2006). However in E. coli it is the replicative DnaG primase that is responsible 
(Heller and Marians, 2006; Yeeles and Marians, 2012). Additionally, all but one fungus do 
not contain PrimPol, so again the role would be presumably carried out by Pol α-Prim, 
as implied by Marini and collegeues (1997).  
 
PrimPol can also be added to the ever-growing list of DNA polymerases present 
in the nuclei of human cells. As in the nucleus there are a much greater variety of DNA 
polymerases it is difficult to speculate possible roles, more so than in the relatively 
simple mitochondrion. Further phenotypic experiments will be required to delineate the 
role of PrimPol in human cells. However speculated roles in DNA repair and damage 
tolerance, whether re-priming or TLS, are possible. In bacteria AEP-like enzymes have 
been shown to be dedicated NHEJ polymerases required for the repair of double-strand 
breaks in DNA (Della et al., 2004; Brissett and Doherty, 2009); this could be a role for 
PrimPol, although the nuclei of human cells contain an abundance of NHEJ polymerases 
from the X-family. The observation that PrimPol becomes chromatin bound when DNA 
replication is stalled, but lesser so when cells are progressing through S-phase, suggests 
that PrimPol may not be required during unperturbed DNA replication, and may play a 
role in the cellular response to stalled replication forks. This is investigated further in the 
following chapter. 
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Chapter 6 
 
PrimPol, a new player in DNA damage tolerance in 
human cells 
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6.1. Introduction 
Chapter 5 established that human PrimPol is present in both the nucleus and 
mitochondrion. The aim of the current chapter was to build upon these findings, together 
with other data obtained in the Doherty lab, and uncover the specific cellular function(s) 
of PrimPol. Early experiments in the Doherty lab involved the disruption of the PrimPol 
gene in chicken DT40 cells, and it became evident that as a result of PrimPol deletion 
these cells became sensitive to UV-C radiation (Julie Bianchi and Aidan Doherty, 
unpublished). Exposure of cells to UV-C light results in the formation of covalent linkages 
between adjacent pyrimidines on the same DNA strand, primarily producing CPDs and 
6-4 photoproducts. These DNA lesions significantly distort the DNA helix and therefore 
pose a significant block to DNA metabolic processes such as DNA replication and 
transcription (Batista et al., 2009; Rastogi et al., 2010). DNA polymerases are required for 
the repair of these lesions during the DNA synthetic step of NER (Lehmann, 2011), and 
also required for the tolerance of these potentially lethal lesions during DNA replication, 
which is largely performed by the Y-family DNA polymerases (Sale et al., 2012). Primases 
have also been implicated in DNA damage tolerance, being required to re-prime 
downstream of DNA lesions thereby allowing continued progression of the replication 
fork. This has been demonstrated in bacteria (Heller and Marians, 2006; Yeeles and 
Marians, 2012) and evidence exists that it also occurs in eukaryotes (Lehmann, 1972; 
Lopez et al., 2006; Elvers et al., 2011). The following experiments explore the role of 
human PrimPol in the cellular response to UV-C radiation. 
 
6.2. PrimPol re-localises in the nucleus following UV-C irradiation 
I first explored whether UV-C irradiation had an effect on the sub-cellular localisation of 
PrimPol. This was done first using the Flp-In T-REx-293 cells (HEK-293 derivative) 
engineered for inducible expression of recombinant PrimPol, which is expressed fused to 
either a carboxyl-terminal HA or tandem Flag-Strep-Tag-II (see section 5.2.1). As 
discussed in Chapter 5, both the nuclear and mitochondrial localisation is much more 
apparent when PrimPol is stably over-expressed in these cells (Figure 5.3).  
 
6.2.1. PrimPol assembles into detergent-resistant foci in UV-C irradiated cells  
The Flp-In T-REx-293 cells over-expressing recombinant PrimPol were either mock-
irradiated or exposed to 30 J/m2 UV-C light and then analysed by immunofluoresence 
microscopy following various recovery times (Figure 6.1a). Exposure of cells to UV-C 
radiation resulted in no obvious change in the observed localisation of PrimPol, whether 
cells were analysed following a 1, 8, or 24 hour recovery after irradiation (Figure 6.1b). To 
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visualise chromatin associated proteins, as this would be the presumed location of active 
DNA metabolising enzymes within the nucleus, cells were washed with a Triton X-100 
containing buffer prior to fixation (termed pre-extraction). This permeabilises cells in situ, 
removing the majority of soluble proteins leaving only those bound to cellular structures 
such as chromatin (Kannouche et al., 2001). In mock-irradiated cells, over-expressed 
PrimPol was more or less undetectable following pre-extraction (Figure 6.1b). However, 
following exposure to 30 J/m2 UV-C radiation, PrimPol was visible as multiple tiny bright 
spots within ~40 % of nuclei (Figure 6.1b), numbering between 50 and several hundred 
per cell (Figure 6.1c). These UV-C induced focal accumulations of PrimPol were 
observed in 2 independent stable cell lines, being present 1 hour after irradiation and 
persisting for at least 24 hours. Together, these data show that PrimPol re-localises 
following exposure of cells to UV-C radiation, and becomes tightly associated with a 
nuclear sub-structure, which is presumably chromatin. 
 
6.2.2. PrimPol foci assemble in a UV-C dose-dependant manner 
To further investigate the relationship between PrimPol foci and UV-C radiation, PrimPol 
over-expressing cells were exposed to a range of UV-C doses before pre-extraction and 
immunofluorescent analysis. Exposure of cells to 5 J/m2 UV-C radiation resulted in very 
little to no detectable PrimPol foci (Figure 6.2a). Following 10 J/m2 UV-C radiation around 
10 % of cells presented focal PrimPol, which increased to almost 40 % following 
irradiation with 30 J/m2 UV-C (Figure 6.2a). This appeared to be the upper limit of 
PrimPol focal cells. These data indicate that PrimPol accumulates into sub-nuclear 
detergent-resistant foci in a UV-C dose dependant manner. 
 
6.2.3. PrimPol foci do not assemble following exposure to ionising radiation 
To test whether PrimPol’s re-localisation following UV-C irradiation was a non-specific 
cellular response to DNA damage, the distribution of over-expressed PrimPol was 
monitored following exposure of cells to ionising radiation, which produces both single-
strand and double-strand breaks in DNA (Ward, 1975). Immunofluorescent analysis of 
pre-extracted cells revealed no focal accumulation of PrimPol following exposure to 5 Gy 
X-radiation, with little to no PrimPol being detected following recovery times varying from 
1-24 hours (Figure 6.3). This suggests that focal accumulation of PrimPol only occurs 
following the production of specific DNA lesions, such as those caused by UV-C 
irradiation. 
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6.3. Does PrimPol re-localise to stalled replication forks?  
Collision of a replicative DNA polymerase with a DNA lesion can cause functional 
uncoupling of the MCM helicase complex and DNA polymerase, which in turn produces 
long tracts of unwound single-stranded DNA that becomes coated with the single-
stranded DNA binding protein RPA (Byun et al, 2005). These long stretches of single-
stranded DNA have actually been visualised in vivo by electron microscopy in yeast 
(Lopez et al., 2006). Following treatment of cells with replication fork blocking agents 
RPA re-localises into detergent-resistant sub-nuclear foci (Vassin et al, 2004; Robison et 
al, 2004) thought to represent these long stretches of RPA-coated single-stranded DNA 
rather than sites of DNA repair such as NER (Despras et al., 2010; Pathania et al, 2011; 
Diamant et al., 2012). It was therefore investigated whether PrimPol co-localised with 
RPA following UV-C irradiation, as this would suggest PrimPol was present at replication 
forks stalled at UV photoproducts. Following exposure of cells over-expressing PrimPol 
to UV-C radiation, all cells that were focal for RPA2 were also focal for PrimPol (Figure 
6.4a), suggesting PrimPol foci occur during S-phase. Furthermore, a proportion of 
PrimPol foci co-localised with RPA foci (Figure 6.4a and b), suggesting PrimPol was 
localised at a sub-population of stalled replication forks.  
  
 To investigate this further, cells over-expressing PrimPol were UV-C irradiated 
and during a 1 hour recovery, pulse labelled with EdU (5-ethynyl-2’-deoxyuridine) (Figure 
6.5a), a nucleoside analogue of thymidine that would be incorporated into DNA during 
DNA synthesis. Therefore immunofluorescent detection of EdU would allow 
determination of S-phase cells in an asynchronous population, and it was tested whether 
these cells contained focal PrimPol following UV-C irradiation. The vast majority of cells 
focal for PrimPol also contained EdU staining, and were therefore S-phase cells, 
following exposure to 15 J/m2 UV-C radiation (Figure 6.5b). This suggests that UV-C 
induced focal accumulation of PrimPol occurs in S-phase cells. Although this last result 
is preliminary, taken together with the co-incidence of PrimPol and RPA foci, these data 
suggest that re-localisation of PrimPol in UV-C irradiated cells occurs during S-phase, 
and that a proportion of PrimPol may localise to replication forks stalled at UV 
photoproducts. This would be consistent with the previous observation that the upper 
limit of PrimPol focal cells in an asynchronous population was ~40 % (Figure 6.2a), 
which would correspond to the proportion of S-phase cells in an asynchronous 
population.  
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6.4. PrimPol associates tightly with chromatin in UV-C irradiated cells 
The accumulation of PrimPol into detergent resistant sub-nuclear foci would be 
consistent with PrimPol being associated to chromatin. To test this, chromatin was 
prepared from UV-C irradiated cells using the method described in the previous chapter 
(section 5.4). Briefly, cells were resuspended in a cytoskeletal buffer containing Triton X-
100 and the resulting soluble and insoluble fractions were then separated by 
centrifugation. Cellular sub-structures such as chromatin are enriched in the Triton 
insoluble fraction. 
 
6.4.1. Recombinant PrimPol associates with chromatin in UV-C irradiated cells 
The Flp-In T-REx-293 cells over-expressing recombinant PrimPol were either mock-
irradiated or exposed to 30 J/m2 UV-C radiation, and following a 1 or 8 hour recovery, 
the Triton soluble and insoluble fractions were prepared and analysed by Western blot 
(Figure 6.6a). The chromatin component Histone H1 was exclusively detected in the 
insoluble fraction (Figure 6.6b), indicating this fraction was enriched for chromatin. 
Mono-ubiquitinated PCNA, visible following UV-C irradiation, was also predominantly in 
the insoluble fraction reflecting the role of this protein at replication forks stalled at UV 
photoproducts (Kannouche et al., 2004; Chang et al., 2006). In mock-irradiated cells 
PrimPol was detected in the insoluble fraction, albeit at low levels (Figure 6.6b), however 
following exposure of cells to 30 J/m2 UV-C radiation, the level of insoluble PrimPol 
increased substantially (Figure 6.6b). Given that the total level of PrimPol did not change 
following irradiation, whilst the level of soluble PrimPol decreased (Figure 6.6b), this is 
consistent with a re-distribution of the PrimPol cellular pool following irradiation, which 
may not be surprising given PrimPol was ectopically expressed. The mtDNA replicase 
Pol γ was also present in the insoluble fraction, and actually became more insoluble 
following irradiation (Figure 6.6b). However, given that PrimPol assembles into sub-
nuclear foci, the increase of insoluble PrimPol following UV-C irradiation most likely 
reflects association of PrimPol with a nuclear sub-structure, presumably chromatin.  
 
To determine unequivocally PrimPol’s association with chromatin, the Triton X-
100 insoluble fraction from UV-C irradiated cells was treated with DNase, and further 
separated into soluble and insoluble fractions by centrifugation (Figure 6.7a). Consistent 
with a previous report, this completely solubilised mono-ubiquitinated PCNA (Figure 
6.7b), which will be bound to DNA at stalled replication forks (Kannouche et al, 2004). 
Similarly, PrimPol was almost completely solubilised by DNase treatment (Figure 6.7b), 
confirming that PrimPol becomes insoluble following UV-C irradiation due to its 
association with DNA. 
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6.4.2. Endogenous PrimPol becomes Triton insoluble in UV-C irradiated cells 
The previous immunofluorescent and sub-cellular fractionation experiments were 
performed using cells over-expressing recombinant PrimPol, as this increased the 
likelihood of detecting changes in PrimPol localisation. It is important to determine 
whether endogenous PrimPol also re-localises following UV-C irradiation. To that end, 
SV40-transformed non-diseased (MRC5) fibroblasts were separated into Triton X-100 
soluble and insoluble fractions following UV-C irradiation and analysed by Western blot. 
Both Histone H1 and mono-ubiquitinated PCNA were enriched in the insoluble fraction 
(Figure 6.8). Very little PrimPol was insoluble in mock-irradiated cells, however following 
UV-C irradiation, a substantial increase of insoluble PrimPol was visible (Figure 6.8), 
consistent with the observations of over-expressed PrimPol. Also, the total level of 
PrimPol did not change following irradiation (Figure 6.8) suggesting there is a re-
distribution of the PrimPol cellular pool. Taken together, these data suggest that 
following exposure of cells to UV-C irradiation the soluble pool of PrimPol re-localises 
and tightly associates with chromatin at a number of discrete locations, possibly 
replication forks stalled at UV photoproducts, where presumably it is required for a 
nucleic acid synthetic process.  
 
6.5. RNAi depletion of PrimPol in normal and XP-V patient cells 
Given the re-localisation of PrimPol onto chromatin following UV-C irradiation, it was 
speculated that PrimPol could play a role in the tolerance of UV photoproducts. To 
explore this possibility, experiments were performed on SV40-transformed normal 
(MRC5) and XP-V patient derived (XP30RO) fibroblasts treated with PrimPol RNAi. XP-V 
is an inherited disorder characterised by sunlight hypersensitivity and a high incidence of 
skin cancers due to a mutation in the gene encoding Pol η (Masutani et al., 1999b; 
Johnson et al., 1999b), the Y-family polymerase which is highly specialised to accurately 
and efficiently bypass the most common UV photoproduct (Johnson et al., 1999a; 
McCulloch et al., 2004; Silverstein et al., 2010; Biertümpfel et al., 2010). By using cells 
that are deficient in a major UV DNA damage tolerance pathway, the role of PrimPol 
within the cell may become more apparent. PrimPol was efficiently depleted using RNAi 
in both normal and XP-V fibroblasts (Figure 6.9a), and it is noteworthy that a significant 
growth defect was observed in both cell lines, and this growth defect was much more 
pronounced in XP-V cells (Figure 6.9b).  
 
6.5.1. PrimPol is required for the tolerance of UV-C induced DNA damage 
Defects in the tolerance of UV-induced DNA damage lead to enhanced activation of the 
intra-S checkpoint following exposure of cells to UV-C radiation, which was shown not to 
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be the case for defects in the NER pathway required to remove UV photoproducts 
(Bomgarden et al., 2006). RPA-coated single-stranded DNA is an initial trigger of the 
intra-S checkpoint, produced when the replisome encounters a UV photoproduct and 
functional uncoupling of leading and lagging strand synthesis occurs (Chang and 
Cimprich, 2009). Normal and XP-V fibroblasts were treated with two rounds of mock or 
PrimPol RNAi and then exposed to 10 J/m2 UV-C radiation. Following a 6 hour recovery 
these cells were detergent extracted and subjected to immunofluorescent analysis to 
detect RPA2 (Figure 6.10a). In mock-irradiated cells very little to no RPA was detected 
(Figure 6.10b), consistent with no great perturbation of DNA replication. UV-C irradiation 
of normal fibroblasts resulted in ~20 % of cells containing sub-nuclear detergent-
resistant RPA foci, which increased significantly to ~30 % in PrimPol RNAi treated cells 
(Figure 6.10b). This indicates a greater proportion of chromatin-associated RPA in UV-C 
irradiated PrimPol depleted cells, which would be consistent with increased replication 
fork stalling at UV photoproducts and therefore more RPA-coated single-stranded DNA. 
DNA replication in UV-C irradiated XP-V cells was already substantially perturbed, as to 
be expected (Despras et al., 2010; Elvers et al., 2012), and so no significant increase 
from ~30 % of focal RPA cells was observed following PrimPol RNAi (Figure 6.10b). This 
is because detergent-resistant RPA foci following UV-C irradiation occur in S-phase 
cells, and in an asynchrounous population, 30-40 % of cells will be in S-phase. 
 
 The formation of RPA-coated single-stranded DNA recruits and activates the 
ATR kinase that phosphorylates its main effector kinase Chk1 (Kaufmann, 2010). 
Previous studies of XP-V cells found that a low dose of 2 J/m2 UV-C led to an S-phase 
delay and over-activation of the intra-S checkpoint (Bullock et al., 2001; Cordeiro-Stone 
et al., 2002; Despras et al, 2010). For this reason, both normal and XP-V fibroblasts 
treated with mock or PrimPol RNAi were exposed to 2 J/m2 UV-C radiation and the level 
of Chk1 phosphorylation on serine 345 determined, as this reflects the level of Chk1 
activation (Capasso et al., 2002). RNAi depletion of PrimPol resulted in over-activation of 
Chk1 in UV-C irradiated normal fibroblasts, which was visible 3 hours after irradiation 
and had returned almost to basal levels following 24 hours (Figure 6.11b). XP-V cells 
showed substantially more Chk1 activation following UV-C irradiation (Figure 6.11b), 
indicating a greater perturbation of DNA replication in the absence of Pol η than in the 
absence of PrimPol. PrimPol depletion in XP-V cells did not increase the initial level of 
Chk1 activation, however Chk1 activation was persistent in these cells, remaining at a 
similar level 24 hours after irradiation (Figure 6.11b). Consistent with this, 24 hours after 
UV-C irradiation an increase in hyperphosphorylated RPA2 was also observed, which is 
a direct downstream target of ATR, and is phosphorylated following perturbation of DNA 
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replication (Olson et al., 2006) (Figure 6.11b). Taken together, these data indicate that 
PrimPol is required for the proper cellular response to low dose UV-C radiation in normal 
and XP-V cells. These data suggest that in the absence of PrimPol, UV-C irradiation 
produces a greater number of stalled replication forks that in turn over-activate the intra-
S checkpoint. Further, these data implicate PrimPol in the tolerance of UV-induced DNA 
damage. 
 
6.5.2. PrimPol protects XP-V, but not normal cells, from UV-C cytotoxicity 
It was next investigated whether PrimPol contributed to cell survival following UV-C 
irradiation in both normal and XP-V fibroblasts, using the clonogenic survival assay. This 
tests the ability of a cell to survive a particular cytotoxic threat and continue to proliferate 
indefinitely, forming a large colony of cells visible by the naked eye. The following 
survivals were performed in the absence of a low concentration of caffeine, which is 
widely used in the literature and renders XP-V cells hypersensitive to UV-C killing (Arlett 
et al., 1975). RNAi depletion of PrimPol did not sensitise cells to UV-C killing (Figure 
6.12), and XP-V cells treated with mock RNAi were only mildly sensitive (Figure 6.12), 
consistent with previous reports (Arlett et al., 1975). However, PrimPol depletion in XP-V 
cells rendered them synergistically sensitive to UV-C irradiation, decreasing the surviving 
fraction up to 4-fold (Figure 6.12). This demonstrates that PrimPol protects XP-V cells 
from UV cytotoxicity, and operates in a damage tolerance pathway that is non-epistatic 
with Pol ". 
 
6.6. PrimPol associates with chromatin at discrete foci following 
nucleotide deprivation  
UV-C irradiation of cells is a potent inducer of replication fork stalling due to the physical 
blockage the UV photoproducts present to the replicative DNA polymerases. Replication 
forks can also stall in the absence of physical blockage, by inhibition of DNA replication 
enzymes. Hydroxyurea (HU) inhibits ribonucleotide reductase (RNR) and as a result 
lowers the cellular pool of dNTPs, thus stalling DNA replication (Young and Hodas, 1964; 
Moore, 1969). It was next investigated whether treatment of cells with HU resulted in the 
re-distribution of PrimPol, as previously observed for UV-C irradiation. Flp-In T-REx-293 
cells over-expressing recombinant PrimPol were treated with 10 mM HU for 6 hours, 
before detergent extraction and immunofluorescent analysis. As observed with UV-C 
irradiation, PrimPol re-localised to sub-nuclear detergent-resistant foci after HU 
treatment (Figure 6.13a). These foci were also co-incident with focal RPA (Figure 6.13a). 
Separation of HU treated cells into Triton X-100 soluble and insoluble fractions revealed 
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that HU treatment did not cause up-regulation of PrimPol protein, but rather PrimPol re-
localised from the soluble to the insoluble fraction (Figure 6.13b), presumably interacting 
with DNA. These data suggest PrimPol may not only play a role in the tolerance of UV-C 
induced DNA damage, but could also function during nucleotide deprivation, this is 
discussed further below. 
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6.7. Discussion  
Exposure of cells to UV-C light results in the formation of DNA damage. Covalent 
linkages form between adjacent pyrimidines that distort the DNA double helix, and if not 
repaired, pose a severe block to the DNA replication and transcription machineries. 
PrimPol, a novel primase-polymerase, re-localises within human cells following UV-C 
irradiation, tightly associating with chromatin at a number of discrete foci. These foci 
occur in cells undergoing DNA replication and may represent replication forks stalled at 
UV photoproducts. In line with this, human cells depleted of PrimPol contain more 
chromatin-bound RPA and an over-activated intra-S checkpoint following UV-C 
irradiation, indicative of increased replication fork stalling. These data are consistent with 
PrimPol functioning in the tolerance of UV-C induced DNA damage. An initial hypothesis 
was that PrimPol was required for re-initiating DNA synthesis on the leading strand 
downstream of the DNA lesion using its primase activity, a phenomenon demonstrated in 
E. coli (Heller and Marians, 2006; Yeeles and Marians, 2012) and suggested to occur in 
eukaryotes (Lehmann, 1972; Lopes et al, 2006, Elvers et al, 2011). However, work in the 
Doherty lab has demonstrated that human PrimPol, like the two diverse PrimPol 
homologues in Chapter 4, could catalyse TLS of UV photoproducts in vitro. PrimPol 
could extend from mismatched termini opposite a CPD and more strikingly, bypass a 6-4 
photoproduct, which it did in an error-prone manner (Stanislaw Jozwiakowski and Aidan 
Doherty, unpublished; Chapter 4). Thus two mechanisms of PrimPol-dependant bypass 
of UV photoproducts can be envisaged, one in which PrimPol re-primes DNA synthesis 
downstream of the DNA lesion and a second in which PrimPol performs TLS of the lesion 
(Figure 6.14).  
 
6.9.1. UV-induced foci formation and chromatin association of PrimPol 
The assembly of proteins into discrete foci on chromatin following exposure to UV-C 
radiation is a common feature among numerous DNA damage signalling, repair, and 
tolerance enzymes, including TLS polymerases (Kannouche et al., 2001, 2003; Tissier et 
al., 2004; Ogi et al., 2005; Andersen et al., 2011). Foci often represent locations of UV-C 
induced DNA damage, and in the case of Y-family polymerases, represent replication 
factories where DNA replication has stalled at a UV photoproduct (Kannouche et al., 
2001, 2003; Tissier et al., 2004; Ogi et al., 2005). This remains to be determined for 
PrimPol; however, focal accumulations of PrimPol do represent a substantial number of 
PrimPol molecules concentrated into a number of discrete locations, which most likely 
correspond to ‘active’ PrimPol. This is supported by the correlation of DNA damage 
induced PrimPol foci and the sensitivities observed for PrimPol-/- chicken cells to 
particular DNA damaging agents (Julie Bianchi and Aidan Doherty, unpublished). PrimPol 
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foci were observed following treatment of cells with agents known to cause replication 
fork stalling, such as UV-C radiation and HU, and further work in the Doherty lab showed 
both the “UV mimetic” 4-nitroquinoline 1-oxide (4NQO) and the alkylating agent MMS 
also triggered focal accumulation of PrimPol (Julie Bianchi and Aidan Doherty, 
unpublished). Furthermore, PrimPol foci were not observed following ionising radiation, 
which does not induce replication stalling and actually prevents DNA synthesis by 
inhibiting DNA initiation (Lamb et al., 1989). UV-dependant PrimPol foci occurred in ~35 
% of cells at higher fluencies and these likely corresponded to S-phase cells, additionally 
PrimPol foci partially co-localised with detergent-resistant focal RPA. Although RPA is an 
essential component of NER (Araujo et al., 2000), detergent-resistant RPA foci largely 
represent RPA-coated single-stranded DNA present at stalled replication forks and not 
the much smaller RPA complexes formed at NER intermediates (Despras et al., 2010; 
Pathania et al., 2011; Diamant et al., 2012). Together, these data would be consistent 
with PrimPol associating with chromatin at sites of replication fork stalling following 
exposure of cells to UV-C irradiation. Future studies could determine whether PrimPol 
foci represent bona fide replication factories, as with Y-family polymerases, by analysing 
co-localisation with PCNA or DNA replication foci. In addition, mapping of the PrimPol 
domain(s) required for focus formation would prove insightful, and testing whether focus 
formation is dependant upon other proteins, such as Rad6/Rad18 dependant mono-
ubiquitination of PCNA or interaction with Y-family polymerases such as REV1. 
 
6.9.2. PrimPol mediated DNA damage tolerance in normal and XP-V cells 
RNAi-mediated depletion of PrimPol in normal human fibroblasts led to increased 
chromatin-bound RPA following UV-C irradiation, consistent with more replication fork 
stalling. This is in line with analysis of spread DNA fibres from UV-C irradiated PrimPol-/- 
chicken cells, which demonstrated that PrimPol was required for replication of UV 
damaged DNA in vivo (Julie Bianchi and Aidan Doherty, unpublished). UV-C irradiation of 
PrimPol depleted fibroblasts also led to over-activation of the intra-S checkpoint kinase 
Chk1, which is consistent with PrimPol functioning in the tolerance of UV-C induced 
DNA damage. XP-V cells lacking functional Pol η, required to accurately bypass UV 
photoproducts, show enhanced activation of Chk1 following UV-C irradiation 
(Bomgarden et al., 2006 Despras et al., 2010). Similarly, cells depleted of Pol κ, which is 
known to bypass non-UV bulky adducts, were reported to have over-activation of Chk1 
following treatment with benzo(#)pyrene-dihydrodiol epoxide (Bi et al., 2005). A defect in 
NER, however, which is required to remove UV photoproducts from DNA, results in no 
further activation of the intra-S checkpoint following UV-C irradiation (Bomgarden et al., 
2006). Although the over-activation of the intra-S checkpoint observed in PrimPol 
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depleted cells could be accounted for by PrimPol RNAi increasing the proportion of S-
phase cells, various human tumour cell lines treated with PrimPol RNAi show no 
significant pertubation of the cell cycle (Julie Bianchi, Laura Bailey, Aidan Doherty, 
unpublished). Further, cultures of PrimPol-/- chicken cells actually show fewer S-phase 
cells than wild-type cultures (Julie Bianchi and Aidan Doherty, unpublished). 
 
 Despite PrimPol being required for the tolerance of UV-C induced DNA damage, 
depletion of PrimPol did not sensitise normal human fibroblasts to UV-C induced killing. 
This may not be surprising; when considering PrimPol as a TLS polymerase, CPDs are 
efficiently bypassed by Pol η (McCulloch et al., 2004) whilst 6-4 photoproducts, 
accounting for ~30 % of UV-C induced lesions are rapidly repaired by NER (Mitchell et 
al., 1990). When considering PrimPol as a primase required for re-initiation of DNA 
synthesis downstream of a lesion, it would presumably only be required for leading 
strand, (and so ~50 % of) damage tolerance, as Okazaki fragment synthesis by Pol α-
Prim would initiate downstream of lagging strand lesions, as observed in vitro (Svoboda 
and Vos, 1995). PrimPol depletion only rendered cells sensitive to UV-C induced killing in 
the absence of functional Pol η in XP-V cells. This demonstrates PrimPol operates in a 
DNA damage tolerance pathway that is non-epistatic with Pol η, and that loss of both 
these pathways lowers the threshold level of UV photoproducts that cells can tolerate. 
This may be due to the complementary TLS activities of these two polymerases: whilst 
Pol η can bypass CPDs and insert opposite 6-4 photoproducts, PrimPol can bypass 6-4 
photoproducts and extend from CPDs (Johnson et al., 1999 and 2001). Future studies 
could determine PrimPol’s contribution to TLS in vivo, using plasmids containing UV 
photoproducts (Ziv et al., 2012) or antibodies specific to the lesions (Temviriyanukul et 
al., 2012). Determining whether PrimPol contributes to UV-C induced mutagenesis will 
also prove insightful, especially for XP-V patients, in which mutagenesis leads to 
carcinogenesis. 
 
6.9.3. Non UV-induced DNA damage tolerance roles of PrimPol 
In addition to PrimPol’s damage tolerance role following UV-C irradiation, nucleotide 
deprivation by HU treatment, which causes replication fork stalling but in the absence of 
DNA lesions, resulted in PrimPol’s association with chromatin at discrete foci. This is 
also a common feature of Y-family polymerases (Ogi et al., 2005; de Feraudy et al., 
2007), but a role for these enzymes during nucleotide deprivation is not yet fully 
understood. It is conceivable that foci formation following HU treatment could represent 
the polymerases presence at replication factories that are now stalled. Although it has 
been demonstrated that Pol η and the E. coli Y-family polymerases Pol IV and Pol V are 
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required for DNA replication during HU treatments (de Feraudy et al., 2007; Godoy et al., 
2006). In the case of the latter, it was suggested that because these Y-family 
polymerases have much lower Kms for dNTPs than replicative polymerases, they could 
take over DNA replication at times of nucleotide deprivation to prevent replication fork 
collapse (Godoy et al., 2006). In addition to the roles proposed for Y-family polymerases, 
it is also conceivable that PrimPol may be attempting to re-initiate DNA synthesis 
downstream of the stalled fork through its primase activity. Further studies could 
elucidate whether PrimPol is required for DNA replication or restart following HU 
treatment.  
 
 PrimPol depletion in normal human fibroblasts led to a significant growth detect, 
indicating a role for PrimPol in normal cell proliferation. Further work in Aidan Doherty’s 
laboratory demonstrated that this proliferative defect was independent of PrimPol’s 
mitochondrial function using cells depleted of their mitochondrial DNA (Laura Bailey and 
Aidan Doherty, unpublished), suggesting that it is PrimPol’s nuclear role that is 
responsible. It is also intriguing that PrimPol depletion in XP-V cells resulted in a greater 
proliferative defect. Consistent with a role for PrimPol in an unperturbed S-phase, 
analysis of spread DNA fibres from PrimPol-/- chicken cells showed that overall 
replication fork speeds were reduced in these cells (Julie Bianchi and Aidan Doherty, 
unpublished). A role for Pol η during unperturbed DNA replication has been described, 
showing that it is required for replication of chromosomal fragile sites (Rey et al., 2009). 
Many endogenous processes can result in DNA modifications, whether DNA lesions or 
structures, which impede replication, and it is possible that PrimPol is involved in the 
tolerance of these modifications.  
 
6.9.4. PrimPol – a TLS polymerase or primase, or perhaps both? 
One important question underlying PrimPol’s role in damage tolerance is whether 
PrimPol functions as a TLS polymerase, or a primase, or perhaps both (Figure 6.14). Re-
initiation of DNA synthesis downstream of a DNA lesion was demonstrated in E. coli to 
be an inherent property of the replisome, being dependant on the replicative DnaG 
primase (Yeeles and Marians, 2012). Similarly, electron micrographs of DNA replicated in 
UV irradiated S. cerevisiae show single-stranded gaps present behind replication forks, 
consistent with re-priming events (Lopes et al., 2006). Yeast, however, lack an 
identifiable PrimPol homologue, suggesting Pol α-Prim is responsible. Re-priming occurs 
on the lagging strand of DNA replication by Pol α-Prim, and is inherently DNA damage 
tolerant due to the discontinuous nature of Okazaki fragment synthesis (Svoboda and 
Vos, 1995). Pol α-Prim is therefore already present at the replication fork, and upon the 
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replisome encountering a DNA lesion on the leading strand and the uncoupling of leading 
and lagging strand synthesis occurs, it would seem likely that Pol α-Prim would be 
responsible for this leading strand re-initiation on the unwound single-stranded DNA. It 
could be speculated that PrimPol may provide a more flexible option perhaps, being 
capable of a number of nucleotidyl transferase activities including TLS, and so may be 
required for re-initiation on particularly challenging templates containing clustered DNA 
damage. But yet again, presumably DNA synthesis would re-initiate downstream of these 
difficult templates.  
 
A further point is that primed single-stranded DNA is required for activation of the 
intra-S checkpoint (MacDougall et al., 2007). The accumulation of newly synthesised 
primers at stalled replication forks, shown to require Pol α-Prim, and their elongation by 
the leading and lagging strand polymerases contributes to the activation of Chk1 in 
Xenopus egg extracts (Van et al., 2010). Therefore, if PrimPol was required to synthesise 
these primers at stalled replication forks, in an attempt to re-initiate DNA synthesis, this 
would be expected to result in reduced Chk1 activation in UV irradiated PrimPol 
depleted cells. However, this was not the case, as an increase in Chk1 activation was 
observed. Additionally, PrimPol-/- chicken cells were just as capable as wild-type cells in 
converting newly synthesised small molecular weight DNA into large molecular weight 
DNA following UV-C irradiation (Julie Bianchi and Aidan Doherty, unpublished). This is 
consistent with these cells having no defect in filling single-stranded DNA gaps that 
encompass UV photoproducts, which are created by re-priming events occurring 
downstream of the DNA lesion. This again, suggests PrimPol is not required for re-
priming downstream of a replication blocking lesion. On the other hand, evidence is yet 
to be obtained of PrimPol-dependant TLS of UV photoproducts in vivo. PrimPol 
preferentially incorporates T opposite the 3’ T of a T-T 6-4 photoproduct, and C or G 
opposite the 5’ T (Chapter 4; Stanislaw Jozwiakowski and Aidan Doherty, unpublished). 
Bypass of 6-4 photoproducts in vivo has been reported to be largely error-free, although 
the most frequent mis-insertion was reported to be T opposite the 3’ T (Yoon et al., 
2010a; Szuts et al., 2008; Hendel et al., 2008, Hirota et al., 2010), which could be 
PrimPol-dependant. Further experiments are required to clarify the in vivo role of PrimPol 
in the tolerance of UV-C induced DNA damage. 
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Chapter 7 
 
Towards the identification of human PrimPol protein 
partners 
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7.1. Introduction 
Protein-protein interactions play a fundamental role in biological processes. Among the 
plethora of examples are the network of proteins required to propagate the eukaryotic 
replication fork (Johnson and O’Donnell, 2005) and the protein complexes responsible 
for repairing DNA damage (Hoeijmakers, 2001). Protein-protein interactions often play 
important roles in regulating the activity of enzymes, and this is true of both DNA 
polymerases and primases (Kelman et al., 1998; Frick and Richardson, 2001). PrimPol is 
a novel primase-polymerase present in the nucleus and mitochondrion of human cells 
(Chapter 3). Before the discovery of PrimPol’s role in DNA damage tolerance (Chapters 4 
and 6) initial attempts to determine the function of this novel enzyme focused on 
identifying its protein partners, which was the aim of this current chapter. The rationale 
was that identifying proteins that interact with PrimPol would highlight the cellular 
pathways in which PrimPol operates, and possibly provide a mechanistic insight into the 
role of this novel enzyme. A number of approaches were adopted to identify PrimPol 
protein partners, with the central method being the affinity purification of PrimPol from 
cultured human cells and analysis of the purifications by mass-spectrometry.  
 
7.2. Identification of in vivo protein partners using the Strep-tag system 
The primary strategy to identify proteins that interact with PrimPol was to purify PrimPol 
from cultured human cells and identify any co-purifying proteins using mass-
spectrometry. To facilitate affinity purification of PrimPol it was decided to express 
PrimPol fused to a Strep-tag, which exploits the high affinity and specific binding 
between streptavidin and its natural ligand biotin (Schmidt et al., 1996). Specifically, the 
eight amino acid long Strep-Tag II (WSHPQFEK) was used, which allows affinity 
purification with the streptavidin derivative Strep-Tactin and specific elution with 
desthiobiotin (Schmidt et al., 1996; Voss and Skerra, 1997; Korndörfer and Skerra, 2002). 
Affinity purified Strep-tagged PrimPol and co-purifying proteins could then be resolved 
by SDS-PAGE and analysed by mass-spectrometry (Figure 7.1). 
 
7.2.1. Over-expressed PrimPol was initially degraded 
The Flp-In T-REx system was used to generate a stable cell line with inducible 
expression of Strep-tagged PrimPol. The PrimPol cDNA was cloned without a stop 
codon in frame with tandem Flag and Strep-Tag II epitopes into an inducible expression 
vector, generating the construct pcDNA5/FRT/TO:PrimPol-Flag-Strep-Tag II. This was 
then used to make a stable inducible cell line in HEK-293 cell derivates (Flp-In T-REx-293 
!"!#$%&'()((
*+,,#,-./012*.013(+4+53,6,(
73,+0.(812*(/.55,(.9-1.,,64:(
!01.-#0+::.;(-120.64(
!"#$%#<+/=4(
!"#$%#<+:(>>(
>40.1+/=4:(-120.64,(
?24#640.1+/=4:(
-120.64,(
@64;(
A+,B(
'5C0.(
;.,0B62D62=4(
!"#$%&'()*)'+,-&./0,'12&%2"&3'14'!"#$%56/#'/78"69':$%";,/018'.&6-1<)'
<B.(-120.64(28(640.1.,0(6,(.9-1.,,.;(64(BC*+4(/.55,(8C,.;(02(+(!"#$%#<+:(>>E(73,+0.(6,(-1.-+1.;(
812*( 0B.,.( /.55,( +4;( +--56.;( 02( !"#$%#<%F<>?( 1.,64G( HB6/B( ,.5./=I.53( D64;,( 0B.( !"#$%#<+:( >>(
H60B(B6:B(+J4603E(<B6,(6**2D656,.,(0B.(-120.64(8C,.;(02(0B.(!"#$%#<+:(>>(+4;(+,,2/6+0.;(-120.64(
/2*-5.9.,G(HB65,0( 424#640.1+/=4:(-120.64,(H655( D.(H+,B.;( +H+3E( !-./6K/+553( D2C4;(-120.64,(
/+4(0B.4(D.(.5C0.;(C,64:(;.,0B62D62=4(+4;(1.5.+,.;(-120.64(/2*-5.9.,(1.,25I.;(D3(!"!#$%&'(
+4;(+4+53,.;(D3(*+,,#,-./012*.013E(
! 113!
cells) (described in section 5.2.1), generating a cell line with doxycycline-inducible 
expression of PrimPol fused to a carboxyl-terminal Flag and Strep-Tag II (PrimPolFlagStrep). 
 
Although these stable, inducible cell lines eventually worked as desired (Chapters 
5 and 6), they were initially problematic, and this affected the affinity purification process. 
Western blot analysis of lysates prepared from cells grown in the presence of 
doxycycline revealed that over-expressed PrimPol was largely degraded, with very little 
full-length PrimPol being detected (Figure 7.2a and b). Further, no endogenous PrimPol 
was detected (Figure 7.2a and b). This is possibly due to leaky expression of 
recombinant PrimPol due to trace amount of tetracycline in the cell media, which is 
having a dominant negative affect resulting in the degradation of endogenous PrimPol. 
Cell lines were remade selecting both clonal and pooled populations, and additional cell 
lines expressing HA-tagged PrimPol were generated, but the same result was observed 
(not shown). Expression conditions were optimised with this caveat, and cells grown in 
the presence of 10 ng/ml doxycycline for 24 hours gave the most promising expression 
(Figure 7.2a and b). Despite the high level of degradation observed in whole cell lysates, 
Western blot analysis of mitochondrial lysates revealed a significant amount of full-length 
over-expressed PrimPol, with no detectable degradation products (Figure 7.2c), and so it 
was decided to proceed with the affinity purification. 
 
7.2.2 Affinity purification of Strep-tagged PrimPol from whole cell lysate 
As PrimPol is localised to both nuclei and mitochondria, the goal was to perform affinity 
purification from these two compartments, but first, a preliminary affinity purification from 
whole cell extract was attempted. Flp-In T-REx-293 cells engineered for inducible 
expression of Strep-tagged PrimPol were grown in the presence or absence of 10 ng/ml 
doxycycline for ~24 hours and then harvested, with a ~1 g cell pellet obtained for both 
the induced and uninduced cultures. The soluble whole cell lysate was prepared and 
Strep-Tactin resin added. The mixture was then applied to a gravity flow column and 
washed extensively before successive elutions with desthiobiotin. Western blot analysis 
shows that full-length over-expressed PrimPol and various truncations were enriched in 
the elutions from the induced sample, both in comparison to the input, but also to the 
non-induced sample, indicating affinity purification of PrimPol was successful (Figure 
7.3a). Elutions 2 and 3 were selected from the induced and non-induced and resolved on 
a gradient SDS-polyacrylamide gel and stained with colloidal Coomassie (Figure 7.3b), 
and although no obvious difference was visible, it was decided to analyse these 
purification by mass-spectrometry. Whole lane gel extraction was performed and 
samples were analysed in collaboration with Mark Skehel (CRUK, Clare Hall). 
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7.2.3. Mass-spectrometry analysis of Strep-tagged PrimPol purifications 
The proteins identified in the mass-spectrometry analysis were ranked according to 
percentage of total spectra in the induced sample, and the fold enrichment calculated for 
each. A large set of proteins (1249) was identified, of these ~550 were present only in the 
induced sample and a further 65 showed a 3 or more-fold enrichment, with PrimPol 
having a 20-fold enrichment. Input of these proteins into the Database of Annotation, 
Visualisation, and Integrated Discovery (DAVID) (Dennis et al., 2003; Huang et al., 2008) 
clustered these proteins into a number of functionally related groups (Figure 7.4). 
Consistent with the dual localisation of PrimPol, two of the predominant groups were 
nuclear and mitochondrial proteins. A large proportion of DNA and nucleotide binding 
proteins were also present, and more specifically some proteins involved in DNA 
replication and repair, such as some RPA and MCM subunits. In contrast, no 
mitochondrial replication enzymes were present, although mtSSB was present below the 
3-fold enrichment cut-off. Core mitochondrial nucleoid components were present, such 
as ATAD3A and PDIP2. One ominous hit was the 22-fold enrichment of streptavidin in 
the induced sample, suggesting contamination of this sample with Strep-Tactin resin. 
The mass-spectrometry data was preliminary and so in-depth analysis would be 
superfluous, further experiments need to be performed with more stringency to increase 
the likelihood of identifying a PrimPol protein partner. 
 
7.2.4 Validating potential protein partners - RPA and mtSSB co-purify with 
PrimPol from human cells 
To validate the potential PrimPol interacting proteins from the preliminary mass-
spectrometry analysis, small-scale affinity purifications of Strep-tagged PrimPol from 
whole cell lysate were performed and analysed by Western blot. It was at this time that it 
became apparent that over-expressed PrimPol was no longer being degraded. Following 
addition of doxycycline a predominant species of ~69 kDa was detected by Western blot 
analysis with an anti-PrimPol antibody (Figure 7.5), and furthermore, endogenous 
PrimPol was also detected (Figure 7.5). These cells were the same as previously used 
when PrimPol degradation was visible, except these cells were a higher passage. Strep-
tagged PrimPol was largely depleted from the soluble cell lysate following addition of the 
Strep-Tactin resin, and was successfully eluted using desthiobiotin (Figure 7.5). Very little 
Strep-tagged PrimPol was visible in the non-induced lysate, although leaky expression 
was observed (Figure 7.5). Analysis of the affinity purification with antibodies for RPA 
subunits 1 and 2, and the mitochondrial equivalent mtSSB, all gave specific bands in the 
elutions (Figure 7.5), suggesting PrimPol may associate with these proteins.  ATAD3, a 
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mitochondrial membrane associated ATPase and core nucleoid component, was also 
detected in the elutions, however ATAD3 did appear to bind to the Strep-tactin resin in 
the non-induced sample (Figure 7.5). Other proteins were probed for, such as MCM2, 
PCNA, and PARP, but these were not detected in the elutions. In addition, proteins that 
were not identified in the mass-spectrometry analysis but were likely candidates for 
interaction, such as the mitochondrial replicase Pol γ and helicase Twinkle, were probed 
for but again no co-elution was observed (Figure 7.5 and data not shown). Although the 
preliminary hits obtained from the mass-spectrometry were many, the small-scale 
purifications have validated some of them as proteins that co-purify with PrimPol, such 
as the single-stranded DNA binding proteins RPA and mtSSB. It remains to be 
determined whether these interactions are protein-protein or DNA-mediated.  
 
7.2.5. PrimPol is phosphorylated in vivo on serine 499 and 501 
In addition to identifying potential protein partners, mass-spectrometry can also be used 
to identify post-translational modifications. In the early stages of PrimPol characterisation 
it was noted that PrimPol resolved as a doublet by SDS-PAGE. Therefore, to test 
whether this doublet was due to the common post-translational modification of 
phosphorlyation, Strep-tagged PrimPol was affinity purified and treated with lambda 
phosphatase in the presence or absence of a phosphatase inhibitor cocktail. Affinity 
purified PrimPol protein resolved as a doublet and addition of lamda phosphatase led to 
a significant reduction of the upper band, which was specific on phosphatase activity, 
indicating that PrimPol was phosphorylated in vivo (Figure 7.6a). Thus, during mass-
spectrometry analysis of affinity purified Strep-tagged PrimPol (section 7.2.2), the 
phosphorylation site(s) was investigated. PrimPol was phosphorylated on serine residues 
499 and 501 located at the carboxyl-terminus of the protein (Figure 7.6b). Further 
investigation into the significance of these phosphorylations will no doubt impact upon 
our understanding of this novel enzyme. 
 
7.3. Identification of potential protein partners in vitro using recombinant 
candidate proteins 
In addition to the affinity purification and mass-spectrometry strategy, various other 
approaches were tried to identify PrimPol protein partners. One of which was a 
candidate approach in which proteins were selected that are likely to interact with 
PrimPol and the interaction tested in vitro using far-Western slot blot analysis with 
recombinant proteins. Components of the mitochondrial replisome were likely 
candidates and the mtDNA replicase Pol γ was first tested.  
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7.3.1 Purification of recombinant PolG2 produced in E. coli 
Pol γ exists as a heterotrimer of one catalytic subunit (PolG1) and two accessory 
subunits (PolG2) (Kaguni, 2004). Over-expression and purification of recombinant human 
PolG2 has been reported previously in E. coli and was shown to be a single-step 
procedure (Di Re et al., 2009), unlike the more complex preparation of the catalytic 
subunit (Lee et al., 2009). For this reason, initial efforts focused on the accessory PolG2 
subunit. A culture of E. coli B834s transformed with an expression vector encoding 
human PolG2 with an amino-terminal 10-histidine tag (pRUN:POLG2, Table 2.5) (gift 
from Ian Holt, MRC, Cambridge) (Di Re et al., 2009) was grown until exponential phase 
and induced for expression by addition of 0.6 mM IPTG and grown overnight at 25 oC. 
Soluble lysate was prepared from these cells and subjected to Ni2+-NTA agarose affinity 
chromatography and the bound proteins eluted by increasing concentrations of 
imidazole. Recombinant human PolG2 was purified to homogeneity in this single-step, 
visible by SDS-PAGE analysis as a protein with a relative mass of ~50 kDa in the 300 
mM imidazole elution (Figure 7.7). 
 
7.3.2. PrimPol interacts with the mtDNA replicase Pol γ in vitro 
Recombinant PolG2 was then used in Far-Western blot analysis. Increasing 
concentrations of recombinant human PolG2 and recombinant human PrimPol (gift from 
Julie Bianchi, Doherty Lab) (Figure 7.8a) were slot-blotted onto a membrane and probed 
with the other recombinant protein followed by the corresponding antibody. PolG2 could 
be detected using recombinant PrimPol and likewise, PrimPol could be detected using 
recombinant PolG2 (Figure 7.8b), confirming an in vitro interaction between these two 
proteins. This potential interaction between PrimPol and the mtDNA replicase was 
investigated further using recombinant human PolG1 (gift from Whitney Yin, University of 
Austin, Texas). Increasing concentrations of PolG1 and as a negative control the 
bacterial NHEJ polymerase PolDom (gift from Nigel Brissett, Doherty Lab), were blotted 
onto a membrane and probed with recombinant PrimPol. Whilst PrimPol did not detect 
recombinant PolDom, it did detect PolG1 (Figure 7.8c). Together these data suggest that 
PrimPol does interact with the mtDNA replicase, although further experiments need to be 
performed to determine whether this is the case in vivo.  
 
7.4. Identification of protein partners using the Yeast-Two Hybrid assay 
The yeast two-hybrid assay was also chosen as a method to identify PrimPol interacting 
proteins. This reporter-based assay exploits the modular structure of transcription 
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factors, in particular the S. cerevisiae GAL4 transcriptional activator (Fields and Song, 
1989). The DNA binding domain of the GAL4 protein is expressed as a fusion to protein X 
(bait), and the transcriptional activation domain is expressed as a fusion to protein Y 
(prey). Interaction of protein X and Y results in the recruitment of the basal transcriptional 
machinery to the promoters of a number of reporter genes, thus activating their 
transcription and providing evidence for protein-protein interaction (Fields and Song, 
1989) (Figure 7.9). Initially the yeast-two hybrid assay was to be used in a candidate 
approach, using specific cDNAs in a small-scale study, but the eventual aim was to 
perform a genome-wide screen with a human cDNA library. 
 
7.4.1. PrimPol carboxyl-terminal containing the UL52 zinc finger auto-activates 
The PrimPol cDNA was cloned into the yeast-two hybrid vector pGBKT7, creating the 
construct pGBKT7:PrimPol (gift from Andrew Green, Doherty Lab) (Table 2.10). This 
construct encodes for a PrimPol fusion protein with the GAL4 DNA binding domain. It 
was first tested whether expression of PrimPol in the Y190 S. cerevisiae strain resulted in 
auto-activation of the LacZ and HIS3 reporter genes; LacZ transcription results in 
expression of β-galactosidase and transcription of HIS3 allows growth on media 
containing no histidine. Y190 were co-transformed with pGBKT7:PrimPol and empty 
pACT2, which encodes for the GAL4 transcriptional activation domain, and cells 
containing both plasmids tested for transcription of the reporter genes. Expression of the 
PrimPol-GAL4 binding domain fusion, in the absence of a prey protein, resulted in auto-
activation of both reporter genes; transformants tested positive for β-galactosidase 
activity and were able to grow on media containing 3-AT, a competitive inhibitor of the 
yeast HIS3 gene product (Durfee et al., 1993). Thus, expression of the PrimPol – DNA 
binding domain fusion results in auto-activation, and therefore this fusion protein cannot 
be used in a yeast two-hybrid assay. 
 
To overcome this problem I truncated the PrimPol protein in order to remove the 
residues responsible for auto-activation. Two truncations were generated in total, both 
using PCR methods: one encompassing the AEP domain (1-341) and a second 
encompassing the UL52 domain (370-560) (Figure 7.10a). For expression of the AEP 
domain, complementary primers were designed to introduce a stop codon in the PrimPol 
cDNA truncating the protein at residue 341 (Table 2.11). These primers were used in a 
site-directed mutagenesis PCR reaction with the construct pGBKT7:PrimPol to generate 
the construct pGBKT7:PrimPol 1-341 (Table 2.10). In order to express the UL52 domain 
an inverse deletion PCR was performed. This method uses a primer pair in a “back-to-
back” orientation (opposite to usual PCR) that contain a 5’ phosphate, which allows 
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ligation of the PCR product. A desired sequence can then be deleted by having the 
primers flank this region. Primers were designed (Table 2.11) and an inverse deletion 
PCR performed with pGBKT7-PrimPol in order to remove the sequence corresponding 
to residues 2-369, generating the construct pGBKT7-PrimPol 370-560 (Table 2.10). To 
test whether the PrimPol truncations fused to the GAL4 DNA binding domain result in 
auto-activation of the reporter genes, Y190 S. cerevisae were co-transformed with either 
pGBKT7-PrimPol 1-341 or 370-560 and empty pACT2, and cells containing both 
plasmids were tested for reporter gene transcription. Whilst cells transformed with 
pGBKT7:PrimPol 370-560 construct tested positive for activation of both reporter genes, 
cells transformed with pGBKT7:PrimPol 1-341 did not (Figure 7.10b). These cells did not 
test positive for β-galactosidase activity and were not able to grow on media containing 
3-AT. Thus, the carboxyl-terminus of PrimPol containing the UL52 domain is responsible 
for auto-activation in the yeast-two hybrid assay.  
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7.5. Discussion 
The experiments in this chapter reflect some of the initial attempts to discover the role of 
PrimPol in human cells. It was reasoned that by identifying proteins that interact with 
PrimPol, this would shed light on the cellular pathways in which this novel enzyme 
operates. The central approach adopted in this study was to stably express a Strep-
tagged PrimPol in cultured human cells that could be affinity purified and then co-
purifying proteins could be identified by mass-spectrometry analysis. However, the initial 
attempts documented here were not wholly successful. Far too many proteins were 
detected in the mass-spectrometry analysis indicating that a more stringent affinity 
purification process would be required in future, perhaps purifying PrimPol from a 
specific cellular compartment (nuclei or mitochondria) and using a two-step procedure 
taking advantage of both the Flag and Strep-Tag II epitopes. But even with increased 
stringency, it is not a certainty that PrimPol protein partners would be identified. It is not 
clear how ‘active’ PrimPol may be in an unperturbed cell, and so therefore may not be 
interacting with other proteins to perform its cellular role. It has become clear during the 
work performed in this thesis that PrimPol is involved in the tolerance of DNA damage, 
with a particular focus on DNA damage caused by UV-C irradiation, and so future 
experiments should affinity purify PrimPol from UV-C irradiated cells. Chapter 6 of this 
thesis showed that PrimPol becomes chromatin bound in 30-40 % of cells following 
irradiation with 20-30 J/m2 UV-C, with binding occurring as quickly as 1 hour after 
irradiation; affinity purification of Strep-tagged PrimPol could be performed following a 
similar treatment. In addition, to remove the high level of over-expressed soluble PrimPol 
a chromatin preparation could be performed to enrich ‘active’ PrimPol, which can then 
be affinity purified. This could be done in one of two ways: following the enrichment of 
chromatin, DNA bound proteins could be released with a DNase (Benzonase) treatment 
and then affinity purification performed, or alternatively, a cross-linking approach could 
be applied similar to that used by Kannouche and colleagues in demonstrating Pol η’s 
interaction with mono-ubiquitinated PCNA (Kannouche et al., 2004). Using one of these 
approaches on UV-C irradiated cells could identify PrimPol protein partners and shed 
light on the cellular processes this novel enzyme is involved in. 
 
 Despite the preliminary nature of the potential PrimPol protein partners obtained 
from the affinity purification mass-spectrometry experiment, some of these were re-
produced in small-scale pull-downs. The single-stranded DNA binding proteins RPA and 
mtSSB both specifically co-purified with Strep-tagged PrimPol. Although little functional 
information can be gained from interaction with these two proteins given that single-
stranded DNA binding proteins are involved in almost all DNA metabolic processes 
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(Oakley and Patrick, 2011). An important further experiment is to determine whether 
PrimPol’s co-purification with these proteins is by protein-protein interaction or protein-
DNA interaction. It could prove insightful to test the affect of RPA and mtSSB on 
PrimPol’s catalytic activity in vitro as RPA was shown to be essential for Pol α-Prim-
dependant primer synthesis and Okazaki fragment synthesis on DNA substrates 
(Matsumoto et al., 1990), and also, RPA along with PCNA was shown to promote error-
free bypass of templated 8-oxo-G by a number of DNA polymerases (Maga et al., 2007). 
With PrimPol being implicated in the tolerance of UV-C induced DNA damage (Chapter 
6), one very interesting hit is Pol δ interacting protein of 38 kDa, PDIP38 (also called 
PDIP2). As the name implies, PDIP38 associates with the replicative polymerase Pol δ in 
addition to PCNA (Liu et al., 2003), and is also a core component of mitochondrial 
nucleoids (Cheng et al., 2005). PDIP38 was recently shown to provide a novel link 
between replicative polymerases and TLS polymerases, interacting with and modulating 
the focal accumulation of Pol η (Tissier et al., 2010). It would be interesting to verify 
PrimPol’s potential interaction with PDIP38, and test whether PDIP38 regulates the 
damage tolerance role of PrimPol in human cells.  
 
 Although no components of the mitochondrial replication machinery were 
identified in the preliminary mass-spectrometry analysis, a potential protein-protein 
interaction between PrimPol and the mtDNA replicase was identified using a far Western 
slot blot technique. Further experiments are required to verify this potential interaction, 
however it is interesting to speculate that interaction with Pol γ could allow PrimPol to 
become transiently associated with the mtDNA replisome and perform its yet to be fully 
characterised role in mtDNA metabolism. The yeast two-hybrid assay was also employed 
to identify PrimPol protein partners, however the carboxyl-terminus of PrimPol was found 
to cause auto-activation of the reporter genes. Further experiments could define the 
residues responsible for auto-activation within the carboxyl-terminus and the remainder 
of PrimPol could be used in a yeast-two hybrid assay, or alternatively, a mammalian two-
hybrid could be attempted. 
 
 Protein-protein interactions play a fundamental role in cellular processes, and it is 
highly likely that PrimPol’s interaction with other proteins is critical for its cellular role. 
Although the experiments in this chapter were not wholly successful, they lay the 
groundwork for further studies that could identify PrimPol protein partners. 
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Chapter 8 
 
Conclusion 
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This thesis describes one of the first characterisations of the novel eukaryotic primase-
polymerase PrimPol (also called CCDC111). At the outset of this work no reports were 
published regarding the function of this protein, only an in silico analysis by Iyer and 
colleagues (2005) that identified this protein as a putative member of the AEP 
superfamily. Subsequent unpublished work in the laboratories of Aidan Doherty and 
collaborator Luis Blanco (CBMSO, Madrid) confirmed PrimPol was an active AEP, and 
akin to its bacterial and archaeal counterparts, was a versatile nucleotidyl transferase, 
capable of de novo DNA-dependant DNA/RNA primase and DNA-dependant DNA/RNA 
polymerase activities in vitro. The general aim of this thesis was to elucidate the cellular 
role of this novel enzyme. A two-pronged approach was taken, characterising PrimPol in 
both human cells and the divergent eukaryotic model organism, and important human 
pathogen, the African trypanosome. Together these studies established a role for 
PrimPol in the cellular tolerance of DNA damage. 
 
Whilst humans and most other eukaryotes encode a single PrimPol homologue, 
work detailed in Chapter 3 showed that trypanosomatids, a group of protozoan parasites 
responsible for a number of neglected human diseases, encode two PrimPol-like 
proteins. In the African trypanosome one of these PrimPol homologues, called 
TbPrimPol2, was demonstrated to be essential for cell survival. TbPrimPol2 localised to 
the nuclei of G2/M-phase cells and upon RNAi-mediated depletion, an irreversible cell 
cycle arrest occurred following the bulk of DNA synthesis. This cell cycle arrest 
coincided with the activation of the DNA damage response and was ultimately lethal. It 
was hypothesised that TbPrimPol2 was required for post-replication bypass of 
endogenously occurring DNA lesions, and consistent with this, Chapter 4 demonstrated 
that TbPrimPol2 (and its non essential paralogue TbPrimPol1) was capable of trans-
lesion DNA synthesis in vitro. Both TbPrimPol1 and 2 could synthesise DNA opposite 
lesions that stall replicative DNA polymerases, such as the UV light-induced 6-4 
photoproduct. Taken together, these data are consistent with a novel role for an AEP, in 
that is required for the completion of DNA replication by the post-replicative bypass of 
naturally occurring DNA damage. This also indicates that the mechanism of DNA 
replication in T. brucei has not only diverged with respect to the early steps of initiation, 
but also a downstream process. 
 
The second half of this thesis focused on human PrimPol, with Chapter 5 
detailing that unlike its essential T. brucei homologue, human PrimPol was present in 
both the nucleus and mitochondria of cells. Chapter 6 focused on the role of PrimPol in 
the nucleus and established that human PrimPol was also involved in DNA damage 
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tolerance. PrimPol re-localised in the nucleus following UV-C irradiation and assembled 
into numerous discrete foci tightly associated with chromatin. Preliminary data 
suggested these foci were largely restricted to S-phase cells and may represent 
replication factories stalled at UV photoproducts. RNAi-mediated depletion of PrimPol in 
normal human fibroblasts revealed increased chromatin-bound RPA and over-activation 
of the intra-S checkpoint following UV-C irradiation. This is indicative of increased 
replication fork stalling due to a defect in DNA damage tolerance. RNAi-mediated 
depletion of PrimPol in XP-V patient cells, which are deficient in the major UV 
photoproduct bypass polymerase Pol η, exacerbated the over-activation of the intra-S 
checkpoint following exposure to UV light. Although PrimPol depletion did not render 
normal cells sensitive to UV-C irradiation, it did sensitise XP-V cells, indicating PrimPol 
operates in a DNA damage tolerance pathway independent of Pol η, and that this 
pathway has increased importance in XP-V patient cells. 
 
Although both human PrimPol and the T. brucei homologue TbPrimPol2 are 
implicated in DNA damage tolerance, their cellular role within this pathway may differ. 
TbPrimPol2 is an essential enzyme whilst higher eukaryotic PrimPol is not (Julie Bianchi, 
Laura Bailey, Aidan Doherty, unpublished). It is possible that TbPrimPol2 represents a 
trypanosomatid-specific PrimPol, perhaps required due to some of the novel features of 
trypanosomatid DNA metabolism, and that TbPrimPol1 is in fact performing a similar role 
to human PrimPol in the African trypanosome. In Chapter 3, a minor DNA damage 
response was observed in the nuclei of TbPrimPol1 depleted cells indicating a possible 
nuclear role, although this enzyme did not re-localise into foci following treatment with 
replication fork stalling agents (Lucy Glover and David Horn, unpublished), as observed 
with both TbPrimPol2 and human PrimPol. Although human PrimPol does not have an 
essential role in cell proliferation as demonstrated for TbPrimPol2, a growth defect was 
observed following RNAi of PrimPol in normal human fibroblasts, indicating human 
PrimPol does have a function in unperturbed cells. Although, studies of PrimPol-/- 
chicken cells indicated this defect was in replication fork progression as replication fork 
speeds were slowed in these cells (Julie Bianchi and Aidan Doherty, unpublished), whilst 
TbPrimPol2 depeleted cells show no defect in S-phase progression. Further work is 
required to elucidate the role of this novel primase-polymerase in both human cells and 
the African trypanosome. Regarding TbPrimPol2, it remains to be established what the 
endogenously occurring DNA modification is that requires TbPrimPol2 activity. A 
remaining question of human PrimPol is the in vivo activity of this enzyme, whether 
DNA/RNA priming is relevant to its cellular function or if its DNA/RNA polymerase activity 
that is required, or even both. In vitro experiments with recombinant human PrimPol can 
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begin to determine its preferences of substrate but additional cellular studies would also 
be required. Considering that African trypanosomes depleted of TbPrimPol2 can 
efficiently duplicate the bulk of their genome, this suggests TbPrimPol2 is not functioning 
as a primase, at least in the canonical sense of re-initiating DNA synthesis, as this would 
not be required following bulk DNA synthesis. Given human PrimPol is also present 
within the mitochondrion, future studies should explore the role of PrimPol within this 
essential organelle. It is highly likely that PrimPol would be playing a similar role, and 
deducing the mechanism of PrimPol-dependant DNA damage tolerance may prove 
easier in this small plasmid genome. 
 
Despite the outstanding questions, the work presented in this thesis has 
established the involvement of the novel eukaryotic primase-polymerase PrimPol, in the 
universal mechanism of DNA damage tolerance, from one of the earliest diverging 
eukaryotic organisms to man. 
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Multiple sequence alignment of PrimPol homologues from a broad range of eukaryotic 
species, including trypanosomatid PrimPol1 and PrimPol2 families. 
 
The accession numbers of homologues used are as follows:  
Homo sapien, NP_689896.1; Pan troglodytes, XP_001162592.1; Macaca mulatta, 
XP_001083404.2; Equus caballus, XP_001491218; Canis lupis familiaris, 
XP_532846.3; Monodelphis domestica, XP_001369409; Rattus norvegicus, 
XP_341434.3; Mus musculus, NP_001001184.1; Taeniopygia guttata, 
XP_002190203; Danio rerio, NP_001032455.1; Strongylocentrotus purpuratus, 
XP_785583; Ciona intestinalis, XP_002123260; Monosigna brevicollis, 
XP_001749128; Ricinus communis, XP_002513641; Vitis vinifera, XP_002274252; 
Arabidopsis thaliana, AED96263; Zea Mays, NP_001141209; Oryza sativa japonica 
BAG93719; Batrachochytrium dendrobatidis, EGF82076; Micromonas pusilla, 
XP_003063911; Thalassiosira pseudonana, XP_002287384; Brugia malayi, 
XP_001898035; Ostreococcus tauri, XP_003081466; Cryptosporidium parvum, 
XP_626834; Ixodes scapularis, XP_002402586; Nasonia vitripennis, XP_001603706; 
Pediculus humanus XP_002428759; Apis mellifera XP_001121815; Dictyostelium 
discoideum, XP_646915; Trichomonas vaginalis,XP_001305445 
 
PrimPol1, indicated by (1): Trypanosoma cruzi, XP_812815; Trypanosoma brucei, 
XP_845077; Leishmania major XP_001685728 
 
PrimPol2, indicated by (2): Leishmania major, XP_001686100; Trypanosoma brucei, 
XP_822505.1; Trypanosoma cruzi, XP_819101 
 
Alignment was generated using ClustalW2 (Larkin et al., 2007), TCoffee (Notredame 
et al., 2007), MUSCLE (Edgar, 2004), and edited in JALview (Waterhouse et al., 
2009). Blue shading indicates #40 % sequence identity. !
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